FALSEQ3202412/310001834622http://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://www.global.hayward.com/20240928#AccruedLiabilitiesAndOtherLiabilitiesCurrenthttp://www.global.hayward.com/20240928#AccruedLiabilitiesAndOtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations214203xbrli:sharesiso4217:USDiso4217:USDxbrli:shareshayw:manufacturing_facilityxbrli:purehayw:segmenthayw:classActionhayw:votehayw:incentivePlan00018346222024-01-012024-09-2800018346222024-10-2500018346222024-09-2800018346222023-12-3100018346222024-06-302024-09-2800018346222023-07-022023-09-3000018346222023-01-012023-09-300001834622us-gaap:CommonStockMember2023-12-310001834622us-gaap:AdditionalPaidInCapitalMember2023-12-310001834622us-gaap:TreasuryStockCommonMember2023-12-310001834622us-gaap:RetainedEarningsMember2023-12-310001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001834622us-gaap:RetainedEarningsMember2024-01-012024-03-3000018346222024-01-012024-03-300001834622us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-300001834622us-gaap:CommonStockMember2024-01-012024-03-300001834622us-gaap:TreasuryStockCommonMember2024-01-012024-03-300001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-300001834622us-gaap:CommonStockMember2024-03-300001834622us-gaap:AdditionalPaidInCapitalMember2024-03-300001834622us-gaap:TreasuryStockCommonMember2024-03-300001834622us-gaap:RetainedEarningsMember2024-03-300001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-3000018346222024-03-300001834622us-gaap:RetainedEarningsMember2024-03-312024-06-2900018346222024-03-312024-06-290001834622us-gaap:AdditionalPaidInCapitalMember2024-03-312024-06-290001834622us-gaap:CommonStockMember2024-03-312024-06-290001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-312024-06-290001834622us-gaap:CommonStockMember2024-06-290001834622us-gaap:AdditionalPaidInCapitalMember2024-06-290001834622us-gaap:TreasuryStockCommonMember2024-06-290001834622us-gaap:RetainedEarningsMember2024-06-290001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-2900018346222024-06-290001834622us-gaap:RetainedEarningsMember2024-06-302024-09-280001834622us-gaap:AdditionalPaidInCapitalMember2024-06-302024-09-280001834622us-gaap:CommonStockMember2024-06-302024-09-280001834622us-gaap:TreasuryStockCommonMember2024-06-302024-09-280001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-302024-09-280001834622us-gaap:CommonStockMember2024-09-280001834622us-gaap:AdditionalPaidInCapitalMember2024-09-280001834622us-gaap:TreasuryStockCommonMember2024-09-280001834622us-gaap:RetainedEarningsMember2024-09-280001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-280001834622us-gaap:CommonStockMember2022-12-310001834622us-gaap:AdditionalPaidInCapitalMember2022-12-310001834622us-gaap:TreasuryStockCommonMember2022-12-310001834622us-gaap:RetainedEarningsMember2022-12-310001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-3100018346222022-12-310001834622us-gaap:RetainedEarningsMember2023-01-012023-04-0100018346222023-01-012023-04-010001834622us-gaap:AdditionalPaidInCapitalMember2023-01-012023-04-010001834622us-gaap:CommonStockMember2023-01-012023-04-010001834622us-gaap:TreasuryStockCommonMember2023-01-012023-04-010001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-04-010001834622us-gaap:CommonStockMember2023-04-010001834622us-gaap:AdditionalPaidInCapitalMember2023-04-010001834622us-gaap:TreasuryStockCommonMember2023-04-010001834622us-gaap:RetainedEarningsMember2023-04-010001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-0100018346222023-04-010001834622us-gaap:RetainedEarningsMember2023-04-022023-07-0100018346222023-04-022023-07-010001834622us-gaap:AdditionalPaidInCapitalMember2023-04-022023-07-010001834622us-gaap:CommonStockMember2023-04-022023-07-010001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-022023-07-010001834622us-gaap:CommonStockMember2023-07-010001834622us-gaap:AdditionalPaidInCapitalMember2023-07-010001834622us-gaap:TreasuryStockCommonMember2023-07-010001834622us-gaap:RetainedEarningsMember2023-07-010001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-0100018346222023-07-010001834622us-gaap:RetainedEarningsMember2023-07-022023-09-300001834622us-gaap:AdditionalPaidInCapitalMember2023-07-022023-09-300001834622us-gaap:CommonStockMember2023-07-022023-09-300001834622us-gaap:TreasuryStockCommonMember2023-07-022023-09-300001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-022023-09-300001834622us-gaap:CommonStockMember2023-09-300001834622us-gaap:AdditionalPaidInCapitalMember2023-09-300001834622us-gaap:TreasuryStockCommonMember2023-09-300001834622us-gaap:RetainedEarningsMember2023-09-300001834622us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-3000018346222023-09-300001834622hayw:ResidentialPoolMember2024-06-302024-09-280001834622hayw:ResidentialPoolMember2023-07-022023-09-300001834622hayw:ResidentialPoolMember2024-01-012024-09-280001834622hayw:ResidentialPoolMember2023-01-012023-09-300001834622hayw:CommercialPoolMember2024-06-302024-09-280001834622hayw:CommercialPoolMember2023-07-022023-09-300001834622hayw:CommercialPoolMember2024-01-012024-09-280001834622hayw:CommercialPoolMember2023-01-012023-09-300001834622hayw:FlowControlMember2024-06-302024-09-280001834622hayw:FlowControlMember2023-07-022023-09-300001834622hayw:FlowControlMember2024-01-012024-09-280001834622hayw:FlowControlMember2023-01-012023-09-300001834622country:US2024-06-302024-09-280001834622country:US2023-07-022023-09-300001834622country:US2024-01-012024-09-280001834622country:US2023-01-012023-09-300001834622country:CA2024-06-302024-09-280001834622country:CA2023-07-022023-09-300001834622country:CA2024-01-012024-09-280001834622country:CA2023-01-012023-09-300001834622srt:EuropeMember2024-06-302024-09-280001834622srt:EuropeMember2023-07-022023-09-300001834622srt:EuropeMember2024-01-012024-09-280001834622srt:EuropeMember2023-01-012023-09-300001834622hayw:RestOfWorldMember2024-06-302024-09-280001834622hayw:RestOfWorldMember2023-07-022023-09-300001834622hayw:RestOfWorldMember2024-01-012024-09-280001834622hayw:RestOfWorldMember2023-01-012023-09-300001834622hayw:TotalInternationalMember2024-06-302024-09-280001834622hayw:TotalInternationalMember2023-07-022023-09-300001834622hayw:TotalInternationalMember2024-01-012024-09-280001834622hayw:TotalInternationalMember2023-01-012023-09-300001834622hayw:FirstLienTermFacilityDueMay282028Memberhayw:TermLoanMember2024-09-280001834622hayw:FirstLienTermFacilityDueMay282028Memberhayw:TermLoanMember2023-12-310001834622hayw:IncrementalBFirstLienTermFacilityDueMay282028Memberhayw:TermLoanMember2024-09-280001834622hayw:IncrementalBFirstLienTermFacilityDueMay282028Memberhayw:TermLoanMember2023-12-310001834622hayw:ABLRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-09-280001834622hayw:ABLRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-12-310001834622hayw:FirstLienTermFacilityMemberhayw:IncrementalTermLoanBMember2024-04-012024-04-300001834622hayw:FirstLienTermFacilityMemberhayw:IncrementalTermLoanBMember2024-04-300001834622hayw:FirstLienTermFacilityDueMay282028Memberhayw:TermLoanMembersrt:MinimumMember2023-03-312023-04-300001834622hayw:FirstLienTermFacilityDueMay282028Memberhayw:TermLoanMembersrt:MaximumMember2023-03-312023-04-300001834622hayw:FirstLienTermFacilityDueMay282028Memberhayw:TermLoanMember2023-05-222023-05-220001834622us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2024-09-280001834622us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2023-12-310001834622us-gaap:InterestRateSwapMember2024-09-280001834622hayw:ExistingSwapAgreementsMember2024-09-280001834622us-gaap:ForeignExchangeContractMember2024-06-302024-09-280001834622us-gaap:ForeignExchangeContractMember2023-07-022023-09-300001834622us-gaap:ForeignExchangeContractMember2024-01-012024-09-280001834622us-gaap:ForeignExchangeContractMember2023-01-012023-09-300001834622us-gaap:OtherCurrentAssetsMemberus-gaap:CashFlowHedgingMember2024-09-280001834622us-gaap:OtherNoncurrentAssetsMemberus-gaap:CashFlowHedgingMember2024-09-280001834622hayw:AccruedExpensesAndOtherLiabilitiesCurrentMemberus-gaap:CashFlowHedgingMember2024-09-280001834622us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CashFlowHedgingMember2024-09-280001834622us-gaap:OtherCurrentAssetsMemberus-gaap:CashFlowHedgingMember2023-12-310001834622us-gaap:OtherNoncurrentAssetsMemberus-gaap:CashFlowHedgingMember2023-12-310001834622hayw:AccruedExpensesAndOtherLiabilitiesCurrentMemberus-gaap:CashFlowHedgingMember2023-12-310001834622us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CashFlowHedgingMember2023-12-310001834622us-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2024-09-280001834622us-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2024-09-280001834622hayw:AccruedExpensesAndOtherLiabilitiesCurrentMemberus-gaap:ForeignExchangeContractMember2024-09-280001834622us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2024-09-280001834622us-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-12-310001834622us-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-12-310001834622hayw:AccruedExpensesAndOtherLiabilitiesCurrentMemberus-gaap:ForeignExchangeContractMember2023-12-310001834622us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2023-12-310001834622us-gaap:OtherCurrentAssetsMember2024-09-280001834622us-gaap:OtherNoncurrentAssetsMember2024-09-280001834622hayw:AccruedExpensesAndOtherLiabilitiesCurrentMember2024-09-280001834622us-gaap:OtherNoncurrentLiabilitiesMember2024-09-280001834622us-gaap:OtherCurrentAssetsMember2023-12-310001834622us-gaap:OtherNoncurrentAssetsMember2023-12-310001834622hayw:AccruedExpensesAndOtherLiabilitiesCurrentMember2023-12-310001834622us-gaap:OtherNoncurrentLiabilitiesMember2023-12-310001834622us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMember2024-06-302024-09-280001834622us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMember2023-07-022023-09-300001834622us-gaap:InterestExpenseMember2024-06-302024-09-280001834622us-gaap:InterestExpenseMember2023-07-022023-09-300001834622us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMember2024-01-012024-09-280001834622us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMember2023-01-012023-09-300001834622us-gaap:InterestExpenseMember2024-01-012024-09-280001834622us-gaap:InterestExpenseMember2023-01-012023-09-300001834622us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-280001834622us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-280001834622us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-280001834622us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2024-09-280001834622us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001834622us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001834622us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001834622us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2023-12-310001834622us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-280001834622us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-280001834622us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-280001834622us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2024-09-280001834622us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001834622us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001834622us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001834622us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2023-12-310001834622us-gaap:FairValueInputsLevel1Memberus-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-280001834622us-gaap:FairValueInputsLevel2Memberus-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-280001834622us-gaap:FairValueInputsLevel3Memberus-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-280001834622us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2024-09-280001834622us-gaap:FairValueInputsLevel1Memberus-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001834622us-gaap:FairValueInputsLevel2Memberus-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001834622us-gaap:FairValueInputsLevel3Memberus-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001834622us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2023-12-310001834622us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-09-280001834622us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-280001834622us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001834622us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001834622us-gaap:OperatingSegmentsMemberhayw:NorthAmericaSegmentMember2024-06-302024-09-280001834622us-gaap:OperatingSegmentsMemberhayw:EuropeAndRestOfWorldSegmentMember2024-06-302024-09-280001834622us-gaap:OperatingSegmentsMember2024-06-302024-09-280001834622us-gaap:OperatingSegmentsMemberhayw:NorthAmericaSegmentMember2023-07-022023-09-300001834622us-gaap:OperatingSegmentsMemberhayw:EuropeAndRestOfWorldSegmentMember2023-07-022023-09-300001834622us-gaap:OperatingSegmentsMember2023-07-022023-09-300001834622us-gaap:IntersegmentEliminationMemberhayw:NorthAmericaSegmentMember2024-06-302024-09-280001834622us-gaap:IntersegmentEliminationMemberhayw:EuropeAndRestOfWorldSegmentMember2024-06-302024-09-280001834622us-gaap:IntersegmentEliminationMember2024-06-302024-09-280001834622us-gaap:IntersegmentEliminationMemberhayw:NorthAmericaSegmentMember2023-07-022023-09-300001834622us-gaap:IntersegmentEliminationMemberhayw:EuropeAndRestOfWorldSegmentMember2023-07-022023-09-300001834622us-gaap:IntersegmentEliminationMember2023-07-022023-09-300001834622us-gaap:OperatingSegmentsMemberhayw:NorthAmericaSegmentMember2024-01-012024-09-280001834622us-gaap:OperatingSegmentsMemberhayw:EuropeAndRestOfWorldSegmentMember2024-01-012024-09-280001834622us-gaap:OperatingSegmentsMember2024-01-012024-09-280001834622us-gaap:OperatingSegmentsMemberhayw:NorthAmericaSegmentMember2023-01-012023-09-300001834622us-gaap:OperatingSegmentsMemberhayw:EuropeAndRestOfWorldSegmentMember2023-01-012023-09-300001834622us-gaap:OperatingSegmentsMember2023-01-012023-09-300001834622us-gaap:IntersegmentEliminationMemberhayw:NorthAmericaSegmentMember2024-01-012024-09-280001834622us-gaap:IntersegmentEliminationMemberhayw:EuropeAndRestOfWorldSegmentMember2024-01-012024-09-280001834622us-gaap:IntersegmentEliminationMember2024-01-012024-09-280001834622us-gaap:IntersegmentEliminationMemberhayw:NorthAmericaSegmentMember2023-01-012023-09-300001834622us-gaap:IntersegmentEliminationMemberhayw:EuropeAndRestOfWorldSegmentMember2023-01-012023-09-300001834622us-gaap:IntersegmentEliminationMember2023-01-012023-09-300001834622us-gaap:CorporateNonSegmentMember2024-06-302024-09-280001834622us-gaap:CorporateNonSegmentMember2023-07-022023-09-300001834622us-gaap:CorporateNonSegmentMember2024-01-012024-09-280001834622us-gaap:CorporateNonSegmentMember2023-01-012023-09-300001834622hayw:SouthfieldAndErieMember2023-12-190001834622us-gaap:SubsequentEventMember2024-10-022024-10-020001834622hayw:A2021EquityIncentivePlanMember2021-03-310001834622us-gaap:EmployeeStockOptionMemberhayw:A2021EquityIncentivePlanMember2024-01-012024-09-280001834622us-gaap:RestrictedStockUnitsRSUMemberhayw:A2021EquityIncentivePlanMember2024-01-012024-09-280001834622hayw:PerformanceBasedRestrictedStockUnitsMemberhayw:A2021EquityIncentivePlanMember2024-01-012024-09-280001834622us-gaap:EmployeeSeveranceMember2024-06-302024-09-280001834622us-gaap:EmployeeSeveranceMember2024-01-012024-09-280001834622us-gaap:OneTimeTerminationBenefitsMember2023-12-310001834622us-gaap:OneTimeTerminationBenefitsMember2024-01-012024-09-280001834622us-gaap:OneTimeTerminationBenefitsMember2024-09-280001834622us-gaap:FacilityClosingMember2023-12-310001834622us-gaap:FacilityClosingMember2024-01-012024-09-280001834622us-gaap:FacilityClosingMember2024-09-280001834622us-gaap:OtherRestructuringMember2023-12-310001834622us-gaap:OtherRestructuringMember2024-01-012024-09-280001834622us-gaap:OtherRestructuringMember2024-09-280001834622us-gaap:OneTimeTerminationBenefitsMember2022-12-310001834622us-gaap:OneTimeTerminationBenefitsMember2023-01-012023-09-300001834622us-gaap:OneTimeTerminationBenefitsMember2023-09-300001834622us-gaap:OtherRestructuringMember2022-12-310001834622us-gaap:OtherRestructuringMember2023-01-012023-09-300001834622us-gaap:OtherRestructuringMember2023-09-300001834622hayw:ChlorKingHoldCoLLCMember2024-06-262024-06-260001834622hayw:ChlorKingHoldCoLLCMember2024-06-302024-09-280001834622hayw:ChlorKingHoldCoLLCMember2024-01-012024-09-280001834622hayw:ChlorKingHoldCoLLCMember2024-06-260001834622hayw:ChlorKingHoldCoLLCMember2024-06-262024-09-280001834622hayw:ChlorKingHoldCoLLCMember2024-09-280001834622hayw:ChlorKingHoldCoLLCMemberus-gaap:TradeNamesMember2024-06-262024-06-260001834622hayw:ChlorKingHoldCoLLCMemberus-gaap:TradeNamesMember2024-06-260001834622hayw:ChlorKingHoldCoLLCMemberus-gaap:CustomerRelationshipsMember2024-06-262024-06-260001834622hayw:ChlorKingHoldCoLLCMemberus-gaap:CustomerRelationshipsMember2024-06-260001834622hayw:ChlorKingHoldCoLLCMemberus-gaap:DevelopedTechnologyRightsMember2024-06-262024-06-260001834622hayw:ChlorKingHoldCoLLCMemberus-gaap:DevelopedTechnologyRightsMember2024-06-260001834622hayw:ChlorKingHoldCoLLCMemberus-gaap:NoncompeteAgreementsMember2024-06-262024-06-260001834622hayw:ChlorKingHoldCoLLCMemberus-gaap:NoncompeteAgreementsMember2024-06-260001834622hayw:KevinHolleranMember2024-01-012024-09-280001834622hayw:KevinHolleranMember2024-06-302024-09-280001834622hayw:KevinHolleranMember2024-09-280001834622hayw:EifionJonesMember2024-01-012024-09-280001834622hayw:EifionJonesMember2024-06-302024-09-280001834622hayw:EifionJonesMember2024-09-28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 28, 2024

OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from   to

Commission file number 001-40208
LogoAdded.jpg
Hayward Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
1415 Vantage Park Drive
Suite 400
Charlotte, NC
(Address of Principal Executive
Office)
82-2060643
(I.R.S. Employer Identification No.)

28203
(Zip Code)
(704) 837-8002
Registrants telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $.001 per shareHAYWNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐ 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes  ☒   No  ☐ 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes   ☐     No  

The registrant had outstanding 215,424,560 shares of common stock as of October 25, 2024.


SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q of Hayward Holdings, Inc. (the “Company,” “we” or “us”) contains certain “forward-looking statements” as that term is defined under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to us are based on the beliefs of our management as well as assumptions made by, and information currently available to, us. These statements include, but are not limited to, statements about our strategies, plans, objectives, expectations, intentions, expenditures and assumptions and other statements contained in or incorporated by reference in this Quarterly Report on Form 10-Q that are not historical facts. When used in this document, words such as “may,” “will,” “should,” “could,” “intend,” “potential,” “continue,” “anticipate,” “believe,” “estimate,” “expect,” “plan,” “target,” “predict,” “project,” “seek” and similar expressions as they relate to us are intended to identify forward-looking statements. We believe that it is important to communicate our future expectations to our shareholders, and we therefore make forward-looking statements in reliance upon the safe harbor provisions of the Act. However, there may be events in the future that we are not able to accurately predict or control, and actual results may differ materially from the expectations we describe in our forward-looking statements.
Examples of forward-looking statements include, among others, statements we make regarding: our financial position; business plans and objectives; general economic and industry trends; business prospects; future product development and acquisition strategies; future channel stocking levels; growth and expansion opportunities; operating results; and working capital and liquidity. The forward-looking statements in this Quarterly Report on Form 10-Q are only predictions. We may not achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place significant reliance on our forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of forward-looking statements taken from third-party industry and market reports.
Important factors that could affect our future results and could cause those results or other outcomes to differ materially from those indicated in our forward-looking statements include the following:
• our relationships with and the performance of distributors, builders, buying groups, retailers and servicers who sell our products to pool owners;
• impacts on our business from the sensitivity of our business to seasonality and unfavorable economic and business conditions;
• competition from national and global companies, as well as lower cost manufacturers;
• our ability to develop, manufacture and effectively and profitably market and sell our new planned and future products;
• our ability to execute on our growth strategies and expansion opportunities;
• our exposure to credit risk on our accounts receivable;
• impacts on our business from political, regulatory, economic, trade and other risks associated with operating foreign businesses, including risks associated with geopolitical conflict;
• our ability to maintain favorable relationships with suppliers and manage disruptions to our global supply chain and the availability of raw materials;
• our ability to identify emerging technological and other trends in our target end markets;
• failure of markets to accept new product introductions and enhancements;
• the ability to successfully identify, finance, complete and integrate acquisitions;
• our reliance on information technology systems and susceptibility to threats to those systems, including cybersecurity threats, and risks arising from our collection and use of personal information data;
• regulatory changes and developments affecting our current and future products;
• volatility in currency exchange rates and interest rates;
• our ability to service our existing indebtedness and obtain additional capital to finance operations and our growth opportunities;


• our ability to establish, maintain and effectively enforce intellectual property protection for our products, as well as our ability to operate our business without infringing, misappropriating or otherwise violating the intellectual property rights of others;
• the impact of material cost and other inflation;
• our ability to attract and retain senior management and other qualified personnel;
• the impact of changes in laws, regulations and administrative policy, including those that limit U.S. tax benefits, impact trade agreements and tariffs, or address the impacts of climate change;
• the outcome of litigation and governmental proceedings;
• the impact of product manufacturing disruptions, including as a result of catastrophic and other events beyond our businesses;
• uncertainties related to distribution channel inventory practices and the impact on net sales volumes;
• our ability to realize cost savings from restructuring activities; and
• other factors set forth in the respective “Risk Factors” section of this Quarterly Report on Form 10-Q and of our Annual Report on Form 10-K for the year ended December 31, 2023.         
Many of these factors are macroeconomic in nature and are, therefore, beyond our control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from those described in this Quarterly Report on Form 10-Q as anticipated, believed, estimated, expected, intended, planned or projected. The forward-looking statements included in this Quarterly Report on Form 10-Q are made only as of the date of this report. Unless required by United States federal securities laws, we neither intend nor assume any obligation to update these forward-looking statements for any reason after the date of this Quarterly Report on Form 10-Q to conform these statements to actual results or to changes in our expectations.


HAYWARD HOLDINGS, INC.
Table of Contents
ITEM 2.
Unregistered Sales of Equity Securities and Use of Proceeds
ITEM 5.
ITEM 6.
i


PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
Hayward Holdings, Inc.
Unaudited Condensed Consolidated Balance Sheets
(Dollars in thousands, except per share data)
September 28, 2024December 31, 2023
Assets
Current assets
Cash and cash equivalents$274,184 $178,097 
Short-term investments 25,000 
Accounts receivable, net of allowances of $2,881 and $2,870, respectively
99,932 270,875 
Inventories, net229,363 215,180 
Prepaid expenses15,541 14,331 
Income tax receivable11,634 9,994 
Other current assets18,898 11,264 
Total current assets649,552 724,741 
Property, plant, and equipment, net of accumulated depreciation of $108,726 and $95,917, respectively
164,654 158,979 
Goodwill953,175 935,013 
Trademark736,000 736,000 
Customer relationships, net209,836 206,308 
Other intangibles, net92,479 94,082 
Other non-current assets84,168 91,161 
Total assets$2,889,864 $2,946,284 
Liabilities and Stockholders’ Equity
Current liabilities
Current portion of long-term debt$14,079 $15,088 
Accounts payable73,562 68,943 
Accrued expenses and other liabilities159,709 155,543 
Income taxes payable825 109 
Total current liabilities248,175 239,683 
Long-term debt, net959,906 1,079,280 
Deferred tax liabilities, net239,362 248,967 
Other non-current liabilities69,266 66,896 
Total liabilities1,516,709 1,634,826 
Commitments and contingencies (Note 12)
Stockholders’ equity
Preferred stock, $0.001 par value, 100,000,000 authorized, no shares issued or outstanding as of September 28, 2024 and December 31, 2023
  
Common stock $0.001 par value, 750,000,000 authorized; 244,078,929 issued and 215,412,560 outstanding at September 28, 2024; 242,832,045 issued and 214,165,676 outstanding at December 31, 2023
244 243 
Additional paid-in capital1,089,782 1,080,894 
Common stock in treasury; 28,666,369 and 28,666,369 at September 28, 2024 and December 31, 2023, respectively
(358,125)(357,755)
Retained earnings644,831 580,909 
Accumulated other comprehensive income(3,577)7,167 
Total stockholders’ equity
1,373,155 1,311,458 
Total liabilities, redeemable stock, and stockholders’ equity
$2,889,864 $2,946,284 



See accompanying notes to the unaudited condensed consolidated financial statements.
1

Hayward Holdings, Inc.
Unaudited Condensed Consolidated Statements of Operations
(Dollars in thousands, except per share data)

Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Net sales$227,569 $220,304 $724,531 $713,983 
Cost of sales114,474 114,893 361,770 374,171 
Gross profit113,095 105,411 362,761 339,812 
Selling, general and administrative expense64,509 59,454 187,678 172,057 
Research, development and engineering expense6,449 6,177 18,870 19,027 
Acquisition and restructuring related expense1,145 3,348 2,488 6,220 
Amortization of intangible assets7,576 7,523 21,425 22,777 
Operating income33,416 28,909 132,300 119,731 
Interest expense, net13,209 17,448 48,600 55,939 
Loss on debt extinguishment  4,926  
Other (income) expense, net(705)1,932 (1,989)1,798 
Total other expense12,504 19,380 51,537 57,737 
Income from operations before income taxes20,912 9,529 80,763 61,994 
Provision (benefit) for income taxes4,411 (2,259)16,841 12,343 
Net income$16,501 $11,788 $63,922 $49,651 
Earnings per share
Basic$0.08 $0.06 $0.30 $0.23 
Diluted$0.07 $0.05 $0.29 $0.23 
Weighted average common shares outstanding
Basic215,231,886213,416,502 214,836,643 212,933,763 
Diluted221,436,206220,863,228 221,251,355 220,634,232 











See accompanying notes to the unaudited condensed consolidated financial statements.

2

Hayward Holdings, Inc.
Unaudited Condensed Consolidated Statements of Comprehensive Income
(In thousands)

Three Months Ended
September 28, 2024September 30, 2023
GrossTaxesNetGrossTaxesNet
Net income$16,501 $11,788 
Other comprehensive income (loss):
Foreign currency translation adjustments6,605  6,605 (5,235) (5,235)
Net change on cash flow hedges
(13,914)3,478 (10,436)961 (240)721 
Comprehensive income$12,670 $7,274 
Nine Months Ended
September 28, 2024September 30, 2023
GrossTaxesNetGrossTaxesNet
Net income$63,922 $49,651 
Other comprehensive income (loss):
Foreign currency translation adjustments(1,436) (1,436)(1,625) (1,625)
Net change on cash flow hedges
(12,411)3,103 (9,308)1,562 (390)1,172 
Comprehensive income$53,178 $49,198 











See accompanying notes to the unaudited condensed consolidated financial statements.

3

Hayward Holdings, Inc.
Unaudited Condensed Consolidated Statements of Changes in Redeemable Stock and Stockholders' Equity
(Dollars in thousands)

Common StockAdditional Paid-in CapitalTreasury StockRetained EarningsAccumulated Other Comprehensive Income (Loss)
Total Stockholders’ Equity
SharesAmount
Balance as of December 31, 2023214,165,676 $243 $1,080,894 $(357,755)$580,909 $7,167 $1,311,458 
Net income— — — — 9,840 — 9,840 
Stock-based compensation— — 1,983 — — — 1,983 
Issuance of Common Stock for compensation plans550,713 1 799 — — — 800 
Repurchase of stock— — (355)— — (355)
Other comprehensive loss— — — — (3,234)(3,234)
Balance as of March 30, 2024214,716,389 $244 $1,083,676 $(358,110)$590,749 $3,933 $1,320,492 
Net income— — — — 37,581 — 37,581 
Stock-based compensation— — 2,649 — — — 2,649 
Issuance of Common Stock for compensation plans355,409 — 355 — — — 355 
Other comprehensive loss— — — — (3,679)(3,679)
Balance as of June 29, 2024215,071,798 $244 $1,086,680 $(358,110)$628,330 $254 $1,357,398 
Net income— — — — 16,501 — 16,501 
Stock-based compensation— — 2,667 — — — 2,667 
Issuance of Common Stock for compensation plans340,762 — 435 — — — 435 
Repurchase of stock— — (15)— — (15)
Other comprehensive loss— — — — (3,831)(3,831)
Balance as of September 28, 2024215,412,560 $244 $1,089,782 $(358,125)$644,831 $(3,577)$1,373,155 


See accompanying notes to the unaudited condensed consolidated financial statements.

4

Hayward Holdings, Inc.
Unaudited Condensed Consolidated Statements of Changes in Redeemable Stock and Stockholders' Equity
(Dollars in thousands)
Common StockAdditional Paid-in CapitalTreasury StockRetained EarningsAccumulated Other Comprehensive Income (Loss)
Total Stockholders’ Equity
SharesAmount
Balance as of December 31, 2022211,862,781 $241 $1,069,878 $(357,415)$500,222 $10,108 $1,223,034 
Net income— — — — 8,410 — 8,410 
Stock-based compensation— — 2,047 — — — 2,047 
Issuance of Common Stock for compensation plans912,288 1 569 — — — 570 
Repurchase of stock— — — (9)— — (9)
Other comprehensive loss— — — — — (3,933)(3,933)
Balance as of April 1, 2023212,775,069 $242 $1,072,494 $(357,424)$508,632 $6,175 $1,230,119 
Net income— — — — 29,453 — 29,453 
Stock-based compensation— — 2,099 — — — 2,099 
Issuance of Common Stock for compensation plans231,354 — 156 — — — 156 
Other comprehensive income— — — — — 7,994 7,994 
Balance as of July 1, 2023213,006,423 $242 $1,074,749 $(357,424)$538,085 $14,169 $1,269,821 
Net income— — — — 11,788 — 11,788 
Stock-based compensation— — 2,555 — — — 2,555 
Issuance of Common Stock for compensation plans683,385 1 896 — — — 897 
Repurchase of stock— — — (213)— — (213)
Other comprehensive loss— — — — — (4,514)(4,514)
Balance as of September 30, 2023213,689,808 $243 $1,078,200 $(357,637)$549,873 $9,655 $1,280,334 

See accompanying notes to the unaudited condensed consolidated financial statements.

5

Hayward Holdings, Inc.
Unaudited Condensed Consolidated Statements of Cash Flows
(In thousands)
Nine Months Ended
September 28, 2024September 30, 2023
Cash flows from operating activities
Net income$63,922 $49,651 
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation13,929 13,018 
Amortization of intangible assets26,299 27,803 
Amortization of deferred debt issuance fees3,248 3,458 
Stock-based compensation7,299 6,701 
Deferred income taxes(8,344)(5,965)
Allowance for bad debts(62)(906)
Loss on debt extinguishment4,926  
(Gain) loss on sale of property, plant and equipment(451)945 
Changes in operating assets and liabilities
Accounts receivable173,400 85,216 
Inventories(4,204)61,715 
Other current and non-current assets(6,203)9,500 
Accounts payable2,871 (6,265)
Accrued expenses and other liabilities(868)(27,934)
Net cash provided by operating activities275,762 216,937 
Cash flows from investing activities
Purchases of property, plant, and equipment(17,552)(22,623)
Acquisitions, net of cash acquired(61,636) 
Proceeds from sale of property, plant, and equipment311 13 
Proceeds from short-term investments25,000  
Net cash used in investing activities(53,877)(22,610)
Cash flows from financing activities
Proceeds from revolving credit facility 144,100 
Payments on revolving credit facility (144,100)
Proceeds from issuance of long-term debt2,886 3,320 
Payments of long-term debt(129,971)(9,325)
Proceeds from issuance of short-term notes payable6,340 6,130 
Payments of short-term notes payable(4,676)(5,174)
Other, net(427)(149)
Net cash used in financing activities(125,848)(5,198)
Effect of exchange rate changes on cash and cash equivalents50 (1,061)
Change in cash and cash equivalents96,087 188,068 
Cash and cash equivalents, beginning of period178,097 56,177 
Cash and cash equivalents, end of period$274,184 $244,245 
Supplemental disclosures of cash flow information
Cash paid-interest$47,965 $56,438 
Cash paid-income taxes26,853 14,913 
Equipment financed under finance leases843  

See accompanying notes to the unaudited condensed consolidated financial statements.

6

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements


1. Nature of Operations and Organization
Hayward Holdings, Inc. (“Holdings,” the “Company,” “we” or “us”) is a global designer and manufacturer of pool and outdoor living technology. The Company has seven manufacturing facilities worldwide, which are located in North Carolina, Georgia, Tennessee, Rhode Island, Spain (two) and China, and other facilities in the United States, Canada, France and Australia. Cash flow is impacted by the seasonality of the swimming pool business. Cash flow is usually higher in the second and third quarters due to terms of sale to our customers.
We establish actual interim closing dates using a fiscal calendar in which our fiscal quarters end on the Saturday closest to the calendar quarter end, with the exception of year-end which ends on December 31 of each fiscal year. The interim closing date for the first, second and third quarters of 2024 are March 30, June 29, and September 28, compared to the respective April 1, July 1, and September 30, 2023 dates. We had equal working days in the three and nine months ended September 28, 2024 and September 30, 2023.

2. Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of the Company included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The financial statements reflect all adjustments that are, in the opinion of management, necessary for a fair statement of such information. All such adjustments are of a normal recurring nature. Certain information and note disclosures, including a description of significant accounting policies normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), have been condensed or omitted pursuant to such rules and regulations.
These interim financial statements should be read in conjunction with the Company’s annual consolidated financial statements and notes thereto for the fiscal year ended December 31, 2023. The results of operations for the three and nine months ended September 28, 2024 are not necessarily indicative of the results for any subsequent periods or the entire fiscal year ending December 31, 2024.
The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified for comparative purposes to conform to the current presentation.
Recently Issued Accounting Standards
Segment Reporting
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Improvements to Reportable Segment Disclosures, which requires enhanced disclosures about significant segment expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company will adopt the standard in the Company's annual report on Form 10-K for the year ended December 31, 2024. In addition to other required disclosures, the Company will disclose cost of goods sold, selling, general and administrative expense (“SG&A”) and research, development and engineering expense (“RD&E”) by segment.
Income Taxes
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which is intended to improve income tax disclosure requirements by requiring (i) consistent categories and greater disaggregation of information in the rate reconciliation and (ii) the disaggregation of income taxes paid by jurisdiction. The guidance makes several other changes to the income tax disclosure requirements. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and is required to be applied prospectively with the option of retrospective application. The Company is evaluating the impact of the standard on its income tax disclosures and does not intend to early adopt.



7

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements

3. Revenue
The following table disaggregates net sales between product groups and geographic regions, respectively (in thousands):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Product groups
Residential pool$200,794 $198,073 $652,697 $646,608 
Commercial pool14,172 9,518 34,259 30,595 
Flow control12,603 12,713 37,575 36,780 
Total$227,569 $220,304 $724,531 $713,983 
Geographic
United States$182,435 $174,317 $562,510 $543,471 
Canada12,533 10,754 47,000 41,655 
Europe16,807 17,495 71,290 72,705 
Rest of World15,794 17,738 43,731 56,152 
Total International45,134 45,987 162,021 170,512 
Total$227,569 $220,304 $724,531 $713,983 

4. Inventories
Inventories, net, consist of the following (in thousands):
September 28, 2024December 31, 2023
Raw materials$87,359 $103,559 
Work in progress21,378 15,374 
Finished goods120,626 96,247 
Total$229,363 $215,180 

5. Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consist of the following (in thousands):
September 28, 2024December 31, 2023
Selling, promotional and advertising$47,467 $48,440 
Employee compensation and benefits20,569 16,923 
Warranty reserve20,052 22,154 
Inventory purchases18,097 20,790 
Insurance reserve10,837 9,450 
Operating lease liability - short term9,062 7,828 
Payroll taxes4,155 1,700 
Freight4,019 6,034 
Short-term notes payable3,956 2,292 
Deferred income2,197 4,021 
Professional fees2,140 1,449 
Taxes - non income1,582 679 
Business restructuring costs659 1,690 
Other accrued liabilities14,917 12,093 
Total$159,709 $155,543 

The Company offers warranties on certain of its products and records an accrual for estimated future claims. Such accruals are based on historical experience and management’s estimate of the level of future claims.
8

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements


The following table summarizes the warranty reserve activities (in thousands):

Balance at December 31, 2023
$22,154 
Accrual for warranties issued during the period 8,202 
Payments(6,999)
Balance at March 30, 2024
23,357 
Accrual for warranties issued during the period 11,637 
Payments(10,124)
Balance at June 29, 2024
24,870 
Acquisitions
1,105 
Accrual for warranties issued during the period9,167 
Payments(15,090)
Balance at September 28, 2024
$20,052 

Balance at December 31, 2022
$19,652 
Accrual for warranties issued during the period 5,424 
Payments(7,076)
Balance at April 1, 2023
18,000 
Accrual for warranties issued during the period10,135 
Payments(11,309)
Balance at July 1, 2023
16,826 
Accrual for warranties issued during the period16,382 
Payments(16,172)
Balance at September 30, 2023
$17,036 

Warranty expenses for the three and nine months ended September 28, 2024 were $9.2 million and $29.0 million, respectively, and $16.4 million and $31.9 million, respectively, for the three and nine months ended September 30, 2023.

6. Income Taxes
The Company’s effective tax rate for the three months ended September 28, 2024 and September 30, 2023 was 21.1% and (23.7)%, respectively, after discrete items. The change in the Company’s effective tax rate was primarily due to the exercise of stock options, the release of the valuation allowance against foreign tax credit carryovers and return-to-provision adjustments in the three months ended September 30, 2023.
The Company’s effective tax rate for the nine months ended September 28, 2024 and September 30, 2023 was 20.9% and 19.9%, respectively. The change in the Company’s effective tax rate was primarily due to a decrease in excess tax benefit from stock compensation and the release of the valuation allowance against foreign tax credit carryovers in the nine months ended September 30, 2023, partially offset with a change to the Company's permanent reinvestment assertion for one jurisdiction in the nine months ended September 30, 2023.
The Company will recognize a tax benefit in the financial statements for an uncertain tax position only if the Company’s assessment is that the position is “more likely than not” (i.e., a likelihood greater than 50 percent) to be allowed by the tax jurisdiction based solely on the technical merits of the position. The term “tax position” refers to a position in a previously filed tax return or a position expected to be taken in a future tax return that is reflected in measuring current or deferred income tax assets and liabilities for financial reporting purposes. There were no uncertain tax positions at September 28, 2024 or December 31, 2023.
In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities and projected future taxable income in making this assessment. Management evaluates the need for valuation allowances on the deferred tax assets according to the provisions of ASC 740,
9

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements

Income Taxes. In making this determination, the Company assesses all available evidence (positive and negative) including recent earnings, internally-prepared income tax projections, and historical financial performance.
7. Long-Term Debt
Long-term debt, net, consists of the following (in thousands):
September 28, 2024December 31, 2023
First Lien Term Facility, due May 28, 2028$970,000 $975,000 
Incremental B First Lien Term Facility, due May 28, 2028 123,438 
ABL Revolving Credit Facility  
Other bank debt11,267 8,775 
Finance lease obligations2,800 4,729 
Subtotal984,067 1,111,942 
Less: Current portion of the long-term debt(14,079)(15,088)
Less: Unamortized debt issuance costs(10,082)(17,574)
Total$959,906 $1,079,280 

In April 2024, the Company made $123.1 million of voluntary principal prepayments of the incremental term loan portion of the First Lien Term Facility (the “Incremental Term Loan B”). As a result of these prepayments, there is zero aggregate principal outstanding remaining on the Incremental Term Loan B.
On June 26, 2024, the Company entered into the Fourth Amendment to its existing ABL Revolving Credit Facility (the “ABL Facility”) to replace the Canadian reference rate from the Canadian Dollar Offered Rate (“CDOR”) to the Canadian Overnight Repo Rate Average (“CORRA”).
The Company’s First Lien Term Facility and ABL Revolving Credit Facility (collectively “Credit Facilities”) contain collateral requirements, restrictions, and covenants, including restrictions under the First Lien Term Facility on the Company’s ability to pay dividends on the Common Stock. Under the agreement governing the First Lien Credit Facility (the “First Lien Credit Agreement”), the Company must also make an annual mandatory prepayment of principal commencing April 2023 for between 0% and 50% of the excess cash, as defined in the First Lien Credit Agreement, generated in the prior calendar year. The amount due varies with the First Lien Leverage Ratio as defined in the First Lien Credit Agreement, from zero if the First Lien Leverage Ratio is less than or equal to 2.5x, to fifty percent if the First Lien Leverage Ratio is greater than 3.0x less certain allowed deductions. The Company did not have a mandatory prepayment in 2024 based on the First Lien Leverage Ratio as of December 31, 2023 and the applicable criteria under the First Lien Credit Agreement. All outstanding principal under the First Lien Credit Agreement is due at maturity on May 28, 2028. The maturity date under the ABL Revolving Credit Facility (“ABL Facility”) is June 1, 2026. As of September 28, 2024, the Company was in compliance with all covenants under the Credit Facilities.















10

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements

8. Derivatives and Hedging Transactions
The Company holds derivative financial instruments for the purpose of hedging the risks of certain identifiable and anticipated transactions. In general, the types of risks hedged are those relating to the variability of future earnings and cash flows caused by movements in foreign currency exchange rates and interest rates. In hedging these transactions, the Company holds the following types of derivatives in the normal course of business.
Interest Rate Swap Agreements
The Company enters into interest rate swap agreements designated as cash flow hedges to manage interest rate risk related to its variable rate debt obligations. As cash flow hedges, unrealized gains are recognized as assets while unrealized losses are recognized as liabilities. The interest rate swap agreements are highly correlated to the changes in interest rates to which the Company is exposed. Unrealized gains and losses on these instruments have been designated as effective and as such, the related gains or losses have been recorded as a component of accumulated other comprehensive income, net of tax. Other comprehensive income or loss is reclassified into current period income when the hedged interest expense affects earnings.
As of September 28, 2024 and December 31, 2023, the Company was a party to interest rate swap agreements that hedged a notional amount of $600.0 million of the Company’s variable rate debt. During the three months ended September 28, 2024, the Company entered into interest rate swap agreements with a notional amount of $250.0 million that will become effective in March 2025 and replace existing swap agreements with a notional amount of $250.0 million that had March 2025 maturity dates. These new agreements mature in March 2028.
Foreign Exchange Contracts
The Company enters into foreign exchange contracts to manage risks associated with future intercompany and foreign currency transactions that may be adversely affected by changes in exchange rates. These contracts are marked-to-market with the resulting gains and losses recognized in earnings. For the three months ended September 28, 2024 and September 30, 2023, the Company recognized $0.6 million of expense and $1.2 million of income, respectively, and for the nine months ended September 28, 2024 and September 30, 2023, the Company recognized $0.3 million of income and $0.3 million of expense, respectively in Other (income) expense, net, related to foreign exchange contracts.
The following table summarizes the gross fair values and location of the significant derivative instruments within the Company’s unaudited condensed consolidated balance sheets (in thousands):
Other Current AssetsOther Non-Current AssetsAccrued Expenses and Other LiabilitiesOther Non-Current LiabilitiesOther Current AssetsOther Non-Current AssetsAccrued Expenses and Other LiabilitiesOther Non-Current Liabilities
September 28, 2024December 31, 2023
Interest rate swaps$2,084 $9,435 $ $2,976 $ $21,398 $ $445 
Foreign exchange contracts  394  227  872  
Total$2,084 $9,435 $394 $2,976 $227 $21,398 $872 $445 
11

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements

The following tables present the effects of derivative instruments by contract type in accumulated other comprehensive income (AOCI) in the Companys unaudited condensed consolidated statements of comprehensive income (in thousands):
Gain (Loss) Recognized in AOCI (1)
Gain (Loss) Reclassified From AOCI to Earnings (2)
Location of Gain (Loss) Reclassified from AOCI into Earnings
Three Months EndedThree Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Interest rate swaps (3)
$(9,542)$5,244 $4,372 $4,284 Interest expense, net
(1) The tax benefit and expense, respectively, on the gain (loss) recognized in AOCI for the three months ended September 28, 2024 and September 30, 2023 was $2.4 million and $0.2 million, respectively.
(2) The tax expense on the gain reclassified from AOCI to earnings for the three months ended September 28, 2024 and September 30, 2023 was $1.1 million and $1.1 million, respectively.
(3) The Company estimates that $6.6 million of unrealized gains will be reclassified from AOCI into earnings in the next twelve months.
Gain (Loss) Recognized in AOCI (1)
Gain (Loss) Reclassified From AOCI to Earnings (2)
Location of Gain (Loss) Reclassified from AOCI into Earnings
Nine Months EndedNine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Interest rate swaps$716 $12,753 $13,127 $11,191 Interest expense, net
(1) The tax expense on the gain recognized in AOCI for the nine months ended September 28, 2024 and September 30, 2023 was $0.2 million and $0.4 million, respectively.
(2) The tax expense on the gain reclassified from AOCI to earnings for the nine months ended September 28, 2024 and September 30, 2023 was $3.3 million and $2.8 million, respectively.

9. Fair Value Measurements
The Company is required to disclose the estimated fair values of all financial instruments, even if they are not carried at their fair value. The fair values of financial instruments are estimates based upon market conditions and perceived risks. These estimates require management’s judgment and may not be indicative of the future fair values of the assets and liabilities.
The accounting guidance for fair value measurements and disclosures establishes a three-level fair value hierarchy:
Level 1 - Inputs are based on quoted prices in active markets for identical assets and liabilities.
Level 2 - Inputs are based on observable inputs other than quoted prices in active markets for identical or similar assets and liabilities.
Level 3 - One or more inputs are unobservable and significant.
Financial and nonfinancial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount of these instruments approximate fair value because of their short-term nature.
The Company’s interest rate swaps and foreign exchange contracts are measured in the financial statements at fair value on a recurring basis. The fair values of these instruments are estimated using industry standard valuation models using market-based observable inputs, including interest rate curves. These instruments are customary, over-the-counter contracts with various bank counterparties. Accordingly, the fair value measurements of the interest rate swaps and foreign exchange contracts are categorized as Level 2.
The Company’s investment plan assets as part of the nonqualified Hayward Industries Supplemental Retirement Plan (the “Supplemental Retirement Plan”) are presented in the financial statements at fair value on a recurring basis and are based on quoted market prices in active markets. Accordingly, the fair value measurements of the Supplemental Retirement Plan assets
12

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements

are categorized as Level 1. The value of investments related to the Supplemental Retirement Plan is included in other assets and a corresponding liability to participants is recorded in other liabilities.
The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis (in thousands):
September 28, 2024December 31, 2023
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Assets:
Interest rate swaps
$ $11,519 $ $11,519 $ $21,398 $ $21,398 
Foreign exchange contracts
     227  227 
Supplemental Retirement Plan assets
7,551   7,551 5,910   5,910 
Liabilities:
Interest rate swaps
$ $2,976 $ $2,976 $ $445 $ $445 
Foreign exchange contracts
 394  394  872  872 
Supplemental Retirement Plan liabilities
7,551   7,551 5,910   5,910 
The estimated fair value of the long-term debt and related current maturities (excluding finance leases, the ABL Facility, and other bank debt) is based on observable quoted prices in active markets for similar liabilities and is classified as a Level 2 input. The fair value of the ABL Facility approximates its carrying value.
The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value (in thousands):
September 28, 2024December 31, 2023
Carrying ValueFair ValueCarrying ValueFair Value
Assets:
Short-term investments$ $ $25,000 $25,000 
Liabilities:
Long-term debt and related current maturities$970,000 $973,036 $1,098,438 $1,098,422 


10. Segments and Related Information
The Company’s operational and management structure is aligned to its key geographies and go-to market strategy resulting in two reportable segments: North America (“NAM”) and Europe & Rest of World (“E&RW”). Operating segments have not been aggregated to form the reportable segments. The Company determined its reportable segments based on how the Company’s Chief Operating Decision Maker (“CODM”) reviews the Company’s operating results in assessing performance and allocating resources. The CODM reviews net sales, gross profit and segment income for each of the reportable segments. Gross profit is defined as net sales less cost of sales incurred by the segment. The CODM does not evaluate reportable segments using asset information as these are managed on an enterprise-wide basis. Segment income is defined as segment net sales less cost of sales, selling, general and administrative expense (“SG&A”) of the segment and research development and engineering expense (“RD&E”) of the segment, excluding segment acquisition and restructuring related expense as well as amortization of intangible assets recorded within segment SG&A expense. The accounting policies of the segments are the same as those of Holdings.
The North America segment manufactures and sells residential and commercial swimming pool equipment and supplies as well as equipment that controls the flow of fluids.
The Europe & Rest of World segment manufactures and sells residential and commercial swimming pool equipment and supplies.
13

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements

The Company sells its products primarily through distributors and retailers. Financial information by reportable segment, net of intercompany transactions, is included in the following summary (in thousands):
Three Months EndedThree Months Ended
September 28, 2024September 30, 2023
North AmericaEurope & Rest of WorldTotalNorth AmericaEurope & Rest of WorldTotal
External net sales$194,968 $32,601 $227,569 $185,070 $35,234 $220,304 
Segment income51,569 2,475 54,044 40,108 6,413 46,521 
Capital expenditures (1)
6,240 579 6,819 6,524 120 6,644 
Depreciation and amortization (1)(2)
6,081 271 6,352 5,765 246 6,011 
Intersegment sales4,093 66 4,159 1,734 79 1,813 
Nine Months EndedNine Months Ended
September 28, 2024September 30, 2023
North AmericaEurope & Rest of WorldTotalNorth AmericaEurope & Rest of WorldTotal
External net sales$609,510 $115,021 $724,531 $585,126 $128,857 $713,983 
Segment income166,646 16,800 183,446 144,346 25,647 169,993 
Capital expenditures (1)
15,701 1,806 17,507 21,110 1,082 22,192 
Depreciation and amortization (1)(2)
17,493 791 18,284 16,978 694 17,672 
Intersegment sales17,108 126 17,234 9,453 187 9,640 

(1) Capital expenditures and depreciation associated with Corporate are not included in these totals.
(2) Amortization expense excluded from segment income is not included in these totals.

The following table presents a reconciliation of segment income to income from operations before income taxes (in thousands):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Total segment income$54,044 $46,521 $183,446 $169,993 
Corporate expense, net11,907 6,741 27,233 21,265 
Acquisition and restructuring related expense1,145 3,348 2,488 6,220 
Amortization of intangible assets7,576 7,523 21,425 22,777 
Operating income33,416 28,909 132,300 119,731 
Interest expense, net13,209 17,448 48,600 55,939 
Loss on debt extinguishment  4,926  
Other (income) expense, net(705)1,932 (1,989)1,798 
Total other expense12,504 19,380 51,537 57,737 
Income from operations before income taxes$20,912 $9,529 $80,763 $61,994 












14

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements

11. Earnings Per Share
The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders (in thousands, except share and per share data):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Net income attributable to common stockholders$16,501 $11,788 $63,922 $49,651 
Weighted average number of common shares outstanding, basic215,231,886 213,416,502 214,836,643 212,933,763 
Effect of dilutive securities(a)
6,204,320 7,446,726 6,414,712 7,700,469 
Weighted average number of common shares outstanding, diluted221,436,206 220,863,228 221,251,355 220,634,232 
Earnings per share attributable to common stockholders, basic$0.08 $0.06 $0.30 $0.23 
Earnings per share attributable to common stockholders, diluted$0.07 $0.05 $0.29 $0.23 
(a) For the three months ended September 28, 2024 and September 30, 2023 there were potential common shares totaling approximately 2.5 million and 2.9 million, respectively, and for the nine months ended September 28, 2024 and September 30, 2023, there were potential common shares totaling approximately 2.5 million and 2.8 million, respectively, that were excluded from the computation of diluted EPS as the effect of inclusion of such shares would have been anti-dilutive.

12. Commitments and Contingencies
Litigation
The Company is involved in litigation arising in the normal course of business. Where appropriate, these matters have been submitted to the Company’s insurance carrier. The Company determines whether an estimated loss from a contingency should be accrued by assessing whether a loss is deemed probable and can be reasonably estimated. It is not possible to quantify the ultimate liability, if any, in these matters.
On August 2, 2023, a securities class action complaint was filed in the United States District Court for the District of New Jersey against the Company and certain of its current directors and officers (Kevin Holleran and Eifion Jones) and MSD Partners and CCMP Capital Advisors, LP on behalf of a putative class of stockholders who acquired shares of the Company’s common stock between March 2, 2022 and July 27, 2022. That action is captioned City of Southfield Fire and Police Retirement System vs. Hayward Holdings, Inc., et al., 2:23-cv-04146-WJM-ESK (D.N.J.) (“City of Southfield”). On September 28, 2023, a second, related securities class action complaint was filed in the United States District Court for the District of New Jersey against the Company and certain of its current directors and officers (Kevin Holleran and Eifion Jones) and MSD Partners and CCMP Capital Advisors, LP on behalf of a putative class of stockholders who acquired shares of the Company’s common stock between October 27, 2021 and July 28, 2022. That action is captioned Erie County Employees’ Retirement System vs. Hayward Holdings, Inc., et al., 2:23-cv-04146-WJM-ESK (D.N.J.) (“Erie County”). On December 19, 2023, the Court issued a ruling consolidating the two securities class actions (City of Southfield and Erie County) under the City of Southfield docket (the “Securities Class Action”) and appointing a lead plaintiff. In a consolidated class action complaint filed March 4, 2024, the Securities Class Action alleged on behalf of a putative class of stockholders who acquired shares of our common stock between October 27, 2021 and July 28, 2022, among other things, that the Company and certain of its current directors and officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by, among other things, making materially false or misleading statements regarding inventory, growth, and demand trends and the Company’s financial projections for 2022. The complaints seek unspecified monetary damages on behalf of the putative classes and an award of costs and expenses, including reasonable attorneys’ fees. On October 2, 2024, the Court issued an Opinion and Order dismissing the consolidated class action complaint and granted the lead plaintiff leave to file an amended complaint within 30 days.
On November 27, 2023, a shareholder derivative lawsuit was filed in the United States District Court for the District of New Jersey against current and past directors of the Company captioned Heicklen v. Holleran, et al., 2:23-cv-22649 (D.N.J.) (the “Derivative Action”). The Derivative Action alleges breaches of fiduciary duties to Company stockholders, aiding and
15

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements

abetting breaches of fiduciary duties, unjust enrichment, corporate waste, and violations of Section 10(b) of the Securities Exchange Act of 1934 in connection with the claims in the Securities Class Action. The Derivative Action seeks recovery of unspecified damages and attorney’s fees and costs, as well as improvements to the Company’s corporate governance and internal procedures. The Derivative Action has been stayed pending final decision on a motion to dismiss being filed in the Securities Class Action.
We dispute the allegations of wrongdoing in the Securities Class Action and the Derivative Action and intend to vigorously defend ourselves in these matters. In view of the complexity and ongoing and uncertain nature of the outstanding proceedings and inquiries, at this time we are unable to estimate a reasonably possible financial loss or range of financial loss, if any, that we may incur to resolve or settle the Securities Class Action and the Derivative Action.
Contingencies
In September 2024, certain equipment and inventory of the Company located at a supplier’s facility experienced water damage following Hurricane Helene. The Company is pursuing alternative arrangements and does not expect this to have a material effect on the Company’s operations or financial condition.




































16

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements

13. Leases
The Company’s operating and finance lease portfolio is described in Note 15. Leases of Notes to Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2023.
Supplemental cash flow information related to leases was as follows (in thousands):
Nine Months Ended
September 28, 2024September 30, 2023
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$5,507 $885 
Finance leases843  
Supplemental balance sheet information related to leases was as follows (in thousands):
September 28, 2024December 31, 2023
Operating leases
Other non-current assets$57,876 $58,638 
Accrued expenses and other liabilities9,062 7,828 
Other non-current liabilities56,504 58,642 
Total operating lease liabilities65,566 66,470 
Finance leases
Property, plant and equipment9,712 10,858 
Accumulated depreciation(2,891)(2,415)
Property, plant and equipment, net6,821 8,443 
Current maturities of long-term debt1,878 2,121 
Long-term debt922 2,608 
Total finance lease liabilities$2,800 $4,729 

14. Stockholders’ Equity
Preferred Stock
The Company’s Second Restated Certificate of Incorporation authorizes the Company to issue up to 100,000,000 shares of preferred stock, $0.001 value per share, all of which is undesignated.
Common Stock
The Company’s Second Restated Certificate of Incorporation authorizes the Company to issue up to 750,000,000 shares of Common Stock, $0.001 value per share. Each share of Common Stock is entitled to one vote on all matters submitted to a vote of the Company’s stockholders. The holders of Common Stock are entitled to receive dividends, if any, as may be declared by the Board of Directors.
Dividends paid
For the three and nine months ended September 28, 2024 and September 30, 2023, no dividends were declared or paid to the Company’s common stockholders.
Share Repurchase Program
The Board of Directors authorized the Company’s share repurchase program (the “Share Repurchase Program”) such that the Company is authorized to repurchase from time to time up to an aggregate of $450 million of its outstanding shares of common stock, which authorization expires on July 26, 2025. The Company had no repurchases of its common stock in the quarter ended September 28, 2024 under the Share Repurchase Program. As of September 28, 2024, $400.0 million remained available for additional share repurchases under the program.
17

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements

15. Stock-based Compensation
Stock-based compensation expense recorded in the unaudited condensed consolidated statements of operations for equity-classified stock-based awards for the three and nine months ended September 28, 2024 was $2.7 million and $7.3 million, respectively, and $2.6 million and $6.7 million, respectively, for the three and nine months ended September 30, 2023.
The Company has established two equity incentive plans, the 2021 Equity Incentive Plan and the 2017 Equity Incentive Plan. The Company no longer grants awards under the 2017 Equity Incentive Plan.
2021 Equity Incentive Plan
In March 2021, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”). Under the 2021 Plan, up to 13,737,500 shares of common stock may be granted to employees, directors and consultants in the form of stock options, restricted stock units and other stock-based awards. The terms of awards granted under the 2021 Plan are determined by the Compensation Committee of the Board of Directors, subject to the provisions of the 2021 Plan.
Options granted under the 2021 Plan expire no later than ten years from the date of grant. Options and time-based restricted stock units granted under the 2021 Plan generally vest ratably over a three-year period and performance-based restricted stock units vest at the end of three years subject to the performance criteria.
During the nine months ended September 28, 2024, the Company granted 781,719 time-based restricted stock units and 304,518 performance-based restricted stock units (at the target performance level) under the 2021 Plan with a weighted-average grant-date fair value per share of $14.01 and $14.17, respectively.

16. Acquisitions and Restructuring
Acquisition and restructuring related expense, net consists of the following (in thousands):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Business restructuring costs$444 $3,348 $1,232 $5,426 
Acquisition transaction and integration costs701  1,256 794 
Total $1,145 $3,348 $2,488 $6,220 
During the third quarter of 2023, the Company initiated programs to centralize and consolidate operations and professional services in Europe. For the three and nine months ended September 28, 2024, the Company incurred zero and $0.7 million, respectively, of expense related to the programs, which include severance and employee benefit costs, as well as other direct separation benefit costs. The impacted employees must remain with the Company through their planned exit date to receive each of the severance and retention amounts. Such costs are accounted for in accordance with ASC 420, Exit or Disposal Cost Obligations.
During the three months ended September 28, 2024, the Company incurred $0.4 million of costs to finalize actions initiated in prior years.
The following tables summarize the status of the Company’s restructuring related expense and related liability balances (in thousands):
2024 Activity
Liability as of December 31, 2023
Costs RecognizedCash PaymentsNon-cash charges
Liability as of September 28, 2024
One-time termination benefits$2,353 $488 $(2,101)$ $740 
Facility-related 182 (182)  
Other6 562 (456)67 179 
Total$2,359 $1,232 $(2,739)$67 $919 
18

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements

2023 Activity
Liability as of December 31, 2022
Costs RecognizedCash Payments
Liability as of September 30, 2023
One-time termination benefits$2,422 $4,894 $(3,731)$3,585 
Other 532 (470)62 
Total$2,422 $5,426 $(4,201)$3,647 
    
Restructuring costs are included within acquisition and restructuring related costs on the Company’s unaudited condensed consolidated statements of operations, while the restructuring liability is included as a component of accrued expenses and other liabilities on the Company’s unaudited condensed consolidated balance sheets.
Acquisitions
On June 26, 2024, the Company acquired the equity interests of ChlorKing HoldCo, LLC and related entities (“ChlorKing”). The acquired business includes pool saline chlorinators and UV disinfection systems serving the commercial pools and water treatment market segments. The acquisition broadens the Company’s commercial portfolio of products and expands the market of commercial customers while furthering the Company's commitment to sustainable and energy-efficient technology for both commercial and residential pools. The acquisition is included in our North America segment.
The consideration paid net of cash acquired was $61.6 million. The purchase price was funded with cash on hand. For the three and nine months ended September 28, 2024, transaction expenses recognized for the acquisition were $0.7 million and $1.3 million, respectively. These expenses are included within acquisition and restructuring related costs on the Company’s unaudited condensed consolidated statements of operations.
The purchase price allocation is preliminary and subject to change as the Company finalizes the valuation of goodwill, intangible assets, inventory and leases, in addition to identifying and recording all other assets and liabilities and contingencies. Preliminary estimates will be finalized within one year of the date of acquisition. The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed, including measurement period adjustments recorded through September 28, 2024 (in thousands):
Preliminary AllocationMeasurement
Period
Adjustments
Preliminary Allocation
As of June 26, 2024As of September 28, 2024
Cash and cash equivalents$3,898 $134 $4,032 
Receivables3,701 (730)2,971 
Inventory8,978 582 9,560 
Prepaid expenses and other current assets269 830 1,099 
Property, plant and equipment37  37 
Other assets2,565  2,565 
Net Investment in Lease1,867 5,449 7,316 
Intangible assets31,550 (3,075)28,475 
Accounts payable and accrued liabilities(4,302)(3,046)(7,348)
Deferred tax liabilities
 (1,810)(1,810)
Total identifiable net assets acquired48,563 (1,666)46,897 
Goodwill17,835 936 18,771 
Preliminary purchase price$66,398 $(730)$65,668 





19

Hayward Holdings, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements




The estimated preliminary fair value and useful lives of the identifiable intangible assets are as follows:
Estimated Useful LivesEstimated Amounts
(in years)(in thousands)
Finite lived intangible assets
Tradename15$2,600 
Customer relationships1521,200 
Developed technology104,600 
Noncompete agreements575 
Total$28,475 

Goodwill is a result of the expected synergies and cross-selling opportunities this acquisition is expected to bring, as well as the expected growth potential from the integration of the ChlorKing products into Hayward’s existing commercial business. Any changes in the estimated fair values of the assets acquired and liabilities assumed in the acquisition may change the amount of the purchase consideration allocated to goodwill. The goodwill balance has been recorded to the North America reportable segment and is deductible for tax purposes.

Pro forma results of operations including ChlorKing have not been presented as the impact of ChlorKing on the Company's consolidated financial results is not material.

17. Related-Party Transactions
During the three and nine months ended September 28, 2024 and September 30, 2023, the Company did not incur any significant related-party transactions.

20


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion and analysis of our financial condition and results of operations together with our condensed consolidated financial statements and related notes thereto, appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical financial information, this discussion and analysis includes forward-looking statements that reflect our plans, estimates and beliefs and involve risks and uncertainties. As a result of many factors, including those set forth in the section “Special Note Regarding Forward-looking Statements” in this Quarterly Report on Form 10-Q, our actual results may differ materially from those contained in or implied by any forward-looking statements. The results of operations for the three and nine months ended September 28, 2024 are not necessarily indicative of the results for any subsequent periods or the entire fiscal year ending December 31, 2024.

Our Company
The Company is a leading global designer and manufacturer of pool and outdoor living technology. With the pool as the centerpiece of the growing outdoor living space, the pool industry has attractive market characteristics, including significant aftermarket requirements (such as the ongoing repair, replacement, remodeling and upgrading of equipment for existing pools), innovation-led growth opportunities, and a favorable industry structure. We are a leader in this market with a highly-recognized brand, one of the largest installed bases of pool equipment in the world, decades-long relationships with our key channel partners and trade customers and a history of technological innovation. Our engineered products, which include various energy efficient and more environmentally sustainable offerings, enhance the pool owner’s outdoor living lifestyle while also delivering high quality water, pleasant ambiance and ease of use for the ultimate backyard experience. Aftermarket replacements and upgrades to higher value Internet of Things and energy efficient models are a primary growth driver for our business.
We have an estimated North American residential pool market share of approximately 34%. We believe that we are well-positioned for future growth. On average, we have 20+ year relationships with our top 20 customers. We estimate that historically aftermarket sales have represented approximately 80% of net sales and are generally recurring in nature since these products are critical to the ongoing operation of pools given requirements for water quality and sanitization. Our product replacement cycle of approximately 8 to 11 years drives multiple replacement opportunities over the typical life of a pool, creating opportunities to generate aftermarket product sales as pool owners repair, remodel and upgrade their pools. We estimate aftermarket sales based upon feedback from certain representative customers and management’s interpretation of available industry and government data, and not upon our GAAP net sales results.
The Company has seven manufacturing facilities worldwide, which are located in North Carolina, Georgia, Tennessee, Rhode Island, Spain (two) and China, and other facilities in the United States, Canada, France and Australia.

Segments
Our business is organized into two reportable segments: North America (“NAM”) and Europe & Rest of World (“E&RW”). The Company determined its reportable segments based on how the Chief Operating Decision Maker (“CODM”) reviews the Company’s operating results in assessing performance and allocating resources.
The NAM segment manufactures and sells a complete line of residential and commercial swimming pool equipment and supplies in the United States, Canada and Mexico, and manufactures and sells flow control products.
The E&RW segment manufactures and sells residential and commercial swimming pool equipment and supplies in Europe, Central and South America, the Middle East, Australia and other Asia Pacific countries.
NAM accounted for 86% and 84% of total net sales for the three months ended September 28, 2024 and September 30, 2023, respectively, and E&RW accounted for 14% and 16% of total net sales for the three months ended September 28, 2024 and September 30, 2023, respectively.
NAM accounted for 84% and 82% of total net sales for the nine months ended September 28, 2024 and September 30, 2023, respectively, and E&RW accounted for 16% and 18% of total net sales for the nine months ended September 28, 2024 and September 30, 2023, respectively.



21


Factors Affecting the Comparability of our Results of Operations
Our results of operations for the three and nine months ended September 28, 2024 and the three and nine months ended September 30, 2023 have been affected by the following, among other events, which must be understood to assess the comparability of our period-to-period financial performance and condition.
Our fiscal quarters end on the Saturday closest to the calendar quarter end, with the exception of year end which ends on December 31 of each fiscal year. The interim closing date for the first, second and third quarters of 2024 are March 30, June 29, and September 28, compared to the respective April 1, July 1, and September 30, 2023 date. This resulted in no difference in working days for the three and nine months ended September 28, 2024 compared to the respective 2023 periods. Throughout this discussion we may refer to the three months ended September 28, 2024 and the three months ended September 30, 2023 as the “Third Quarter” and “Comparable Quarter,” respectively.
Seasonality
Our business is seasonal, with sales typically higher in the second and fourth quarters. During the second quarter, sales are higher in anticipation of the start of the summer pool season, and in the fourth quarter, we incentivize trade customers to buy and stock in preparation for next year’s pool season under an “Early Buy” program, which features a price discount and extended payment terms. Shipments for the 2024 Early Buy program began in the late third quarter and will continue through approximately the first quarter of 2025. The favorable payment terms extended as part of the Early Buy program generally do not exceed 180 days. We aim to keep our manufacturing plants running at a constant level throughout the year and consequently we typically build inventory in the first and third quarters, and inventory is sold-down in the second and fourth quarters. Our accounts receivable balance increases from September to April as a result of the Early Buy extended terms. Also, because the majority of our sales are to distributors whose inventory of our products may vary, including due to reasons beyond our control, such as end-user demand, supply chain lead times and macroeconomic factors, our revenue may fluctuate from period to period.
Geopolitical Events
Geopolitical conflicts around the world have created substantial uncertainty in the global economy, including as a result of sanctions and penalties imposed in response to these conflicts. In particular, armed conflicts in the Middle East and in Ukraine and Russia have adversely affected market demand in the Middle East and Asia, which has negatively impacted our results in our E&RW segment. See “—Segment—Europe & Rest of World (“E&RW”),” below. Given the nature of our business and global operations, if these or other geopolitical conflicts continue or worsen, our business and results of operations may be adversely affected.

Key Measures We Use to Evaluate Our Business
We consider a variety of financial and operating measures in assessing the performance of our business. The key GAAP measures we use are net sales, gross profit and gross profit margin, selling, general, and administrative expense (“SG&A”), research, development, and engineering expense (“RD&E”), operating income and operating income margin. The key non-GAAP measures we use are EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted segment income, and adjusted segment income margin.

For information about our use of Non-GAAP measures and a reconciliation of these metrics to the most relevant GAAP measure see “—Non-GAAP Reconciliation.”

22


Results of Operations
Consolidated
The following tables summarize key components of our results of operations for the periods indicated. We derived the consolidated statements of operations for the three and nine months ended September 28, 2024 and September 30, 2023 from our unaudited condensed consolidated financial statements. Our historical results are not necessarily indicative of the results that may be expected in the future. The following table summarizes our results of operations:
(In thousands)Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Net sales$227,569 $220,304 $724,531 $713,983 
Cost of sales114,474 114,893 361,770 374,171 
Gross profit113,095 105,411 362,761 339,812 
Selling, general and administrative expense64,509 59,454 187,678 172,057 
Research, development and engineering expense6,449 6,177 18,870 19,027 
Acquisition and restructuring related expense1,145 3,348 2,488 6,220 
Amortization of intangible assets7,576 7,523 21,425 22,777 
Operating income33,416 28,909 132,300 119,731 
Interest expense, net13,209 17,448 48,600 55,939 
Loss on debt extinguishment— — 4,926 — 
Other (income) expense, net(705)1,932 (1,989)1,798 
Total other expense12,504 19,380 51,537 57,737 
Income from operations before income taxes20,912 9,529 80,763 61,994 
Provision (benefit) for income taxes4,411 (2,259)16,841 12,343 
Net income$16,501 $11,788 $63,922 $49,651 
Adjusted EBITDA (a)
$51,093 $47,211 $178,748 $171,618 
(a) See “—Non-GAAP Reconciliation.”

Net sales
Net sales increased to $227.6 million for the three months ended September 28, 2024 from $220.3 million for the three months ended September 30, 2023, an increase of $7.3 million, or 3.3%. See the segment discussion below for further information.
Net sales increased to $724.5 million for the nine months ended September 28, 2024 from $714.0 million for the nine months ended September 30, 2023, an increase of $10.5 million, or 1.5%. See the segment discussion below for further information.
The year-over-year net sales increase was driven by the following:
Three Months EndedNine Months Ended
September 28, 2024September 28, 2024
Volume(4.7)%(2.0)%
Price, net of discounts and allowances5.6 %2.8 %
Acquisitions2.5 %0.8 %
Currency and other(0.1)%(0.1)%
Total3.3 %1.5 %
The net sales increase for the three and nine months ended September 28, 2024 was driven by an increase in net price and the favorable impact from acquisitions, partially offset by a decline in volume.
23


The net sales increase for the three months ended September 28, 2024 was driven by positive net price including normalized allowances and discounts and the positive impact from acquisitions, partially offset by reduced volumes. The decrease in volume resulted from market declines in the Middle East and Asia and lower new construction and remodel activity in the U.S..
The net sales increase for the nine months ended September 28, 2024 was driven by positive net price and the positive impact from acquisitions, partially offset by reduced volumes. The decrease in volume resulted from market declines in the Middle East and Asia and lower new construction and remodel activity in the U.S.
Gross profit and gross profit margin
Gross profit increased to $113.1 million for the three months ended September 28, 2024 from $105.4 million for the three months ended September 30, 2023, an increase of $7.7 million, or 7.3%.
Gross profit margin increased to 49.7% for the three months ended September 28, 2024 compared to 47.8% for the three months ended September 30, 2023, an increase of 190 basis points, driven by operational efficiencies in our manufacturing facilities and net price increases including normalized allowances and discounts, partially offset by a non-cash increase to cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of ChlorKing HoldCo, LLC and related entities ("ChlorKing") and a discrete inventory adjustment in Europe.
Gross profit increased to $362.8 million for the nine months ended September 28, 2024 from $339.8 million for the nine months ended September 30, 2023, an increase of $23.0 million, or 6.8%.
Gross profit margin increased to 50.1% for the nine months ended September 28, 2024 compared to 47.6% for the nine months ended September 30, 2023, an increase of 250 basis points, primarily due to operational efficiencies, net price increases and management of our manufacturing costs.
Selling, general, and administrative expense
Selling, general, and administrative expense (SG&A) increased to $64.5 million for the three months ended September 28, 2024 from $59.5 million for the three months ended September 30, 2023, an increase of $5.0 million, or 8.5%, primarily due to higher salary costs driven by wage inflation and investments in our customer care and selling teams, discrete legal expenses, and increased professional service costs.
As a percentage of net sales, SG&A increased to 28.3% for the three months ended September 28, 2024 as compared to 27.0% for the three months ended September 30, 2023, an increase of 130 basis points, driven by the factors discussed above.
SG&A increased to $187.7 million for the nine months ended September 28, 2024 from $172.1 million for the nine months ended September 30, 2023, an increase of $15.6 million, or 9.1%, driven by higher incentive compensation, higher salary costs driven by wage inflation and investments in our customer care and selling teams, discrete legal expenses, partially offset by decreased warranty costs.
As a percentage of net sales, SG&A increased to 25.9% for the nine months ended September 28, 2024 as compared to 24.1% for nine months ended September 30, 2023, an increase of 180 basis points, due to the factors discussed above.
Research, development, and engineering expense
Research, development, and engineering expense (RD&E) increased to $6.4 million for the three months ended September 28, 2024 from $6.2 million for the three months ended September 30, 2023, primarily as a result of timing of projects compared to the three months ended September 30, 2023. RD&E spend continues to be focused on new product development.
As a percentage of net sales, RD&E was 2.8% for the three months ended September 28, 2024, which was unchanged compared to 2.8% for the three months ended September 30, 2023.
RD&E remained relatively consistent at $18.9 million for the nine months ended September 28, 2024 compared with $19.0 million for the nine months ended September 30, 2023. As a percentage of net sales, RD&E was 2.6% for the nine months ended September 28, 2024 compared to 2.7% for the nine months ended September 30, 2023, a decrease of 10 basis points.
Acquisition and restructuring related expense
For the three months ended September 28, 2024, we incurred $1.1 million of acquisition and restructuring related expense as compared to $3.3 million of expense for the three months ended September 30, 2023. The expense in the Third Quarter was primarily driven by costs associated with the acquisition of the ChlorKing business, compared to the Comparable Quarter
24


which was primarily related to severance and retention costs associated with the centralization and consolidation of operations in Europe, along with the relocation of the corporate headquarters from New Jersey to North Carolina.
For the nine months ended September 28, 2024, we incurred $2.5 million of acquisition and restructuring related expense as compared to $6.2 million of expense for the nine months ended September 30, 2023. The nine months ended September 28, 2024 primarily included costs associated with the centralization and consolidation of operations in Europe and costs related to the acquisition of the ChlorKing business. The acquisition and restructuring related expenses in the nine months ended September 30, 2023 primarily included severance and employee benefit costs as part of the corporate headquarters relocation and costs associated with the centralization and consolidation of operations in Europe.
See Note 16. Acquisitions and Restructuring.
Amortization of intangible assets
For the three months ended September 28, 2024, amortization of intangible assets increased by $0.1 million compared to the three months ended September 30, 2023 due to the amortization of the intangible assets acquired as part of the acquisition of ChlorKing.
For the nine months ended September 28, 2024, amortization of intangible assets decreased $1.4 million compared to the nine months ended September 30, 2023 due to the amortization pattern of certain intangible asset classes based on the declining balance method.
Operating income
For the three and nine months ended September 28, 2024, operating income increased $4.5 million and $12.6 million, respectively, due to the aggregated effect of the items described above.
Interest expense, net
Interest expense, net, decreased to $13.2 million for the three months ended September 28, 2024 from $17.4 million for the three months ended September 30, 2023.
Interest expense, net, for the three months ended September 28, 2024 consisted of $15.9 million of interest expense on the outstanding debt and $1.0 million of amortization of deferred financing fees, partially offset by $3.7 million of interest income on cash deposits. The effective interest rate on our borrowings, including the impact of an interest rate hedge, was 6.78% for the three months ended September 28, 2024.
Interest expense, net, for the three months ended September 30, 2023 consisted of $19.2 million of interest expense on the outstanding debt and $1.2 million of amortization of deferred financing fees, partially offset by $3.0 million of interest income on cash deposits. The effective interest rate on our borrowings, including the impact of an interest rate hedge, was 7.34% for the three months ended September 30, 2023.
Interest expense, net, decreased by $4.2 million for the Third Quarter compared to the Comparable Quarter, primarily due to the repayment of the Incremental Term Loan B principal balance in April 2024 and higher interest income on cash investment balances.
For the nine months ended September 28, 2024, interest expense, net, decreased to $48.6 million from $55.9 million for the nine months ended September 30, 2023.
Interest expense, net, for the nine months ended September 28, 2024 consisted of $52.3 million of interest on the outstanding debt and $3.2 million of amortization of deferred financing fees, partially offset by $6.9 million of interest income. The effective interest rate on our borrowings, including the impact of an interest rate hedge, was 7.00% for the nine months ended September 28, 2024.
Interest expense, net, for the nine months ended September 30, 2023 consisted of $56.5 million of interest on the outstanding debt and $3.5 million of amortization of deferred financing fees, partially offset by $4.1 million of interest income. The effective interest rate on our borrowings, including the impact of an interest rate hedge, was 7.02% for the nine months ended September 30, 2023.
Interest expense, net, decreased by $7.3 million for the nine months ended September 28, 2024 compared to the prior year period primarily due to the repayment of the Incremental Term Loan B principal balance and interest income on cash investment balances.
25


Loss on extinguishment of debt
The $4.9 million loss on extinguishment of debt for the nine months ended September 28, 2024 was incurred as a result of the voluntary repayment of the Incremental Term Loan B principal balance in April 2024. There was no loss on extinguishment of debt for the three and nine months ended September 30, 2023.
Provision for income taxes
We incurred income tax expense of $4.4 million for the three months ended September 28, 2024 compared to an income tax benefit of $2.3 million for the three months ended September 30, 2023, an increase of $6.7 million, or 295.3%.
The increase in the Company’s effective tax rate from (23.7)% for the three months ended September 30, 2023 to 21.1% for the three months ended September 28, 2024 was primarily due to the exercise of stock options, the release of the valuation allowance against foreign tax credit carryovers and return-to-provision adjustments during the Comparable Quarter.
We incurred income tax expense of $16.8 million for the nine months ended September 28, 2024 compared to income tax expense of $12.3 million for the nine months ended September 30, 2023, an increase of $4.5 million, or 36.4%.
The increase in the Company’s effective tax rate from 19.9% for the nine months ended September 30, 2023 to 20.9% for the nine months ended September 28, 2024 was primarily due to a decrease in excess tax benefit from stock compensation and the release of the valuation allowance against foreign tax credit carryovers in the prior year period, partially offset with the change to the Company's permanent reinvestment assertion for one jurisdiction in the prior-year period.
Net income and net income margin
As a result of the foregoing, net income increased $4.7 million and $14.3 million for the three and nine months ended September 28, 2024, respectively.
Net income margin increased to 7.3% for the three months ended September 28, 2024 compared to 5.4% for the three months ended September 30, 2023, an increase of 190 basis points.
Net income margin increased to 8.8% for the nine months ended September 28, 2024 compared to 7.0% for the nine months ended September 30, 2023, an increase of 180 basis points.
Adjusted EBITDA and Adjusted EBITDA margin
Adjusted EBITDA increased to $51.1 million for the three months ended September 28, 2024 from $47.2 million for the three months ended September 30, 2023, an increase of $3.9 million, or 8.2%, driven primarily by increased net sales and higher gross profit, partially offset by an increase in SG&A expense.
Adjusted EBITDA margin increased to 22.5% for the three months ended September 28, 2024 compared to 21.4% for the three months ended September 30, 2023, an increase of 110 basis points.
Adjusted EBITDA increased to $178.7 million for the nine months ended September 28, 2024 from $171.6 million for the nine months ended September 30, 2023, an increase of $7.1 million or 4.2%, driven primarily by increased net sales and higher gross profit, partially offset by an increase in SG&A expense.
Adjusted EBITDA margin increased to 24.7% for the nine months ended September 28, 2024 compared to 24.0% for the nine months ended September 30, 2023, an increase of 70 basis points, due to the factors described above.
See “— Non-GAAP Reconciliation” for a reconciliation of adjusted EBITDA and adjusted EBITDA margin to the most directly comparable GAAP metric.


26


Segment
The Company manages its business primarily on a geographic basis. The Company’s reportable segments consist of NAM and E&RW. We evaluate performance based on net sales, gross profit, segment income and adjusted segment income, and we use gross profit margin, segment income margin and adjusted segment income margin as comparable performance measures for our reporting segments.
Segment income represents segment net sales less cost of sales, segment SG&A and RD&E, excluding acquisition and restructuring related expense as well as amortization of intangible assets. A reconciliation of segment income to our operating income is detailed below. Adjusted segment income represents segment income adjusted for the impact of depreciation, amortization of intangible assets recorded within cost of sales, stock-based compensation and certain non-cash, nonrecurring or other items that are included in segment income that we do not consider indicative of the ongoing segment operating performance. See “—Non-GAAP Reconciliation” for a reconciliation of these metrics to the most directly comparable GAAP metric.

North America (NAM)
(Dollars in thousands)Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Net sales$194,968 $185,070 $609,510 $585,126 
Gross profit$101,877 $91,456 $319,184 $288,911 
Gross profit margin %52.3 %49.4 %52.4 %49.4 %
Segment income$51,569 $40,108 $166,646 $144,346 
Segment income margin %26.4 %21.7 %27.3 %24.7 %
Adjusted segment income (a)
$59,461 $46,063 $186,038 $162,244 
Adjusted segment income margin % (a)
30.5 %24.9 %30.5 %27.7 %
(a) See “—Non-GAAP Reconciliation.”
Net sales
Net sales increased to $195.0 million for the three months ended September 28, 2024 from $185.1 million for the three months ended September 30, 2023, an increase of $9.9 million, or 5.3%.
Net sales increased to $609.5 million for the nine months ended September 28, 2024 from $585.1 million for the nine months ended September 30, 2023, an increase of $24.4 million, or 4.2%.
The year-over-year net sales increase was driven by the following factors:
Three Months EndedNine Months Ended
September 28, 2024September 28, 2024
Volume(3.8)%0.2 %
Price, net of allowances and discounts6.3 %3.1 %
Acquisitions3.0 %1.0 %
Currency and other(0.2)%(0.1)%
Total5.3 %4.2 %
The net sales increase for the three months ended September 28, 2024 was driven by positive net price including normalized allowances and discounts, the positive impact from acquisitions and volume growth in Canada, partially offset by a decline in volume in the US due to lower new construction and remodels.
The net sales increase for the nine months ended September 28, 2024 was driven primarily by increases in price and acquisitions.
Gross profit and gross profit margin
Gross profit increased to $101.9 million for the three months ended September 28, 2024 from $91.5 million for the three months ended September 30, 2023, an increase of $10.4 million, or 11.4%.
27


Gross profit margin increased to 52.3% for the three months ended September 28, 2024 from 49.4% for the three months ended September 30, 2023, an increase of 290 basis points. Gross margin increased due to operational efficiencies in our manufacturing facilities and normalized allowances and discounts, partially offset by a non-cash increase to cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business.
Gross profit increased to $319.2 million for the nine months ended September 28, 2024 from $288.9 million for the nine months ended September 30, 2023, an increase of $30.3 million, or 10.5%.
Gross profit margin increased to 52.4% for the nine months ended September 28, 2024 from 49.4% for the nine months ended September 30, 2023, an increase of 300 basis points. Gross margin increased due to operational efficiencies in our manufacturing facilities and net price increases including normalized allowances and discounts, partially offset by a non-cash increase to cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business.
Segment income and segment income margin
Segment income increased to $51.6 million for the three months ended September 28, 2024 from $40.1 million for the three months ended September 30, 2023, an increase of $11.5 million, or 28.6%. This was primarily driven by an increase in sales and gross profit as discussed above.
Segment income margin increased to 26.4% for the three months ended September 28, 2024 from 21.7% for the three months ended September 30, 2023, an increase of 470 basis points. The increase was driven by the increase in net sales and gross profit as discussed above.
Segment income increased to $166.6 million for the nine months ended September 28, 2024 from $144.3 million for the nine months ended September 30, 2023, an increase of $22.3 million, or 15.4%. This was primarily attributable to the increase in net sales and gross profit as discussed above, partially offset by higher SG&A expense due to increased administrative costs and investments in our customer care and selling teams.
Segment income margin increased to 27.3% for the nine months ended September 28, 2024 from 24.7% for the nine months ended September 30, 2023, an increase of 260 basis points, primarily resulting from higher gross profit as discussed above.
Adjusted segment income and Adjusted segment income margin
Adjusted segment income increased to $59.5 million for the three months ended September 28, 2024 from $46.1 million for the three months ended September 30, 2023, an increase of $13.4 million, or 29.1%. This was driven by the increase in segment income as discussed above, after adjusting for the non-cash and specified costs discussed below in “— Non-GAAP Reconciliation.”
Adjusted segment income margin increased to 30.5% for the three months ended September 28, 2024 from 24.9% for the three months ended September 30, 2023, an increase of 560 basis points.
Adjusted segment income increased to $186.0 million for the nine months ended September 28, 2024 from $162.2 million for the nine months ended September 30, 2023, an increase of $23.8 million or 14.7%. This was driven by the increased segment income as discussed above, after adjusting for the non-cash and specified costs discussed below in “— Non-GAAP Reconciliation.”
Adjusted segment income margin increased to 30.5% for the nine months ended September 28, 2024 from 27.7% for the nine months ended September 30, 2023, an increase of 280 basis points.
Refer to “—Non-GAAP Reconciliation” for a reconciliation of segment income to adjusted segment income.
28


Europe & Rest of World (E&RW)
(Dollars in thousands)Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Net sales$32,601 $35,234 $115,021 $128,857 
Gross profit$11,218 $13,955 $43,577 $50,901 
Gross profit margin %34.4 %39.6 %37.9 %39.5 %
Segment income$2,475 $6,413 $16,800 $25,647 
Segment income margin %7.6 %18.2 %14.6 %19.9 %
Adjusted segment income (a)
$2,746 $6,670 $17,601 $26,375 
Adjusted segment income margin % (a)
8.4 %18.9 %15.3 %20.5 %
(a) See “—Non-GAAP Reconciliation.”
Net sales
Net sales decreased to $32.6 million for the three months ended September 28, 2024 from $35.2 million for the three months ended September 30, 2023, a decrease of $2.6 million, or 7.5%.
Net sales decreased to $115.0 million for the nine months ended September 28, 2024 from $128.9 million for the nine months ended September 30, 2023, a decrease of $13.9 million, or 10.7%.
The year-over-year net sales decrease was driven by the following:
Three Months EndedNine Months Ended
September 28, 2024September 28, 2024
Volume(9.6)%(11.8)%
Price, net of allowances and discounts1.8 %1.2 %
Currency and other0.3 %(0.1)%
Total(7.5)%(10.7)%
The decrease for the three and nine months ended September 28, 2024 in net sales was primarily due to a decline in volume, partially offset by the favorable impact of net price. The decline in volume in the three and nine months ended September 28, 2024 is driven primarily by market declines in the Middle East and Asia.
Gross profit and Gross profit margin
Gross profit decreased to $11.2 million for the three months ended September 28, 2024 from $14.0 million for the three months ended September 30, 2023, a decrease of $2.8 million, or 19.6%.
Gross profit margin decreased to 34.4% for the three months ended September 28, 2024 from 39.6% for the three months ended September 30, 2023, a decrease of 520 basis points, primarily driven by lower operating leverage on lower volumes, a discrete inventory adjustment and unfavorable mix, partially offset by higher net price.
Gross profit decreased to $43.6 million for the nine months ended September 28, 2024 from $50.9 million for the nine months ended September 30, 2023, a decrease of $7.3 million, or 14.4%.
Gross profit margin decreased to 37.9% for the nine months ended September 28, 2024 from 39.5% for the nine months ended September 30, 2023, a decrease of 160 basis points, primarily driven by lower operating leverage and unfavorable mix due to the geopolitical conflicts in the Middle East.
Segment income and Segment income margin
Segment income decreased to $2.5 million for the three months ended September 28, 2024 from $6.4 million for the three months ended September 30, 2023, a decrease of $3.9 million, or 61.4%. This was primarily driven by a decrease in sales and gross profit as discussed above.
Segment income margin decreased by 1,060 basis points from 18.2% for the three months ended September 30, 2023 to 7.6% for the three months ended September 28, 2024, resulting from lower operating expense leverage and unfavorable mix.
29


Segment income decreased to $16.8 million for the nine months ended September 28, 2024 from $25.6 million for the nine months ended September 30, 2023, a decrease of $8.8 million, or 34.5%. This was driven by the factors discussed above.
Segment income margin decreased by 530 basis points, to 14.6% for the nine months ended September 28, 2024 as compared to 19.9% for the same period year over year.
Adjusted segment income and Adjusted segment income margin
Adjusted segment income decreased to $2.7 million for the three months ended September 28, 2024 from $6.7 million for the three months ended September 30, 2023, a decrease of $4.0 million or 58.8%. This was primarily driven by the decreased sales after adjusting for the non-cash and specified costs described in “—Non-GAAP Reconciliation” below.
Adjusted segment income margin decreased to 8.4% for the three months ended September 28, 2024 from 18.9% for the three months ended September 30, 2023, a decrease of 1,050 basis points. Refer to “—Non-GAAP Reconciliation” for a reconciliation of segment income to adjusted segment income.
Adjusted segment income decreased to $17.6 million for the nine months ended September 28, 2024 from $26.4 million for the nine months ended September 30, 2023, a decrease of $8.8 million or 33.3%. This was primarily driven by the decreased sales after adjusting for the non-cash and specified costs described in “—Non-GAAP Reconciliation” below.
Adjusted segment income margin decreased to 15.3% for the nine months ended September 28, 2024 from 20.5% for the nine months ended September 30, 2023, a decrease of 520 basis points. Refer to “—Non-GAAP Reconciliation” for a reconciliation of segment income to adjusted segment income.
Non-GAAP Reconciliation
The Company uses EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted segment income and adjusted segment income margin to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies. These metrics are also frequently used by analysts, investors and other interested parties to evaluate companies in our industry, when considered alongside other GAAP measures.
EBITDA is defined as earnings before interest (including amortization of debt costs), income taxes, depreciation, and amortization. Adjusted EBITDA is defined as EBITDA adjusted for the impact of restructuring related income or expenses, stock-based compensation, currency exchange items, and certain non-cash, nonrecurring, or other items that are included in net income and EBITDA that we do not consider indicative of our ongoing operating performance. Adjusted EBITDA margin is defined as adjusted EBITDA divided by net sales. Adjusted segment income is defined as segment income adjusted for the impact of depreciation, amortization of intangible assets recorded within cost of sales, stock-based compensation and certain non-cash, nonrecurring or other items that are included in segment income that we do not consider indicative of the ongoing segment operating performance. Adjusted segment income margin is defined as adjusted segment income divided by segment net sales.
EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted segment income and adjusted segment income margin are not recognized measures of financial performance under GAAP. We believe these non-GAAP measures provide analysts, investors and other interested parties with additional insight into the underlying trends of our business and assist these parties in analyzing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance, which allows for a better comparison against historical results and expectations for future performance. Management uses these non-GAAP measures to understand and compare operating results across reporting periods for various purposes including internal budgeting and forecasting, short and long-term operating planning, employee incentive compensation, and debt compliance. These non-GAAP measures are not intended to replace the presentation of our financial results in accordance with GAAP.
EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted segment income and adjusted segment income margin are not calculated in the same manner by all companies, and accordingly, are not necessarily comparable to similarly titled measures of other companies and may not be an appropriate measure for performance relative to other companies. EBITDA, adjusted EBITDA, adjusted segment income should not be construed as indicators of a company’s operating performance in isolation from, or as a substitute for, net income (loss) and segment income which are prepared in accordance with GAAP. We have presented EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted segment income and adjusted segment income margin solely as supplemental disclosure because we believe it allows for a more complete analysis of results of operations. In the future we may incur expenses such as those added back to calculate adjusted EBITDA. Our presentation of adjusted EBITDA and adjusted segment income should not be construed as an inference that our future results will be unaffected by these items.
30


Net Income to Adjusted EBITDA and Adjusted EBITDA Margin
Following is a reconciliation from net income to adjusted EBITDA and adjusted EBITDA margin for the three and nine months ended September 28, 2024 and September 30, 2023:
(Dollars in thousands)Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Net income $16,501 $11,788 $63,922 $49,651 
Depreciation4,862 4,428 13,929 13,018 
Amortization9,253 9,260 26,299 27,803 
Interest expense, net
13,209 17,448 48,600 55,939 
Income taxes4,411 (2,259)16,841 12,343 
Loss on debt extinguishment— — 4,926 — 
EBITDA48,236 40,665 174,517 158,754 
Stock-based compensation (a)
136 269 556 1,001 
Currency exchange items (b)
(344)145 (470)1,276 
Acquisition and restructuring related expense, net (c)
1,145 3,348 2,488 6,220 
Other (d)
1,920 2,784 1,657 4,367 
Total Adjustments2,857 6,546 4,231 12,864 
Adjusted EBITDA$51,093 $47,211 $178,748 $171,618 
Net income margin7.3 %5.4 %8.8 %7.0 %
Adjusted EBITDA margin22.5 %21.4 %24.7 %24.0 %
(a)
Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of Hayward’s initial public offering (the “IPO”).
(b)
Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts.
(c)Adjustments in the three months ended September 28, 2024 are primarily driven by $0.7 million of transaction and integration costs associated with the acquisition of the ChlorKing business and $0.4 million of costs to finalize actions initiated in prior years. Adjustments in the three months ended September 30, 2023 are primarily driven by $1.9 million of separation costs associated with the centralization and consolidation of operations in Europe and $1.5 million of costs associated with the relocation of the corporate headquarters.

Adjustments in the nine months ended September 28, 2024 are primarily driven by $1.3 million of transaction and integration costs associated with the acquisition of ChlorKing, $0.7 million of separation and other costs associated with the centralization and consolidation of operations in Europe and $0.4 million of costs to finalize actions initiated in prior years. Adjustments in the nine months ended September 30, 2023 are primarily driven by $2.1 million of costs associated with the relocation of the corporate headquarters, $1.9 million of separation costs associated with the centralization and consolidation of operations in Europe, $1.3 million of separation costs associated with the enterprise cost-reduction program initiated in 2022 and $0.8 million of integration costs from prior acquisitions.
(d)Adjustments in the three months ended September 28, 2024 are primarily driven by a $1.6 million non-cash increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.3 million of costs incurred related to litigation. Adjustments in the three months ended September 30, 2023 primarily include $1.9 million of costs related to inventory and fixed assets as part of the centralization and consolidation of operations in Europe and $0.8 million of costs incurred related to the selling stockholder offerings of shares during 2023, which are reported in SG&A in the unaudited condensed consolidated statement of operations

Adjustments in the nine months ended September 28, 2024 are primarily driven by a $1.6 million non-cash increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.5 million of costs incurred related to litigation, partially offset by $0.5 million of gains on the sale of assets. Adjustments in the nine months ended September 30, 2023 primarily includes $1.9 million of costs related to inventory and fixed assets as part of the centralization of operations in Europe, $1.5 million of costs associated with follow-on equity offerings, $0.4 million of transitional expenses incurred to enable go-forward public company regulatory compliance and other miscellaneous items the Company believes are not representative of its ongoing business operations.



31


Following is a reconciliation from segment income to adjusted segment income for NAM for the three and nine months ended September 28, 2024 and September 30, 2023 (dollars in thousands):
NAMThree Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Segment income$51,569 $40,108 $166,646 $144,346 
Depreciation4,404 4,027 12,619 11,952 
Amortization1,677 1,738 4,874 5,026 
Stock-based compensation107 75 176 417 
Other (a)
1,704 115 1,723 503 
Total adjustments7,892 5,955 19,392 17,898 
Adjusted segment income$59,461 $46,063 $186,038 $162,244 
Segment income margin 26.4 %21.7 %27.3 %24.7 %
Adjusted segment income margin30.5 %24.9 %30.5 %27.7 %
(a)The three months ended September 28, 2024 primarily includes a $1.6 million non-cash increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business. The three months ended September 30, 2023 includes miscellaneous items the Company believes are not representative of its ongoing business operations.
The nine months ended September 28, 2024 primarily includes a $1.6 million non-cash increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business. The nine months ended September 30, 2023 includes miscellaneous items the Company believes are not representative of its ongoing business operations.
Following is a reconciliation from segment income to adjusted segment income for E&RW for the three and nine months ended September 28, 2024 and September 30, 2023 (dollars in thousands):
E&RWThree Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Segment income$2,475 $6,413 $16,800 $25,647 
Depreciation271 246 791 694 
Amortization— — — — 
Stock-based compensation— 11 10 34 
Total Adjustments271 257 801 728 
Adjusted segment income$2,746 $6,670 $17,601 $26,375 
Segment income margin7.6 %18.2 %14.6 %19.9 %
Adjusted segment income margin8.4 %18.9 %15.3 %20.5 %
Liquidity and Capital Resources
Our primary sources of liquidity are net cash provided by operating activities and availability under the ABL Revolving Credit Facility (ABL Facility).
Primary working capital requirements are for raw materials, component and certain finished goods inventories and supplies, payroll, manufacturing, freight and distribution, facility, and other operating expenses. Cash flow from operations and working capital requirements fluctuate during the year, driven primarily by the seasonal demand for our products, an Early Buy program, the timing of inventory purchases and receipt of customer payments, and as such, the utilization of the ABL Facility fluctuates during the year.
Unrestricted cash and cash equivalents totaled $274.2 million as of September 28, 2024, which is an increase of $96.1 million from $178.1 million at December 31, 2023.
32


We focus on increasing cash flow, solidifying the liquidity position through working capital initiatives, and paying our debt obligations, while continuing to fund business growth initiatives and return of capital to shareholders. We believe that net cash provided by operating activities and availability under the ABL Facility will be adequate to finance our working capital requirements, inclusive of capital expenditures, and debt service over the next 12 months.
Accounts Receivable Sales
On July 3, 2024, we entered into a Receivables Purchase Agreement under which we may offer to sell eligible accounts receivable. The agreement is uncommitted and the eligible accounts receivable to be sold under the agreement consist of up to $125 million in accounts receivable generated by sales to specified customers of the Company. The Company will be paid a discounted purchase price for each receivable sold. The discount rate used to determine the purchase price for the subject receivables is based upon an annual interest rate equal to the forward-looking term rate based on the secured overnight financing rate for the period of time between payment to the Company and the due date for the receivable plus a buffer period specific to the obligor, plus a margin applicable to the specified obligor.
Transactions under this agreement are accounted for as sales of accounts receivable, and the receivables sold are removed from the unaudited condensed consolidated balance sheets at the time of the sales transaction. For ease of administration, the Company collects customer payments related to the receivables sold and remits those payments to the purchaser. Proceeds received from the sales of accounts receivable are classified as operating cash flows and collections of previously sold accounts receivable not yet submitted to the financial institution are classified as financing cash flows in the unaudited condensed consolidated statements of cash flows. We record the discount in the “Other expense, net” line in the unaudited condensed consolidated statements of operations. During the three months ended September 28, 2024, there were immaterial proceeds from the sale of receivables under the Receivables Purchase Agreement.
Credit Facilities
The First Lien Term Facility and ABL Facility (collectively “Credit Facilities”) contain various restrictions, covenants and collateral requirements. Refer to Note 7. Long-Term Debt of notes to our unaudited condensed consolidated financial statements for further information on the terms of the Credit Facilities. We also have a revolving credit facility for our Spain subsidiary in the amount of €0.5 million as a local source of liquidity. As of September 28, 2024, the Spain revolving facility balance was zero with a borrowing availability of €0.5 million.
Long-term debt consisted of the following (in thousands):
September 28, 2024December 31, 2023
First Lien Term Facility, due May 28, 2028$970,000 $975,000 
Incremental B First Lien Term Facility, due May 28, 2028— 123,438 
ABL Revolving Credit Facility— — 
Other bank debt11,267 8,775 
Finance lease obligations2,800 4,729 
Subtotal984,067 1,111,942 
Less: Current portion of the long-term debt(14,079)(15,088)
Less: Unamortized debt issuance costs(10,082)(17,574)
Total$959,906 $1,079,280 
33


ABL Facility
The ABL Facility provides for an aggregate amount of borrowings up to $425.0 million, with a peak season commitment of $475.0 million, subject to a borrowing base calculation based on available eligible receivables, eligible inventory, and qualified cash in North America. Accounts receivable for customers whose receivables are eligible for purchase under the Receivables Purchase Agreement, regardless of whether any amount of outstanding accounts receivable with those specific customers have been sold under the Receivables Purchase Agreement, are not eligible accounts receivable under the ABL Facility. An amount of up to 30% (or up to 40% with agent consent) of the then-outstanding commitments under the ABL Facility is available to our Canada and Spain subsidiaries. A portion of the ABL Facility not to exceed $50 million is available for the issuance of letters of credit in U.S. Dollars, of which $20.0 million is available for the issuance of letters of credit in Canadian dollars. The ABL Facility also includes a $50.0 million swingline loan facility and a $21.9 million First-In, Last-Out Sublimit (FILO Sublimit). The maturity of the facility is June 1, 2026.
On June 26, 2024, the Company entered into the Fourth Amendment to its existing ABL Revolving Credit Facility (the “ABL Facility”) to replace the Canadian reference rate from the Canadian Dollar Offered Rate (“CDOR”) to the Canadian Overnight Repo Rate Average (“CORRA”).
The borrowings under the ABL Facility bear interest at a rate equal to the Secured Overnight Financing Rate (“Term SOFR”) plus a 0.10% credit spread adjustment and a margin of between 1.25% to 1.75%, or at a base rate plus a margin of 0.25% to 0.75% with no credit spread adjustment, while the FILO Sublimit borrowings bear interest at a rate equal to Term SOFR or a base rate plus a margin of between 2.25% to 2.75% or 1.25% to 1.75%, respectively.
For the three months ended September 28, 2024, the average borrowing base under the ABL Facility was $109.2 million and the average loan balance outstanding was zero. As of September 28, 2024, the loan balance was zero with a borrowing availability of $113.7 million.
For the nine months ended September 28, 2024, the average borrowing base under the ABL Facility was $237.4 million and the average loan balance outstanding was zero.
First Lien Term Facilities
On May 22, 2023, the Company entered into the Fifth Amendment to the Company's First Lien Credit Agreement (the “First Lien Term Facility” and, together with the ABL Facility, the “Credit Facilities”) to replace the LIBOR based reference rate with an adjusted term Secured Overnight Financing Rate (“SOFR”). The First Lien Term Facility bears interest at a rate equal to a base rate or SOFR, plus, in either case, an applicable margin. In the case of SOFR tranches, the applicable margin is 2.75% per annum with a 0.50% floor, with a stepdown to 2.50% per annum with a 0.50% floor when net secured leverage as defined by the First Lien Credit Agreement is less than 2.5x. The loan under the First Lien Term Facility amortizes quarterly at a rate of 0.25% of the original principal amount and requires a $2.5 million repayment of principal on the last business day of each March, June, September and December. For a portion of the Comparable Quarter and the nine months ended September 30, 2023, the borrowings under the First Lien Term Facility bore interest at a rate equal to LIBOR or a base rate plus an applicable margin of 2.75% per annum with a 0.50% floor, with a stepdown to 2.50% per annum with a 0.50% floor when net secured leverage ratio is less than 2.5x.
The First Lien Term Facility also included an incremental term loan in an aggregate original principal amount of $125 million (the “Incremental Term Loan B”). The Incremental Term Loan B bore interest at an annual floating rate based on a forward-looking rate of the Secured Overnight Financing Rate (with a 0.50% floor) plus 3.25% and a 0.10% credit spread adjustment. In April 2024, the Company used $123.1 million of cash on hand to fund voluntary principal prepayments of the Incremental Term Loan B. As a result of these prepayments, the Company had zero aggregate principal outstanding on the Incremental Term Loan B as of September 28, 2024.
Under the agreement governing the First Lien Credit Facility (the First Lien Credit Agreement), the Company must make an annual mandatory prepayment of principal for between 0% and 50% of the excess cash and subject to permitted deductions, as defined in the First Lien Credit Agreement, generated in the prior calendar year. The amount due varies with the First Lien Leverage Ratio as defined in the First Lien Credit Agreement, from zero if the First Lien Leverage Ratio is less than or equal to 2.5x, to fifty percent if the First Lien Leverage Ratio is greater than 3.0x, in each case as of December 31 of the prior year. The First Lien Term Facility matures on May 28, 2028.
As of September 28, 2024, the balance outstanding under the First Lien Term Facility was $970.0 million.
For the three months ended September 28, 2024, the effective interest rate on borrowings under the First Lien Term Facility, including the impact of an interest rate hedge, was 6.51%. The effective interest rate is comprised of 8.01% for interest and 0.29% for financing costs, partially offset by 1.78% for interest income on the interest rate swaps.
34


For the nine months ended September 28, 2024, the effective interest rate on borrowings under the First Lien Term Facility, including the impact of an interest rate hedge, was 6.76%. The effective interest rate is comprised of 8.10% for interest and 0.34% for financing costs, partially offset by 1.68% for interest income on the interest rate swaps.
Covenant Compliance
The Credit Facilities contain various restrictions, covenants and collateral requirements. As of September 28, 2024, we were in compliance with all covenants under the Credit Facilities.
Sources and Uses of Cash
Following is a summary of our cash flows from operating, investing, and financing activities:
(Dollars in thousands)Nine Months Ended
September 28, 2024September 30, 2023
Net cash provided by operating activities$275,762 $216,937 
Net cash used in investing activities(53,877)(22,610)
Net cash used in financing activities(125,848)(5,198)
Effect of exchange rate changes on cash and cash equivalents50 (1,061)
Change in cash and cash equivalents$96,087 $188,068 
Net cash provided by operating activities
Net cash provided by operating activities increased to $275.8 million for the nine months ended September 28, 2024 from $216.9 million for the nine months ended September 30, 2023, an increase of $58.9 million, or 27.1%. The increase in cash provided was primarily driven by greater cash generated by working capital compared to the prior-year period and due to an increase in net income.
Net cash used in investing activities
Net cash used in investing activities was $53.9 million for the nine months ended September 28, 2024 compared to net cash used in investing activities of $22.6 million for the nine months ended September 30, 2023, a change of $31.3 million, or 138.3%. The increase in cash used in investing activities is driven by the acquisition of the ChlorKing business, partially offset by the proceeds of certificates of deposit investments.
Net cash used in financing activities
Net cash used in financing activities was $125.8 million for the nine months ended September 28, 2024 compared to net cash used in financing activities of $5.2 million for the nine months ended September 30, 2023, a change of $120.6 million, or 2321.1%. The increase in cash used was primarily driven by the prepayment of the Incremental Term Loan B.

Off-Balance Sheet Arrangements
We had $4.3 million of outstanding letters of credit on our ABL Revolving Credit Facility as of each of September 28, 2024 and December 31, 2023.

Critical Accounting Estimates
Our unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. The preparation of financial statements requires management to make estimates and assumptions that affect amounts reported therein. The estimates that require management’s most difficult, subjective or complex judgments are described in Part II, Item 7, under the heading “Critical Accounting Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2023 (our “Annual Report on Form 10-K”), which section is incorporated herein by reference, and remain unchanged through the first nine months of 2024.

Recently Issued Accounting Standards
See Note 2. Significant Accounting Policies of notes to our unaudited condensed consolidated financial statements for additional information.
35



ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Market risk is the potential economic loss that may result from adverse changes in the fair value of financial instruments. We are exposed to various market risks, including changes in interest rates and foreign currency rates. Periodically, we use derivative financial instruments to manage or reduce the impact of changes in interest rates and foreign currency rates. Counterparties to all derivative contracts are major financial institutions. All instruments are entered into for other than trading purposes.
There have been no material changes in the interest rate risk during the nine months ended September 28, 2024 from what we reported in our Annual Report on Form 10-K.

ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures that are designed to provide reasonable assurance that information, which is required to be disclosed by the issuer in the reports that it files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control over Financial Reporting
There have been no changes in the Company’s internal control over financial reporting during the three months ended September 28, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
36


PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS
For a discussion of our “Legal Proceedings,” refer to Note 12. Commitments and Contingencies of notes to our unaudited condensed consolidated financial statements, which discussion is incorporated by reference herein.
In addition to the matters discussed in this report and in the notes to our unaudited condensed consolidated financial statements, we are from time to time subject to, and are presently involved in, other litigation and legal proceedings arising in the ordinary course of business. These proceedings could relate to commercial or contractual disputes with suppliers, customers or parties to acquisitions and divestitures, intellectual property matters, product liability, the use or installation of our products, consumer matters, employment and labor matters, and environmental, safety and health matters, including claims based on alleged exposure to asbestos-containing product components. We believe that the outcome of such other litigation and legal proceedings will not have a material adverse effect on our business, financial condition, results of operations and cash flows.
On August 2, 2023, a securities class action complaint was filed in the United States District Court for the District of New Jersey against the Company and certain of its current directors and officers (Kevin Holleran and Eifion Jones) and MSD Partners and CCMP Capital Advisors, LP on behalf of a putative class of stockholders who acquired shares of our common stock between March 2, 2022 and July 27, 2022. That action is captioned City of Southfield Fire and Police Retirement System vs. Hayward Holdings, Inc., et al., 2:23-cv-04146-WJM-ESK (D.N.J.) (“City of Southfield”). On September 28, 2023, a second, related securities class action complaint was filed in the United States District Court for the District of New Jersey against the Company and certain of its current directors and officers (Kevin Holleran and Eifion Jones) and MSD Partners and CCMP Capital Advisors, LP on behalf of a putative class of stockholders who acquired shares of our common stock between October 27, 2021 and July 28, 2022. That action is captioned Erie County Employees’ Retirement System vs. Hayward Holdings, Inc., et al., 2:23-cv-04146-WJM-ESK (D.N.J.) (“Erie County”). On December 19, 2023, the Court issued a ruling consolidating the two securities class actions (City of Southfield and Erie County) under the City of Southfield docket (the “Securities Class Action”) and appointing a lead plaintiff. In a consolidated class action complaint filed March 4, 2024, the Securities Class Action alleged on behalf of a putative class of stockholders who acquired shares of our common stock between October 27, 2021 and July 28, 2022, among other things, that the Company and certain of its current directors and officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by, among other things, making materially false or misleading statements regarding inventory, growth, and demand trends and the Company’s financial projections for 2022. The Securities Class Action seeks unspecified monetary damages on behalf of the putative classes and an award of costs and expenses, including reasonable attorneys’ fees. On October 2, 2024, the Court issued an Opinion and Order dismissing the consolidated class action complaint and granted the lead plaintiff leave to file an amended complaint within 30 days.
On November 27, 2023, a shareholder derivative lawsuit was filed in the United States District Court for the District of New Jersey against current and past officers and directors of the Company captioned Heicklen v. Holleran, et al., 2:23-cv-22649 (D.N.J.) (the “Derivative Action”). The Derivative Action alleges breaches of fiduciary duties to Company stockholders, aiding and abetting breaches of fiduciary duties, unjust enrichment, corporate waste, and violations of Section 10(b) of the Securities Exchange Act of 1934 in connection with the claims in the Securities Class Action. The Company’s Amended and Restated Bylaws and pre-existing agreements between the Company and these current and former directors provide for the Company, to the fullest extent permitted by applicable law, to indemnify, defend and hold harmless any action, suit or proceeding any person, by reason of the fact that he or she is or was a director of the Company, against all liability and loss suffered. The Derivative Action seeks recovery of unspecified damages and attorney’s fees and costs, as well as improvements to the Company’s corporate governance and internal procedures. The Derivative Action has been stayed pending final decision on a motion to dismiss being filed in the Securities Class Action.
We dispute the allegations of wrongdoing in the Securities Class Action and the Derivative Action and intend to vigorously defend ourselves in these matters. In view of the complexity and ongoing and uncertain nature of the outstanding proceedings and inquiries, at this time we are unable to estimate a reasonably possible financial loss or range of financial loss, if any, that we may incur to resolve or settle the Securities Class Action and the Derivative Action.






37



ITEM 1A. RISK FACTORS
An investment in our common stock involves risks. For a detailed discussion of the risks that affect our business please refer to the section titled “Risk Factors” in our Annual Report on Form 10-K. Other than as noted below, there have been no material changes to our risk factors as previously disclosed in our Annual Report on Form 10-K.

We rely on information technology systems to support our business operations. A significant disturbance or breach of our technological infrastructure, or those of our vendors or others with which we do business, could adversely affect our financial condition and results of operations. Additionally, failure to maintain the security of confidential information could damage our reputation and expose us to litigation.
We rely upon information technology systems and networks in connection with a variety of business activities, some of which are managed by third parties, whose products, services and systems are beyond our control. We expect our reliance on information technology systems to increase as we continue to develop IoT-enabled products, such as our Omni mobile app, and implement new technologies to facilitate our operations, such as our ERP system and human resources information system, which are in the process of being implemented. As a result, our ability to operate effectively on a day-to-day basis and accurately report our results depends on a reliable technological infrastructure, which is inherently susceptible to internal and external threats, including malicious code embedded in open-source software, or misconfigurations, “bugs” or other vulnerabilities in commercial software that is integrated into our (or our suppliers’ or service providers’) information technology systems and networks, products or services. We are vulnerable to interruption and breakdown by system downtime or failure, fire, natural disaster, power loss, telecommunication failures, internet failures, security breaches and other catastrophic events.
We are subject to known and unknown vulnerabilities in our software and systems and those of third parties. We and certain of our third-party service providers have in the past experienced, and we expect in the future will continue to experience, cybersecurity attacks and other incidents that threaten the confidentiality, integrity and availability of information technology systems and networks and confidential information, including personal information, that we or third parties collect, maintain and/or process. We periodically evaluate and test the adequacy of our systems, measures, controls and procedures and perform third-party risk assessments. However, such threats have increased in frequency, scope, and potential impact in recent years. Because the techniques used to obtain unauthorized access or to sabotage systems change frequently and are often not recognized until after they are launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. We prioritize the remediation of identified security vulnerabilities based on known and anticipated risks, and we aim to patch vulnerabilities within reasonable timeframes. However, we are unable to comprehensively identify all vulnerabilities (particularly as related to third-party software and systems), apply patches or confirm that mitigating measures are in place, or ensure that any patches will be applied by us or third parties before exploitation by a threat actor. If attackers are able to exploit vulnerabilities before patches are installed or mitigating measures are implemented, significant compromises could impact our systems and data.
The development of artificial intelligence technologies may exacerbate these cybersecurity risks and pose new or unknown cybersecurity risks and challenges. As a result, we may be unable to detect, investigate, remediate or recover from future attacks or incidents, or to avoid a material adverse impact to our information technology systems and networks, confidential information or business. The accidental or willful security breaches or other unauthorized access by third parties to our information technology systems or facilities, or those of our vendors and/or others with which we do business, or the existence of computer viruses, such as ransomware or other malware, in our or their data or software, and/or any other failure of our or their information technology systems could expose us to a risk of information loss, the misappropriation of proprietary and confidential information, work stoppages, reputational damage, regulatory investigations and enforcement actions, regulatory fines or penalties, litigation by affected parties, possible financial obligations for liabilities and damages related to the theft or misuse of this information and/or the defective manufacture or defective design of our products, which could expose us to liability, and/or significant incident response, system restoration or remediation and future compliance costs. In addition, while we currently maintain insurance coverage that, subject to its terms and conditions, is intended to address costs associated with certain aspects of cybersecurity incidents and information systems failures, this insurance coverage may not, depending on the specific facts and circumstances surrounding an incident, cover all losses or all types of claims that arise from an incident, or the damage to our reputation that may result from an incident. The occurrence of any of these events could have an adverse effect on our business, financial condition, results of operations and reputation. There can be no assurance that our cybersecurity risk management program and processes, including our policies, controls or procedures, will be fully implemented, complied with or effective in protecting our information technology systems and confidential information.
38


Establishing and maintaining systems and processes to address these threats may increase our costs and may be mandated by regulation. For example, the California Internet of Things Security Law, which became effective in 2020, requires us to implement reasonable security measures for IoT devices, and failure to do so could expose us to penalties.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The Company had no repurchases of its common stock, par value $0.001 per share, in the quarter ended September 28, 2024. On July 26, 2022, the Board of Directors renewed the initial authorization of its share repurchase program (the “Share Repurchase Program”) such that the Company is authorized, commencing at that time, to repurchase from time to time up to an aggregate of $450.0 million of its common stock with such authority expiring on July 26, 2025.
Under the Share Repurchase Program, the Company may purchase shares of its common stock on a discretionary basis from time to time and may be conducted through privately negotiated transactions, including with our significant stockholders, as well as through open market repurchases or other means, including through Rule 10b5-1(c) trading plans or through the use of other techniques such as accelerated share repurchases. The amount and timing of future repurchases may vary depending on market conditions and the level of operating, financing and other investing activities.
As of September 28, 2024, $400.0 million remained available under the current authorization for additional share repurchases. The Company did not make purchases of its common stock under the Share Repurchase Program for the three months ended September 28, 2024.
Period(a) Total Number of Shares Purchased(b) Average Price Paid per Share(c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Program(d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Program
June 30 – August 3, 2024— $— — $400,000,000 
August 4 – August 31, 2024— — — 400,000,000 
September 1 – September 28, 2024— — — 400,000,000 
Total— $— — $400,000,000 
























39


ITEM 5. OTHER INFORMATION
Securities Trading Plans of Directors and Executive Officers
During the three months ended September 28, 2024, certain of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) entered into contracts, instructions, or written plans for the purchase or sale of our securities that are intended to satisfy the conditions specified in Rule 10b5-1(c) under the Exchange Act for an affirmative defense against liability for trading in securities on the basis of material nonpublic information. We refer to these contracts, instructions, and written plans as “Rule 10b5-1 Trading Plans” and each one as a “Rule 10b5-1 Trading Plan.”

We describe the material terms of all such trading plans below.
Kevin Holleran, President, Chief Executive Officer
On August 9, 2024, Kevin Holleran, our President and Chief Executive Officer, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Holleran, acting through a broker, may sell up to an aggregate of 600,000 shares of our common stock. Sales of shares under the plan may only occur from November 11, 2024, to June 13, 2025. The plan is scheduled to terminate on June 13, 2025, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Holleran or the broker, or as otherwise provided in the plan.
Eifion Jones, Chief Financial Officer
On August 9, 2024, Eifion Jones, our Senior Vice President, Chief Financial Officer, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Jones, acting through a broker, may sell up to an aggregate of 100,000 shares of our common stock. Sales of shares under the plan may only occur from November 8, 2024, to May 30, 2025. The plan is scheduled to terminate on May 30, 2025, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Jones or the broker, or as otherwise provided in the plan.

40


ITEM 6. EXHIBITS
Exhibit No.Description
Receivables Purchase Agreement, dated July 3, 2024, between Hayward Industries, Inc. and Wells Fargo Bank, N.A. (previously filed as Exhibit 10.1 to the Form 8-K filed on July 9, 2024 and incorporated herein by reference).
Certification of Chief Executive Officer of Hayward Holdings, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Financial Officer of Hayward Holdings, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Executive Officer of Hayward Holdings, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Financial Officer of Hayward Holdings, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INSInline XBRL Instance Document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Taxonomy Calculation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
101.LABInline XBRL Taxonomy Label Linkbase Document.
101.PREInline XBRL Taxonomy Presentation Linkbase Document.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in the Interactive Data Files submitted as Exhibits 101.*)
    
41


SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this day of October 29, 2024.

HAYWARD HOLDINGS, INC.
By:/s/ Eifion Jones
Name:Eifion Jones
Title:Senior Vice President & Chief Financial Officer

42

Exhibit 31.1

CERTIFICATION PURSUANT TO RULES 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Kevin Holleran, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Hayward Holdings, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.     designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.     evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.     disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.     any fraud, whether or not material, that involves management or other employees who have a     significant role in the registrant’s internal control over financial reporting.

Date: October 29, 2024
By: /s/ Kevin Holleran
Kevin Holleran
President and Chief Executive Officer
(Principal Executive Officer)


Exhibit 31.2

CERTIFICATION PURSUANT TO RULES 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Eifion Jones, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Hayward Holdings, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.     designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.     evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in     this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.     disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.     any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 29, 2024
By: /s/ Eifion Jones
Eifion Jones
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)


Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Hayward Holdings, Inc. (the “Company”) for the period ended September 28, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Kevin Holleran, President and Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: October 29, 2024
By: /s/ Kevin Holleran
Kevin Holleran
President and Chief Executive Officer
(Principal Executive Officer)
                                                                                                                        


Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Hayward Holdings, Inc. (the “Company”) for the period ended September 28, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Eifion Jones, Senior Vice President and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: October 29, 2024
By: /s/ Eifion Jones
Eifion Jones
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
    

v3.24.3
Cover - shares
9 Months Ended
Sep. 28, 2024
Oct. 25, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 28, 2024  
Document Transition Report false  
Entity File Number 001-40208  
Entity Registrant Name Hayward Holdings, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 82-2060643  
Entity Address, Address Line One 1415 Vantage Park Drive  
Entity Address, Address Line Two Suite 400  
Entity Address, City or Town Charlotte  
Entity Address, State or Province NC  
Entity Address, Postal Zip Code 28203  
City Area Code 704  
Local Phone Number 837-8002  
Title of 12(b) Security Common stock, $.001 per share  
Trading Symbol HAYW  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   215,424,560
Amendment Flag false  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity Central Index Key 0001834622  
v3.24.3
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 28, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 274,184 $ 178,097
Short-term investments 0 25,000
Accounts receivable, net of allowances of $2,881 and $2,870, respectively 99,932 270,875
Inventories, net 229,363 215,180
Prepaid expenses 15,541 14,331
Income tax receivable 11,634 9,994
Other current assets 18,898 11,264
Total current assets 649,552 724,741
Property, plant, and equipment, net of accumulated depreciation of $108,726 and $95,917, respectively 164,654 158,979
Goodwill 953,175 935,013
Trademark 736,000 736,000
Customer relationships, net 209,836 206,308
Other intangibles, net 92,479 94,082
Other non-current assets 84,168 91,161
Total assets 2,889,864 2,946,284
Current liabilities    
Current portion of long-term debt 14,079 15,088
Accounts payable 73,562 68,943
Accrued expenses and other liabilities 159,709 155,543
Income taxes payable 825 109
Total current liabilities 248,175 239,683
Long-term debt, net 959,906 1,079,280
Deferred tax liabilities, net 239,362 248,967
Other non-current liabilities 69,266 66,896
Total liabilities 1,516,709 1,634,826
Commitments and contingencies (Note 12)
Stockholders’ equity    
Preferred stock, $0.001 par value, 100,000,000 authorized, no shares issued or outstanding as of September 28, 2024 and December 31, 2023 0 0
Common stock $0.001 par value, 750,000,000 authorized; 244,078,929 issued and 215,412,560 outstanding at September 28, 2024; 242,832,045 issued and 214,165,676 outstanding at December 31, 2023 244 243
Additional paid-in capital 1,089,782 1,080,894
Common stock in treasury; 28,666,369 and 28,666,369 at September 28, 2024 and December 31, 2023, respectively (358,125) (357,755)
Retained earnings 644,831 580,909
Accumulated other comprehensive income (3,577) 7,167
Total stockholders’ equity 1,373,155 1,311,458
Total liabilities, redeemable stock, and stockholders’ equity $ 2,889,864 $ 2,946,284
v3.24.3
Unaudited Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 28, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Accounts receivable, allowances $ 2,881 $ 2,870
Property, plant, and equipment, accumulated depreciation $ 108,726 $ 95,917
Preferred stock par value (in usd per share) $ 0.001 $ 0.001
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 0 0
Preferred stock outstanding (in shares) 0 0
Common stock, par value (in usd per share) $ 0.001 $ 0.001
Common stock, authorized (in shares) 750,000,000 750,000,000
Common stock issued (in shares) 244,078,929 242,832,045
Common stock outstanding (in shares) 215,412,560 214,165,676
Common treasury stock (in shares) 28,666,369 28,666,369
v3.24.3
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net sales $ 227,569 $ 220,304 $ 724,531 $ 713,983
Cost of sales 114,474 114,893 361,770 374,171
Gross profit 113,095 105,411 362,761 339,812
Selling, general and administrative expense 64,509 59,454 187,678 172,057
Research, development and engineering expense 6,449 6,177 18,870 19,027
Acquisition and restructuring related expense 1,145 3,348 2,488 6,220
Amortization of intangible assets 7,576 7,523 21,425 22,777
Operating income 33,416 28,909 132,300 119,731
Interest expense, net 13,209 17,448 48,600 55,939
Loss on debt extinguishment 0 0 4,926 0
Other (income) expense, net (705) 1,932 (1,989) 1,798
Total other expense 12,504 19,380 51,537 57,737
Income from operations before income taxes 20,912 9,529 80,763 61,994
Provision (benefit) for income taxes 4,411 (2,259) 16,841 12,343
Net income $ 16,501 $ 11,788 $ 63,922 $ 49,651
Earnings per share        
Basic (in usd per share) $ 0.08 $ 0.06 $ 0.30 $ 0.23
Diluted (in usd per share) $ 0.07 $ 0.05 $ 0.29 $ 0.23
Weighted average common shares outstanding        
Basic (in shares) 215,231,886 213,416,502 214,836,643 212,933,763
Diluted (in shares) 221,436,206 220,863,228 221,251,355 220,634,232
v3.24.3
Unaudited Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Statement of Comprehensive Income [Abstract]        
Net income $ 16,501 $ 11,788 $ 63,922 $ 49,651
Other comprehensive income (loss):        
Foreign currency translation adjustments, gross 6,605 (5,235) (1,436) (1,625)
Foreign currency translation adjustments, taxes 0 0 0 0
Foreign currency translation adjustments, net 6,605 (5,235) (1,436) (1,625)
Net change on cash flow hedges, gross (13,914) 961 (12,411) 1,562
Net change on cash flow hedges, taxes 3,478 (240) 3,103 (390)
Net change on cash flow hedges, net (10,436) 721 (9,308) 1,172
Comprehensive income $ 12,670 $ 7,274 $ 53,178 $ 49,198
v3.24.3
Unaudited Condensed Consolidated Statements of Changes in Redeemable Stock and Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022   211,862,781        
Beginning balance at Dec. 31, 2022 $ 1,223,034 $ 241 $ 1,069,878 $ (357,415) $ 500,222 $ 10,108
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 8,410       8,410  
Stock-based compensation 2,047   2,047      
Issuance of Common Stock for compensation plans (in shares)   912,288        
Issuance of Common Stock for compensation plans 570 $ 1 569      
Repurchase of stock (9)     (9)    
Other comprehensive (loss) income (3,933)         (3,933)
Ending balance (in shares) at Apr. 01, 2023   212,775,069        
Ending balance at Apr. 01, 2023 1,230,119 $ 242 1,072,494 (357,424) 508,632 6,175
Beginning balance (in shares) at Dec. 31, 2022   211,862,781        
Beginning balance at Dec. 31, 2022 1,223,034 $ 241 1,069,878 (357,415) 500,222 10,108
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 49,651          
Ending balance (in shares) at Sep. 30, 2023   213,689,808        
Ending balance at Sep. 30, 2023 1,280,334 $ 243 1,078,200 (357,637) 549,873 9,655
Beginning balance (in shares) at Apr. 01, 2023   212,775,069        
Beginning balance at Apr. 01, 2023 1,230,119 $ 242 1,072,494 (357,424) 508,632 6,175
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 29,453       29,453  
Stock-based compensation 2,099   2,099      
Issuance of Common Stock for compensation plans (in shares)   231,354        
Issuance of Common Stock for compensation plans 156   156      
Other comprehensive (loss) income 7,994         7,994
Ending balance (in shares) at Jul. 01, 2023   213,006,423        
Ending balance at Jul. 01, 2023 1,269,821 $ 242 1,074,749 (357,424) 538,085 14,169
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 11,788       11,788  
Stock-based compensation 2,555   2,555      
Issuance of Common Stock for compensation plans (in shares)   683,385        
Issuance of Common Stock for compensation plans 897 $ 1 896      
Repurchase of stock (213)     (213)    
Other comprehensive (loss) income (4,514)         (4,514)
Ending balance (in shares) at Sep. 30, 2023   213,689,808        
Ending balance at Sep. 30, 2023 $ 1,280,334 $ 243 1,078,200 (357,637) 549,873 9,655
Beginning balance (in shares) at Dec. 31, 2023 214,165,676 214,165,676        
Beginning balance at Dec. 31, 2023 $ 1,311,458 $ 243 1,080,894 (357,755) 580,909 7,167
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 9,840       9,840  
Stock-based compensation 1,983   1,983      
Issuance of Common Stock for compensation plans (in shares)   550,713        
Issuance of Common Stock for compensation plans 800 $ 1 799      
Repurchase of stock (355)     (355)    
Other comprehensive (loss) income (3,234)         (3,234)
Ending balance (in shares) at Mar. 30, 2024   214,716,389        
Ending balance at Mar. 30, 2024 $ 1,320,492 $ 244 1,083,676 (358,110) 590,749 3,933
Beginning balance (in shares) at Dec. 31, 2023 214,165,676 214,165,676        
Beginning balance at Dec. 31, 2023 $ 1,311,458 $ 243 1,080,894 (357,755) 580,909 7,167
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 63,922          
Ending balance (in shares) at Sep. 28, 2024 215,412,560 215,412,560        
Ending balance at Sep. 28, 2024 $ 1,373,155 $ 244 1,089,782 (358,125) 644,831 (3,577)
Beginning balance (in shares) at Mar. 30, 2024   214,716,389        
Beginning balance at Mar. 30, 2024 1,320,492 $ 244 1,083,676 (358,110) 590,749 3,933
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 37,581       37,581  
Stock-based compensation 2,649   2,649      
Issuance of Common Stock for compensation plans (in shares)   355,409        
Issuance of Common Stock for compensation plans 355   355      
Other comprehensive (loss) income (3,679)         (3,679)
Ending balance (in shares) at Jun. 29, 2024   215,071,798        
Ending balance at Jun. 29, 2024 1,357,398 $ 244 1,086,680 (358,110) 628,330 254
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 16,501       16,501  
Stock-based compensation 2,667   2,667      
Issuance of Common Stock for compensation plans (in shares)   340,762        
Issuance of Common Stock for compensation plans 435   435      
Repurchase of stock (15)     (15)    
Other comprehensive (loss) income $ (3,831)         (3,831)
Ending balance (in shares) at Sep. 28, 2024 215,412,560 215,412,560        
Ending balance at Sep. 28, 2024 $ 1,373,155 $ 244 $ 1,089,782 $ (358,125) $ 644,831 $ (3,577)
v3.24.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net income $ 63,922 $ 49,651
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation 13,929 13,018
Amortization of intangible assets 26,299 27,803
Amortization of deferred debt issuance fees 3,248 3,458
Stock-based compensation 7,299 6,701
Deferred income taxes (8,344) (5,965)
Allowance for bad debts (62) (906)
Loss on debt extinguishment 4,926 0
(Gain) loss on sale of property, plant and equipment (451) 945
Changes in operating assets and liabilities    
Accounts receivable 173,400 85,216
Inventories (4,204) 61,715
Other current and non-current assets (6,203) 9,500
Accounts payable 2,871 (6,265)
Accrued expenses and other liabilities (868) (27,934)
Net cash provided by operating activities 275,762 216,937
Cash flows from investing activities    
Purchases of property, plant, and equipment (17,552) (22,623)
Acquisitions, net of cash acquired (61,636) 0
Proceeds from sale of property, plant, and equipment 311 13
Proceeds from short-term investments 25,000 0
Net cash used in investing activities (53,877) (22,610)
Cash flows from financing activities    
Proceeds from revolving credit facility 0 144,100
Payments on revolving credit facility 0 (144,100)
Proceeds from issuance of long-term debt 2,886 3,320
Payments of long-term debt (129,971) (9,325)
Proceeds from issuance of short-term notes payable 6,340 6,130
Payments of short-term notes payable (4,676) (5,174)
Other, net (427) (149)
Net cash used in financing activities (125,848) (5,198)
Effect of exchange rate changes on cash and cash equivalents 50 (1,061)
Change in cash and cash equivalents 96,087 188,068
Cash and cash equivalents, beginning of period 178,097 56,177
Cash and cash equivalents, end of period 274,184 244,245
Supplemental disclosures of cash flow information    
Cash paid-interest 47,965 56,438
Cash paid-income taxes 26,853 14,913
Equipment financed under finance leases $ 843 $ 0
v3.24.3
Nature of Operations and Organization
9 Months Ended
Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Operations and Organization
1. Nature of Operations and Organization
Hayward Holdings, Inc. (“Holdings,” the “Company,” “we” or “us”) is a global designer and manufacturer of pool and outdoor living technology. The Company has seven manufacturing facilities worldwide, which are located in North Carolina, Georgia, Tennessee, Rhode Island, Spain (two) and China, and other facilities in the United States, Canada, France and Australia. Cash flow is impacted by the seasonality of the swimming pool business. Cash flow is usually higher in the second and third quarters due to terms of sale to our customers.
We establish actual interim closing dates using a fiscal calendar in which our fiscal quarters end on the Saturday closest to the calendar quarter end, with the exception of year-end which ends on December 31 of each fiscal year. The interim closing date for the first, second and third quarters of 2024 are March 30, June 29, and September 28, compared to the respective April 1, July 1, and September 30, 2023 dates. We had equal working days in the three and nine months ended September 28, 2024 and September 30, 2023.
v3.24.3
Significant Accounting Policies
9 Months Ended
Sep. 28, 2024
Accounting Policies [Abstract]  
Significant Accounting Policies
2. Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of the Company included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The financial statements reflect all adjustments that are, in the opinion of management, necessary for a fair statement of such information. All such adjustments are of a normal recurring nature. Certain information and note disclosures, including a description of significant accounting policies normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), have been condensed or omitted pursuant to such rules and regulations.
These interim financial statements should be read in conjunction with the Company’s annual consolidated financial statements and notes thereto for the fiscal year ended December 31, 2023. The results of operations for the three and nine months ended September 28, 2024 are not necessarily indicative of the results for any subsequent periods or the entire fiscal year ending December 31, 2024.
The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified for comparative purposes to conform to the current presentation.
Recently Issued Accounting Standards
Segment Reporting
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Improvements to Reportable Segment Disclosures, which requires enhanced disclosures about significant segment expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company will adopt the standard in the Company's annual report on Form 10-K for the year ended December 31, 2024. In addition to other required disclosures, the Company will disclose cost of goods sold, selling, general and administrative expense (“SG&A”) and research, development and engineering expense (“RD&E”) by segment.
Income Taxes
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which is intended to improve income tax disclosure requirements by requiring (i) consistent categories and greater disaggregation of information in the rate reconciliation and (ii) the disaggregation of income taxes paid by jurisdiction. The guidance makes several other changes to the income tax disclosure requirements. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and is required to be applied prospectively with the option of retrospective application. The Company is evaluating the impact of the standard on its income tax disclosures and does not intend to early adopt.
v3.24.3
Revenue
9 Months Ended
Sep. 28, 2024
Revenue from Contract with Customer [Abstract]  
Revenue
3. Revenue
The following table disaggregates net sales between product groups and geographic regions, respectively (in thousands):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Product groups
Residential pool$200,794 $198,073 $652,697 $646,608 
Commercial pool14,172 9,518 34,259 30,595 
Flow control12,603 12,713 37,575 36,780 
Total$227,569 $220,304 $724,531 $713,983 
Geographic
United States$182,435 $174,317 $562,510 $543,471 
Canada12,533 10,754 47,000 41,655 
Europe16,807 17,495 71,290 72,705 
Rest of World15,794 17,738 43,731 56,152 
Total International45,134 45,987 162,021 170,512 
Total$227,569 $220,304 $724,531 $713,983 
v3.24.3
Inventories
9 Months Ended
Sep. 28, 2024
Inventory Disclosure [Abstract]  
Inventories
4. Inventories
Inventories, net, consist of the following (in thousands):
September 28, 2024December 31, 2023
Raw materials$87,359 $103,559 
Work in progress21,378 15,374 
Finished goods120,626 96,247 
Total$229,363 $215,180 
v3.24.3
Accrued Expenses and Other Liabilities
9 Months Ended
Sep. 28, 2024
Payables and Accruals [Abstract]  
Accrued Expenses and Other Liabilities
5. Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consist of the following (in thousands):
September 28, 2024December 31, 2023
Selling, promotional and advertising$47,467 $48,440 
Employee compensation and benefits20,569 16,923 
Warranty reserve20,052 22,154 
Inventory purchases18,097 20,790 
Insurance reserve10,837 9,450 
Operating lease liability - short term9,062 7,828 
Payroll taxes4,155 1,700 
Freight4,019 6,034 
Short-term notes payable3,956 2,292 
Deferred income2,197 4,021 
Professional fees2,140 1,449 
Taxes - non income1,582 679 
Business restructuring costs659 1,690 
Other accrued liabilities14,917 12,093 
Total$159,709 $155,543 

The Company offers warranties on certain of its products and records an accrual for estimated future claims. Such accruals are based on historical experience and management’s estimate of the level of future claims.
The following table summarizes the warranty reserve activities (in thousands):

Balance at December 31, 2023
$22,154 
Accrual for warranties issued during the period 8,202 
Payments(6,999)
Balance at March 30, 2024
23,357 
Accrual for warranties issued during the period 11,637 
Payments(10,124)
Balance at June 29, 2024
24,870 
Acquisitions
1,105 
Accrual for warranties issued during the period9,167 
Payments(15,090)
Balance at September 28, 2024
$20,052 

Balance at December 31, 2022
$19,652 
Accrual for warranties issued during the period 5,424 
Payments(7,076)
Balance at April 1, 2023
18,000 
Accrual for warranties issued during the period10,135 
Payments(11,309)
Balance at July 1, 2023
16,826 
Accrual for warranties issued during the period16,382 
Payments(16,172)
Balance at September 30, 2023
$17,036 
Warranty expenses for the three and nine months ended September 28, 2024 were $9.2 million and $29.0 million, respectively, and $16.4 million and $31.9 million, respectively, for the three and nine months ended September 30, 2023.
v3.24.3
Income Taxes
9 Months Ended
Sep. 28, 2024
Income Tax Disclosure [Abstract]  
Income Taxes
6. Income Taxes
The Company’s effective tax rate for the three months ended September 28, 2024 and September 30, 2023 was 21.1% and (23.7)%, respectively, after discrete items. The change in the Company’s effective tax rate was primarily due to the exercise of stock options, the release of the valuation allowance against foreign tax credit carryovers and return-to-provision adjustments in the three months ended September 30, 2023.
The Company’s effective tax rate for the nine months ended September 28, 2024 and September 30, 2023 was 20.9% and 19.9%, respectively. The change in the Company’s effective tax rate was primarily due to a decrease in excess tax benefit from stock compensation and the release of the valuation allowance against foreign tax credit carryovers in the nine months ended September 30, 2023, partially offset with a change to the Company's permanent reinvestment assertion for one jurisdiction in the nine months ended September 30, 2023.
The Company will recognize a tax benefit in the financial statements for an uncertain tax position only if the Company’s assessment is that the position is “more likely than not” (i.e., a likelihood greater than 50 percent) to be allowed by the tax jurisdiction based solely on the technical merits of the position. The term “tax position” refers to a position in a previously filed tax return or a position expected to be taken in a future tax return that is reflected in measuring current or deferred income tax assets and liabilities for financial reporting purposes. There were no uncertain tax positions at September 28, 2024 or December 31, 2023.
In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities and projected future taxable income in making this assessment. Management evaluates the need for valuation allowances on the deferred tax assets according to the provisions of ASC 740,
Income Taxes. In making this determination, the Company assesses all available evidence (positive and negative) including recent earnings, internally-prepared income tax projections, and historical financial performance.
v3.24.3
Long-Term Debt
9 Months Ended
Sep. 28, 2024
Debt Disclosure [Abstract]  
Long-Term Debt
7. Long-Term Debt
Long-term debt, net, consists of the following (in thousands):
September 28, 2024December 31, 2023
First Lien Term Facility, due May 28, 2028$970,000 $975,000 
Incremental B First Lien Term Facility, due May 28, 2028— 123,438 
ABL Revolving Credit Facility— — 
Other bank debt11,267 8,775 
Finance lease obligations2,800 4,729 
Subtotal984,067 1,111,942 
Less: Current portion of the long-term debt(14,079)(15,088)
Less: Unamortized debt issuance costs(10,082)(17,574)
Total$959,906 $1,079,280 

In April 2024, the Company made $123.1 million of voluntary principal prepayments of the incremental term loan portion of the First Lien Term Facility (the “Incremental Term Loan B”). As a result of these prepayments, there is zero aggregate principal outstanding remaining on the Incremental Term Loan B.
On June 26, 2024, the Company entered into the Fourth Amendment to its existing ABL Revolving Credit Facility (the “ABL Facility”) to replace the Canadian reference rate from the Canadian Dollar Offered Rate (“CDOR”) to the Canadian Overnight Repo Rate Average (“CORRA”).
The Company’s First Lien Term Facility and ABL Revolving Credit Facility (collectively “Credit Facilities”) contain collateral requirements, restrictions, and covenants, including restrictions under the First Lien Term Facility on the Company’s ability to pay dividends on the Common Stock. Under the agreement governing the First Lien Credit Facility (the “First Lien Credit Agreement”), the Company must also make an annual mandatory prepayment of principal commencing April 2023 for between 0% and 50% of the excess cash, as defined in the First Lien Credit Agreement, generated in the prior calendar year. The amount due varies with the First Lien Leverage Ratio as defined in the First Lien Credit Agreement, from zero if the First Lien Leverage Ratio is less than or equal to 2.5x, to fifty percent if the First Lien Leverage Ratio is greater than 3.0x less certain allowed deductions. The Company did not have a mandatory prepayment in 2024 based on the First Lien Leverage Ratio as of December 31, 2023 and the applicable criteria under the First Lien Credit Agreement. All outstanding principal under the First Lien Credit Agreement is due at maturity on May 28, 2028. The maturity date under the ABL Revolving Credit Facility (“ABL Facility”) is June 1, 2026. As of September 28, 2024, the Company was in compliance with all covenants under the Credit Facilities.
v3.24.3
Derivatives and Hedging Transactions
9 Months Ended
Sep. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives and Hedging Transactions
8. Derivatives and Hedging Transactions
The Company holds derivative financial instruments for the purpose of hedging the risks of certain identifiable and anticipated transactions. In general, the types of risks hedged are those relating to the variability of future earnings and cash flows caused by movements in foreign currency exchange rates and interest rates. In hedging these transactions, the Company holds the following types of derivatives in the normal course of business.
Interest Rate Swap Agreements
The Company enters into interest rate swap agreements designated as cash flow hedges to manage interest rate risk related to its variable rate debt obligations. As cash flow hedges, unrealized gains are recognized as assets while unrealized losses are recognized as liabilities. The interest rate swap agreements are highly correlated to the changes in interest rates to which the Company is exposed. Unrealized gains and losses on these instruments have been designated as effective and as such, the related gains or losses have been recorded as a component of accumulated other comprehensive income, net of tax. Other comprehensive income or loss is reclassified into current period income when the hedged interest expense affects earnings.
As of September 28, 2024 and December 31, 2023, the Company was a party to interest rate swap agreements that hedged a notional amount of $600.0 million of the Company’s variable rate debt. During the three months ended September 28, 2024, the Company entered into interest rate swap agreements with a notional amount of $250.0 million that will become effective in March 2025 and replace existing swap agreements with a notional amount of $250.0 million that had March 2025 maturity dates. These new agreements mature in March 2028.
Foreign Exchange Contracts
The Company enters into foreign exchange contracts to manage risks associated with future intercompany and foreign currency transactions that may be adversely affected by changes in exchange rates. These contracts are marked-to-market with the resulting gains and losses recognized in earnings. For the three months ended September 28, 2024 and September 30, 2023, the Company recognized $0.6 million of expense and $1.2 million of income, respectively, and for the nine months ended September 28, 2024 and September 30, 2023, the Company recognized $0.3 million of income and $0.3 million of expense, respectively in Other (income) expense, net, related to foreign exchange contracts.
The following table summarizes the gross fair values and location of the significant derivative instruments within the Company’s unaudited condensed consolidated balance sheets (in thousands):
Other Current AssetsOther Non-Current AssetsAccrued Expenses and Other LiabilitiesOther Non-Current LiabilitiesOther Current AssetsOther Non-Current AssetsAccrued Expenses and Other LiabilitiesOther Non-Current Liabilities
September 28, 2024December 31, 2023
Interest rate swaps$2,084 $9,435 $— $2,976 $— $21,398 $— $445 
Foreign exchange contracts— — 394 — 227 — 872 — 
Total$2,084 $9,435 $394 $2,976 $227 $21,398 $872 $445 
The following tables present the effects of derivative instruments by contract type in accumulated other comprehensive income (AOCI) in the Companys unaudited condensed consolidated statements of comprehensive income (in thousands):
Gain (Loss) Recognized in AOCI (1)
Gain (Loss) Reclassified From AOCI to Earnings (2)
Location of Gain (Loss) Reclassified from AOCI into Earnings
Three Months EndedThree Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Interest rate swaps (3)
$(9,542)$5,244 $4,372 $4,284 Interest expense, net
(1) The tax benefit and expense, respectively, on the gain (loss) recognized in AOCI for the three months ended September 28, 2024 and September 30, 2023 was $2.4 million and $0.2 million, respectively.
(2) The tax expense on the gain reclassified from AOCI to earnings for the three months ended September 28, 2024 and September 30, 2023 was $1.1 million and $1.1 million, respectively.
(3) The Company estimates that $6.6 million of unrealized gains will be reclassified from AOCI into earnings in the next twelve months.
Gain (Loss) Recognized in AOCI (1)
Gain (Loss) Reclassified From AOCI to Earnings (2)
Location of Gain (Loss) Reclassified from AOCI into Earnings
Nine Months EndedNine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Interest rate swaps$716 $12,753 $13,127 $11,191 Interest expense, net
(1) The tax expense on the gain recognized in AOCI for the nine months ended September 28, 2024 and September 30, 2023 was $0.2 million and $0.4 million, respectively.
(2) The tax expense on the gain reclassified from AOCI to earnings for the nine months ended September 28, 2024 and September 30, 2023 was $3.3 million and $2.8 million, respectively.
v3.24.3
Fair Value Measurements
9 Months Ended
Sep. 28, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements
9. Fair Value Measurements
The Company is required to disclose the estimated fair values of all financial instruments, even if they are not carried at their fair value. The fair values of financial instruments are estimates based upon market conditions and perceived risks. These estimates require management’s judgment and may not be indicative of the future fair values of the assets and liabilities.
The accounting guidance for fair value measurements and disclosures establishes a three-level fair value hierarchy:
Level 1 - Inputs are based on quoted prices in active markets for identical assets and liabilities.
Level 2 - Inputs are based on observable inputs other than quoted prices in active markets for identical or similar assets and liabilities.
Level 3 - One or more inputs are unobservable and significant.
Financial and nonfinancial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount of these instruments approximate fair value because of their short-term nature.
The Company’s interest rate swaps and foreign exchange contracts are measured in the financial statements at fair value on a recurring basis. The fair values of these instruments are estimated using industry standard valuation models using market-based observable inputs, including interest rate curves. These instruments are customary, over-the-counter contracts with various bank counterparties. Accordingly, the fair value measurements of the interest rate swaps and foreign exchange contracts are categorized as Level 2.
The Company’s investment plan assets as part of the nonqualified Hayward Industries Supplemental Retirement Plan (the “Supplemental Retirement Plan”) are presented in the financial statements at fair value on a recurring basis and are based on quoted market prices in active markets. Accordingly, the fair value measurements of the Supplemental Retirement Plan assets
are categorized as Level 1. The value of investments related to the Supplemental Retirement Plan is included in other assets and a corresponding liability to participants is recorded in other liabilities.
The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis (in thousands):
September 28, 2024December 31, 2023
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Assets:
Interest rate swaps
$— $11,519 $— $11,519 $— $21,398 $— $21,398 
Foreign exchange contracts
— — — — — 227 — 227 
Supplemental Retirement Plan assets
7,551 — — 7,551 5,910 — — 5,910 
Liabilities:
Interest rate swaps
$— $2,976 $— $2,976 $— $445 $— $445 
Foreign exchange contracts
— 394 — 394 — 872 — 872 
Supplemental Retirement Plan liabilities
7,551 — — 7,551 5,910 — — 5,910 
The estimated fair value of the long-term debt and related current maturities (excluding finance leases, the ABL Facility, and other bank debt) is based on observable quoted prices in active markets for similar liabilities and is classified as a Level 2 input. The fair value of the ABL Facility approximates its carrying value.
The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value (in thousands):
September 28, 2024December 31, 2023
Carrying ValueFair ValueCarrying ValueFair Value
Assets:
Short-term investments$— $— $25,000 $25,000 
Liabilities:
Long-term debt and related current maturities$970,000 $973,036 $1,098,438 $1,098,422 
v3.24.3
Segments and Related Information
9 Months Ended
Sep. 28, 2024
Segment Reporting [Abstract]  
Segments and Related Information
10. Segments and Related Information
The Company’s operational and management structure is aligned to its key geographies and go-to market strategy resulting in two reportable segments: North America (“NAM”) and Europe & Rest of World (“E&RW”). Operating segments have not been aggregated to form the reportable segments. The Company determined its reportable segments based on how the Company’s Chief Operating Decision Maker (“CODM”) reviews the Company’s operating results in assessing performance and allocating resources. The CODM reviews net sales, gross profit and segment income for each of the reportable segments. Gross profit is defined as net sales less cost of sales incurred by the segment. The CODM does not evaluate reportable segments using asset information as these are managed on an enterprise-wide basis. Segment income is defined as segment net sales less cost of sales, selling, general and administrative expense (“SG&A”) of the segment and research development and engineering expense (“RD&E”) of the segment, excluding segment acquisition and restructuring related expense as well as amortization of intangible assets recorded within segment SG&A expense. The accounting policies of the segments are the same as those of Holdings.
The North America segment manufactures and sells residential and commercial swimming pool equipment and supplies as well as equipment that controls the flow of fluids.
The Europe & Rest of World segment manufactures and sells residential and commercial swimming pool equipment and supplies.
The Company sells its products primarily through distributors and retailers. Financial information by reportable segment, net of intercompany transactions, is included in the following summary (in thousands):
Three Months EndedThree Months Ended
September 28, 2024September 30, 2023
North AmericaEurope & Rest of WorldTotalNorth AmericaEurope & Rest of WorldTotal
External net sales$194,968 $32,601 $227,569 $185,070 $35,234 $220,304 
Segment income51,569 2,475 54,044 40,108 6,413 46,521 
Capital expenditures (1)
6,240 579 6,819 6,524 120 6,644 
Depreciation and amortization (1)(2)
6,081 271 6,352 5,765 246 6,011 
Intersegment sales4,093 66 4,159 1,734 79 1,813 
Nine Months EndedNine Months Ended
September 28, 2024September 30, 2023
North AmericaEurope & Rest of WorldTotalNorth AmericaEurope & Rest of WorldTotal
External net sales$609,510 $115,021 $724,531 $585,126 $128,857 $713,983 
Segment income166,646 16,800 183,446 144,346 25,647 169,993 
Capital expenditures (1)
15,701 1,806 17,507 21,110 1,082 22,192 
Depreciation and amortization (1)(2)
17,493 791 18,284 16,978 694 17,672 
Intersegment sales17,108 126 17,234 9,453 187 9,640 

(1) Capital expenditures and depreciation associated with Corporate are not included in these totals.
(2) Amortization expense excluded from segment income is not included in these totals.

The following table presents a reconciliation of segment income to income from operations before income taxes (in thousands):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Total segment income$54,044 $46,521 $183,446 $169,993 
Corporate expense, net11,907 6,741 27,233 21,265 
Acquisition and restructuring related expense1,145 3,348 2,488 6,220 
Amortization of intangible assets7,576 7,523 21,425 22,777 
Operating income33,416 28,909 132,300 119,731 
Interest expense, net13,209 17,448 48,600 55,939 
Loss on debt extinguishment— — 4,926 — 
Other (income) expense, net(705)1,932 (1,989)1,798 
Total other expense12,504 19,380 51,537 57,737 
Income from operations before income taxes$20,912 $9,529 $80,763 $61,994 
v3.24.3
Earnings Per Share
9 Months Ended
Sep. 28, 2024
Earnings Per Share [Abstract]  
Earnings Per Share
11. Earnings Per Share
The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders (in thousands, except share and per share data):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Net income attributable to common stockholders$16,501 $11,788 $63,922 $49,651 
Weighted average number of common shares outstanding, basic215,231,886 213,416,502 214,836,643 212,933,763 
Effect of dilutive securities(a)
6,204,320 7,446,726 6,414,712 7,700,469 
Weighted average number of common shares outstanding, diluted221,436,206 220,863,228 221,251,355 220,634,232 
Earnings per share attributable to common stockholders, basic$0.08 $0.06 $0.30 $0.23 
Earnings per share attributable to common stockholders, diluted$0.07 $0.05 $0.29 $0.23 
(a) For the three months ended September 28, 2024 and September 30, 2023 there were potential common shares totaling approximately 2.5 million and 2.9 million, respectively, and for the nine months ended September 28, 2024 and September 30, 2023, there were potential common shares totaling approximately 2.5 million and 2.8 million, respectively, that were excluded from the computation of diluted EPS as the effect of inclusion of such shares would have been anti-dilutive.
v3.24.3
Commitments and Contingencies
9 Months Ended
Sep. 28, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
12. Commitments and Contingencies
Litigation
The Company is involved in litigation arising in the normal course of business. Where appropriate, these matters have been submitted to the Company’s insurance carrier. The Company determines whether an estimated loss from a contingency should be accrued by assessing whether a loss is deemed probable and can be reasonably estimated. It is not possible to quantify the ultimate liability, if any, in these matters.
On August 2, 2023, a securities class action complaint was filed in the United States District Court for the District of New Jersey against the Company and certain of its current directors and officers (Kevin Holleran and Eifion Jones) and MSD Partners and CCMP Capital Advisors, LP on behalf of a putative class of stockholders who acquired shares of the Company’s common stock between March 2, 2022 and July 27, 2022. That action is captioned City of Southfield Fire and Police Retirement System vs. Hayward Holdings, Inc., et al., 2:23-cv-04146-WJM-ESK (D.N.J.) (“City of Southfield”). On September 28, 2023, a second, related securities class action complaint was filed in the United States District Court for the District of New Jersey against the Company and certain of its current directors and officers (Kevin Holleran and Eifion Jones) and MSD Partners and CCMP Capital Advisors, LP on behalf of a putative class of stockholders who acquired shares of the Company’s common stock between October 27, 2021 and July 28, 2022. That action is captioned Erie County Employees’ Retirement System vs. Hayward Holdings, Inc., et al., 2:23-cv-04146-WJM-ESK (D.N.J.) (“Erie County”). On December 19, 2023, the Court issued a ruling consolidating the two securities class actions (City of Southfield and Erie County) under the City of Southfield docket (the “Securities Class Action”) and appointing a lead plaintiff. In a consolidated class action complaint filed March 4, 2024, the Securities Class Action alleged on behalf of a putative class of stockholders who acquired shares of our common stock between October 27, 2021 and July 28, 2022, among other things, that the Company and certain of its current directors and officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by, among other things, making materially false or misleading statements regarding inventory, growth, and demand trends and the Company’s financial projections for 2022. The complaints seek unspecified monetary damages on behalf of the putative classes and an award of costs and expenses, including reasonable attorneys’ fees. On October 2, 2024, the Court issued an Opinion and Order dismissing the consolidated class action complaint and granted the lead plaintiff leave to file an amended complaint within 30 days.
On November 27, 2023, a shareholder derivative lawsuit was filed in the United States District Court for the District of New Jersey against current and past directors of the Company captioned Heicklen v. Holleran, et al., 2:23-cv-22649 (D.N.J.) (the “Derivative Action”). The Derivative Action alleges breaches of fiduciary duties to Company stockholders, aiding and
abetting breaches of fiduciary duties, unjust enrichment, corporate waste, and violations of Section 10(b) of the Securities Exchange Act of 1934 in connection with the claims in the Securities Class Action. The Derivative Action seeks recovery of unspecified damages and attorney’s fees and costs, as well as improvements to the Company’s corporate governance and internal procedures. The Derivative Action has been stayed pending final decision on a motion to dismiss being filed in the Securities Class Action.
We dispute the allegations of wrongdoing in the Securities Class Action and the Derivative Action and intend to vigorously defend ourselves in these matters. In view of the complexity and ongoing and uncertain nature of the outstanding proceedings and inquiries, at this time we are unable to estimate a reasonably possible financial loss or range of financial loss, if any, that we may incur to resolve or settle the Securities Class Action and the Derivative Action.
Contingencies
In September 2024, certain equipment and inventory of the Company located at a supplier’s facility experienced water damage following Hurricane Helene. The Company is pursuing alternative arrangements and does not expect this to have a material effect on the Company’s operations or financial condition.
v3.24.3
Leases
9 Months Ended
Sep. 28, 2024
Leases [Abstract]  
Leases
13. Leases
The Company’s operating and finance lease portfolio is described in Note 15. Leases of Notes to Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2023.
Supplemental cash flow information related to leases was as follows (in thousands):
Nine Months Ended
September 28, 2024September 30, 2023
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$5,507 $885 
Finance leases843 — 
Supplemental balance sheet information related to leases was as follows (in thousands):
September 28, 2024December 31, 2023
Operating leases
Other non-current assets$57,876 $58,638 
Accrued expenses and other liabilities9,062 7,828 
Other non-current liabilities56,504 58,642 
Total operating lease liabilities65,566 66,470 
Finance leases
Property, plant and equipment9,712 10,858 
Accumulated depreciation(2,891)(2,415)
Property, plant and equipment, net6,821 8,443 
Current maturities of long-term debt1,878 2,121 
Long-term debt922 2,608 
Total finance lease liabilities$2,800 $4,729 
Leases
13. Leases
The Company’s operating and finance lease portfolio is described in Note 15. Leases of Notes to Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2023.
Supplemental cash flow information related to leases was as follows (in thousands):
Nine Months Ended
September 28, 2024September 30, 2023
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$5,507 $885 
Finance leases843 — 
Supplemental balance sheet information related to leases was as follows (in thousands):
September 28, 2024December 31, 2023
Operating leases
Other non-current assets$57,876 $58,638 
Accrued expenses and other liabilities9,062 7,828 
Other non-current liabilities56,504 58,642 
Total operating lease liabilities65,566 66,470 
Finance leases
Property, plant and equipment9,712 10,858 
Accumulated depreciation(2,891)(2,415)
Property, plant and equipment, net6,821 8,443 
Current maturities of long-term debt1,878 2,121 
Long-term debt922 2,608 
Total finance lease liabilities$2,800 $4,729 
v3.24.3
Stockholders’ Equity
9 Months Ended
Sep. 28, 2024
Equity [Abstract]  
Stockholders’ Equity
14. Stockholders’ Equity
Preferred Stock
The Company’s Second Restated Certificate of Incorporation authorizes the Company to issue up to 100,000,000 shares of preferred stock, $0.001 value per share, all of which is undesignated.
Common Stock
The Company’s Second Restated Certificate of Incorporation authorizes the Company to issue up to 750,000,000 shares of Common Stock, $0.001 value per share. Each share of Common Stock is entitled to one vote on all matters submitted to a vote of the Company’s stockholders. The holders of Common Stock are entitled to receive dividends, if any, as may be declared by the Board of Directors.
Dividends paid
For the three and nine months ended September 28, 2024 and September 30, 2023, no dividends were declared or paid to the Company’s common stockholders.
Share Repurchase Program
The Board of Directors authorized the Company’s share repurchase program (the “Share Repurchase Program”) such that the Company is authorized to repurchase from time to time up to an aggregate of $450 million of its outstanding shares of common stock, which authorization expires on July 26, 2025. The Company had no repurchases of its common stock in the quarter ended September 28, 2024 under the Share Repurchase Program. As of September 28, 2024, $400.0 million remained available for additional share repurchases under the program.
v3.24.3
Stock-based Compensation
9 Months Ended
Sep. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation
15. Stock-based Compensation
Stock-based compensation expense recorded in the unaudited condensed consolidated statements of operations for equity-classified stock-based awards for the three and nine months ended September 28, 2024 was $2.7 million and $7.3 million, respectively, and $2.6 million and $6.7 million, respectively, for the three and nine months ended September 30, 2023.
The Company has established two equity incentive plans, the 2021 Equity Incentive Plan and the 2017 Equity Incentive Plan. The Company no longer grants awards under the 2017 Equity Incentive Plan.
2021 Equity Incentive Plan
In March 2021, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”). Under the 2021 Plan, up to 13,737,500 shares of common stock may be granted to employees, directors and consultants in the form of stock options, restricted stock units and other stock-based awards. The terms of awards granted under the 2021 Plan are determined by the Compensation Committee of the Board of Directors, subject to the provisions of the 2021 Plan.
Options granted under the 2021 Plan expire no later than ten years from the date of grant. Options and time-based restricted stock units granted under the 2021 Plan generally vest ratably over a three-year period and performance-based restricted stock units vest at the end of three years subject to the performance criteria.
During the nine months ended September 28, 2024, the Company granted 781,719 time-based restricted stock units and 304,518 performance-based restricted stock units (at the target performance level) under the 2021 Plan with a weighted-average grant-date fair value per share of $14.01 and $14.17, respectively.
v3.24.3
Acquisitions and Restructuring
9 Months Ended
Sep. 28, 2024
Acquisition, Restructuring and Related Activities [Abstract]  
Acquisitions and Restructuring
16. Acquisitions and Restructuring
Acquisition and restructuring related expense, net consists of the following (in thousands):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Business restructuring costs$444 $3,348 $1,232 $5,426 
Acquisition transaction and integration costs701 — 1,256 794 
Total $1,145 $3,348 $2,488 $6,220 
During the third quarter of 2023, the Company initiated programs to centralize and consolidate operations and professional services in Europe. For the three and nine months ended September 28, 2024, the Company incurred zero and $0.7 million, respectively, of expense related to the programs, which include severance and employee benefit costs, as well as other direct separation benefit costs. The impacted employees must remain with the Company through their planned exit date to receive each of the severance and retention amounts. Such costs are accounted for in accordance with ASC 420, Exit or Disposal Cost Obligations.
During the three months ended September 28, 2024, the Company incurred $0.4 million of costs to finalize actions initiated in prior years.
The following tables summarize the status of the Company’s restructuring related expense and related liability balances (in thousands):
2024 Activity
Liability as of December 31, 2023
Costs RecognizedCash PaymentsNon-cash charges
Liability as of September 28, 2024
One-time termination benefits$2,353 $488 $(2,101)$— $740 
Facility-related— 182 (182)— — 
Other562 (456)67 179 
Total$2,359 $1,232 $(2,739)$67 $919 
2023 Activity
Liability as of December 31, 2022
Costs RecognizedCash Payments
Liability as of September 30, 2023
One-time termination benefits$2,422 $4,894 $(3,731)$3,585 
Other— 532 (470)62 
Total$2,422 $5,426 $(4,201)$3,647 
    
Restructuring costs are included within acquisition and restructuring related costs on the Company’s unaudited condensed consolidated statements of operations, while the restructuring liability is included as a component of accrued expenses and other liabilities on the Company’s unaudited condensed consolidated balance sheets.
Acquisitions
On June 26, 2024, the Company acquired the equity interests of ChlorKing HoldCo, LLC and related entities (“ChlorKing”). The acquired business includes pool saline chlorinators and UV disinfection systems serving the commercial pools and water treatment market segments. The acquisition broadens the Company’s commercial portfolio of products and expands the market of commercial customers while furthering the Company's commitment to sustainable and energy-efficient technology for both commercial and residential pools. The acquisition is included in our North America segment.
The consideration paid net of cash acquired was $61.6 million. The purchase price was funded with cash on hand. For the three and nine months ended September 28, 2024, transaction expenses recognized for the acquisition were $0.7 million and $1.3 million, respectively. These expenses are included within acquisition and restructuring related costs on the Company’s unaudited condensed consolidated statements of operations.
The purchase price allocation is preliminary and subject to change as the Company finalizes the valuation of goodwill, intangible assets, inventory and leases, in addition to identifying and recording all other assets and liabilities and contingencies. Preliminary estimates will be finalized within one year of the date of acquisition. The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed, including measurement period adjustments recorded through September 28, 2024 (in thousands):
Preliminary AllocationMeasurement
Period
Adjustments
Preliminary Allocation
As of June 26, 2024As of September 28, 2024
Cash and cash equivalents$3,898 $134 $4,032 
Receivables3,701 (730)2,971 
Inventory8,978 582 9,560 
Prepaid expenses and other current assets269 830 1,099 
Property, plant and equipment37 — 37 
Other assets2,565 — 2,565 
Net Investment in Lease1,867 5,449 7,316 
Intangible assets31,550 (3,075)28,475 
Accounts payable and accrued liabilities(4,302)(3,046)(7,348)
Deferred tax liabilities
— (1,810)(1,810)
Total identifiable net assets acquired48,563 (1,666)46,897 
Goodwill17,835 936 18,771 
Preliminary purchase price$66,398 $(730)$65,668 
The estimated preliminary fair value and useful lives of the identifiable intangible assets are as follows:
Estimated Useful LivesEstimated Amounts
(in years)(in thousands)
Finite lived intangible assets
Tradename15$2,600 
Customer relationships1521,200 
Developed technology104,600 
Noncompete agreements575 
Total$28,475 

Goodwill is a result of the expected synergies and cross-selling opportunities this acquisition is expected to bring, as well as the expected growth potential from the integration of the ChlorKing products into Hayward’s existing commercial business. Any changes in the estimated fair values of the assets acquired and liabilities assumed in the acquisition may change the amount of the purchase consideration allocated to goodwill. The goodwill balance has been recorded to the North America reportable segment and is deductible for tax purposes.
Pro forma results of operations including ChlorKing have not been presented as the impact of ChlorKing on the Company's consolidated financial results is not material.
v3.24.3
Related-Party Transactions
9 Months Ended
Sep. 28, 2024
Related Party Transactions [Abstract]  
Related-Party Transactions
17. Related-Party Transactions
During the three and nine months ended September 28, 2024 and September 30, 2023, the Company did not incur any significant related-party transactions.
v3.24.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Jun. 29, 2024
Mar. 30, 2024
Sep. 30, 2023
Jul. 01, 2023
Apr. 01, 2023
Sep. 28, 2024
Sep. 30, 2023
Pay vs Performance Disclosure                
Net income $ 16,501 $ 37,581 $ 9,840 $ 11,788 $ 29,453 $ 8,410 $ 63,922 $ 49,651
v3.24.3
Insider Trading Arrangements
3 Months Ended 9 Months Ended
Sep. 28, 2024
shares
Sep. 28, 2024
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Kevin Holleran [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement   On August 9, 2024, Kevin Holleran, our President and Chief Executive Officer, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Holleran, acting through a broker, may sell up to an aggregate of 600,000 shares of our common stock. Sales of shares under the plan may only occur from November 11, 2024, to June 13, 2025. The plan is scheduled to terminate on June 13, 2025, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Holleran or the broker, or as otherwise provided in the plan.
Name Kevin Holleran  
Title President and Chief Executive Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 9, 2024  
Expiration Date June 13, 2025  
Arrangement Duration 214 days  
Aggregate Available 600,000 600,000
Eifion Jones [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement   On August 9, 2024, Eifion Jones, our Senior Vice President, Chief Financial Officer, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Jones, acting through a broker, may sell up to an aggregate of 100,000 shares of our common stock. Sales of shares under the plan may only occur from November 8, 2024, to May 30, 2025. The plan is scheduled to terminate on May 30, 2025, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Jones or the broker, or as otherwise provided in the plan.
Name Eifion Jones  
Title Senior Vice President, Chief Financial Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 9, 2024  
Expiration Date May 30, 2025  
Arrangement Duration 203 days  
Aggregate Available 100,000 100,000
v3.24.3
Significant Accounting Policies (Policies)
9 Months Ended
Sep. 28, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of the Company included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The financial statements reflect all adjustments that are, in the opinion of management, necessary for a fair statement of such information. All such adjustments are of a normal recurring nature. Certain information and note disclosures, including a description of significant accounting policies normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), have been condensed or omitted pursuant to such rules and regulations.
These interim financial statements should be read in conjunction with the Company’s annual consolidated financial statements and notes thereto for the fiscal year ended December 31, 2023. The results of operations for the three and nine months ended September 28, 2024 are not necessarily indicative of the results for any subsequent periods or the entire fiscal year ending December 31, 2024.
The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified for comparative purposes to conform to the current presentation.
Recently Issued Accounting Standards
Recently Issued Accounting Standards
Segment Reporting
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Improvements to Reportable Segment Disclosures, which requires enhanced disclosures about significant segment expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company will adopt the standard in the Company's annual report on Form 10-K for the year ended December 31, 2024. In addition to other required disclosures, the Company will disclose cost of goods sold, selling, general and administrative expense (“SG&A”) and research, development and engineering expense (“RD&E”) by segment.
Income Taxes
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which is intended to improve income tax disclosure requirements by requiring (i) consistent categories and greater disaggregation of information in the rate reconciliation and (ii) the disaggregation of income taxes paid by jurisdiction. The guidance makes several other changes to the income tax disclosure requirements. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and is required to be applied prospectively with the option of retrospective application. The Company is evaluating the impact of the standard on its income tax disclosures and does not intend to early adopt.
Fair Value Measurements
The Company is required to disclose the estimated fair values of all financial instruments, even if they are not carried at their fair value. The fair values of financial instruments are estimates based upon market conditions and perceived risks. These estimates require management’s judgment and may not be indicative of the future fair values of the assets and liabilities.
The accounting guidance for fair value measurements and disclosures establishes a three-level fair value hierarchy:
Level 1 - Inputs are based on quoted prices in active markets for identical assets and liabilities.
Level 2 - Inputs are based on observable inputs other than quoted prices in active markets for identical or similar assets and liabilities.
Level 3 - One or more inputs are unobservable and significant.
v3.24.3
Revenue (Tables)
9 Months Ended
Sep. 28, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Net Sales by Product Groups
The following table disaggregates net sales between product groups and geographic regions, respectively (in thousands):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Product groups
Residential pool$200,794 $198,073 $652,697 $646,608 
Commercial pool14,172 9,518 34,259 30,595 
Flow control12,603 12,713 37,575 36,780 
Total$227,569 $220,304 $724,531 $713,983 
Geographic
United States$182,435 $174,317 $562,510 $543,471 
Canada12,533 10,754 47,000 41,655 
Europe16,807 17,495 71,290 72,705 
Rest of World15,794 17,738 43,731 56,152 
Total International45,134 45,987 162,021 170,512 
Total$227,569 $220,304 $724,531 $713,983 
Schedule of Net Sales by Geographic Destinations
The following table disaggregates net sales between product groups and geographic regions, respectively (in thousands):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Product groups
Residential pool$200,794 $198,073 $652,697 $646,608 
Commercial pool14,172 9,518 34,259 30,595 
Flow control12,603 12,713 37,575 36,780 
Total$227,569 $220,304 $724,531 $713,983 
Geographic
United States$182,435 $174,317 $562,510 $543,471 
Canada12,533 10,754 47,000 41,655 
Europe16,807 17,495 71,290 72,705 
Rest of World15,794 17,738 43,731 56,152 
Total International45,134 45,987 162,021 170,512 
Total$227,569 $220,304 $724,531 $713,983 
v3.24.3
Inventories (Tables)
9 Months Ended
Sep. 28, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventories, Net
Inventories, net, consist of the following (in thousands):
September 28, 2024December 31, 2023
Raw materials$87,359 $103,559 
Work in progress21,378 15,374 
Finished goods120,626 96,247 
Total$229,363 $215,180 
v3.24.3
Accrued Expenses and Other Liabilities (Tables)
9 Months Ended
Sep. 28, 2024
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities and Other Current Liabilities
Accrued expenses and other liabilities consist of the following (in thousands):
September 28, 2024December 31, 2023
Selling, promotional and advertising$47,467 $48,440 
Employee compensation and benefits20,569 16,923 
Warranty reserve20,052 22,154 
Inventory purchases18,097 20,790 
Insurance reserve10,837 9,450 
Operating lease liability - short term9,062 7,828 
Payroll taxes4,155 1,700 
Freight4,019 6,034 
Short-term notes payable3,956 2,292 
Deferred income2,197 4,021 
Professional fees2,140 1,449 
Taxes - non income1,582 679 
Business restructuring costs659 1,690 
Other accrued liabilities14,917 12,093 
Total$159,709 $155,543 
Schedule of Change in Warranty Reserve
The following table summarizes the warranty reserve activities (in thousands):

Balance at December 31, 2023
$22,154 
Accrual for warranties issued during the period 8,202 
Payments(6,999)
Balance at March 30, 2024
23,357 
Accrual for warranties issued during the period 11,637 
Payments(10,124)
Balance at June 29, 2024
24,870 
Acquisitions
1,105 
Accrual for warranties issued during the period9,167 
Payments(15,090)
Balance at September 28, 2024
$20,052 

Balance at December 31, 2022
$19,652 
Accrual for warranties issued during the period 5,424 
Payments(7,076)
Balance at April 1, 2023
18,000 
Accrual for warranties issued during the period10,135 
Payments(11,309)
Balance at July 1, 2023
16,826 
Accrual for warranties issued during the period16,382 
Payments(16,172)
Balance at September 30, 2023
$17,036 
v3.24.3
Long-Term Debt (Tables)
9 Months Ended
Sep. 28, 2024
Debt Disclosure [Abstract]  
Schedule of Long-term Debt
Long-term debt, net, consists of the following (in thousands):
September 28, 2024December 31, 2023
First Lien Term Facility, due May 28, 2028$970,000 $975,000 
Incremental B First Lien Term Facility, due May 28, 2028— 123,438 
ABL Revolving Credit Facility— — 
Other bank debt11,267 8,775 
Finance lease obligations2,800 4,729 
Subtotal984,067 1,111,942 
Less: Current portion of the long-term debt(14,079)(15,088)
Less: Unamortized debt issuance costs(10,082)(17,574)
Total$959,906 $1,079,280 
v3.24.3
Derivatives and Hedging Transactions (Tables)
9 Months Ended
Sep. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Effect of Derivative Instruments in the Statement of Financial Position and Operations and Comprehensive Income (Loss)
The following table summarizes the gross fair values and location of the significant derivative instruments within the Company’s unaudited condensed consolidated balance sheets (in thousands):
Other Current AssetsOther Non-Current AssetsAccrued Expenses and Other LiabilitiesOther Non-Current LiabilitiesOther Current AssetsOther Non-Current AssetsAccrued Expenses and Other LiabilitiesOther Non-Current Liabilities
September 28, 2024December 31, 2023
Interest rate swaps$2,084 $9,435 $— $2,976 $— $21,398 $— $445 
Foreign exchange contracts— — 394 — 227 — 872 — 
Total$2,084 $9,435 $394 $2,976 $227 $21,398 $872 $445 
The following tables present the effects of derivative instruments by contract type in accumulated other comprehensive income (AOCI) in the Companys unaudited condensed consolidated statements of comprehensive income (in thousands):
Gain (Loss) Recognized in AOCI (1)
Gain (Loss) Reclassified From AOCI to Earnings (2)
Location of Gain (Loss) Reclassified from AOCI into Earnings
Three Months EndedThree Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Interest rate swaps (3)
$(9,542)$5,244 $4,372 $4,284 Interest expense, net
(1) The tax benefit and expense, respectively, on the gain (loss) recognized in AOCI for the three months ended September 28, 2024 and September 30, 2023 was $2.4 million and $0.2 million, respectively.
(2) The tax expense on the gain reclassified from AOCI to earnings for the three months ended September 28, 2024 and September 30, 2023 was $1.1 million and $1.1 million, respectively.
(3) The Company estimates that $6.6 million of unrealized gains will be reclassified from AOCI into earnings in the next twelve months.
Gain (Loss) Recognized in AOCI (1)
Gain (Loss) Reclassified From AOCI to Earnings (2)
Location of Gain (Loss) Reclassified from AOCI into Earnings
Nine Months EndedNine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Interest rate swaps$716 $12,753 $13,127 $11,191 Interest expense, net
(1) The tax expense on the gain recognized in AOCI for the nine months ended September 28, 2024 and September 30, 2023 was $0.2 million and $0.4 million, respectively.
(2) The tax expense on the gain reclassified from AOCI to earnings for the nine months ended September 28, 2024 and September 30, 2023 was $3.3 million and $2.8 million, respectively.
v3.24.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 28, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis (in thousands):
September 28, 2024December 31, 2023
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Assets:
Interest rate swaps
$— $11,519 $— $11,519 $— $21,398 $— $21,398 
Foreign exchange contracts
— — — — — 227 — 227 
Supplemental Retirement Plan assets
7,551 — — 7,551 5,910 — — 5,910 
Liabilities:
Interest rate swaps
$— $2,976 $— $2,976 $— $445 $— $445 
Foreign exchange contracts
— 394 — 394 — 872 — 872 
Supplemental Retirement Plan liabilities
7,551 — — 7,551 5,910 — — 5,910 
Schedule of Financial Assets and Liabilities
The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value (in thousands):
September 28, 2024December 31, 2023
Carrying ValueFair ValueCarrying ValueFair Value
Assets:
Short-term investments$— $— $25,000 $25,000 
Liabilities:
Long-term debt and related current maturities$970,000 $973,036 $1,098,438 $1,098,422 
v3.24.3
Segments and Related Information (Tables)
9 Months Ended
Sep. 28, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The Company sells its products primarily through distributors and retailers. Financial information by reportable segment, net of intercompany transactions, is included in the following summary (in thousands):
Three Months EndedThree Months Ended
September 28, 2024September 30, 2023
North AmericaEurope & Rest of WorldTotalNorth AmericaEurope & Rest of WorldTotal
External net sales$194,968 $32,601 $227,569 $185,070 $35,234 $220,304 
Segment income51,569 2,475 54,044 40,108 6,413 46,521 
Capital expenditures (1)
6,240 579 6,819 6,524 120 6,644 
Depreciation and amortization (1)(2)
6,081 271 6,352 5,765 246 6,011 
Intersegment sales4,093 66 4,159 1,734 79 1,813 
Nine Months EndedNine Months Ended
September 28, 2024September 30, 2023
North AmericaEurope & Rest of WorldTotalNorth AmericaEurope & Rest of WorldTotal
External net sales$609,510 $115,021 $724,531 $585,126 $128,857 $713,983 
Segment income166,646 16,800 183,446 144,346 25,647 169,993 
Capital expenditures (1)
15,701 1,806 17,507 21,110 1,082 22,192 
Depreciation and amortization (1)(2)
17,493 791 18,284 16,978 694 17,672 
Intersegment sales17,108 126 17,234 9,453 187 9,640 

(1) Capital expenditures and depreciation associated with Corporate are not included in these totals.
(2) Amortization expense excluded from segment income is not included in these totals.

The following table presents a reconciliation of segment income to income from operations before income taxes (in thousands):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Total segment income$54,044 $46,521 $183,446 $169,993 
Corporate expense, net11,907 6,741 27,233 21,265 
Acquisition and restructuring related expense1,145 3,348 2,488 6,220 
Amortization of intangible assets7,576 7,523 21,425 22,777 
Operating income33,416 28,909 132,300 119,731 
Interest expense, net13,209 17,448 48,600 55,939 
Loss on debt extinguishment— — 4,926 — 
Other (income) expense, net(705)1,932 (1,989)1,798 
Total other expense12,504 19,380 51,537 57,737 
Income from operations before income taxes$20,912 $9,529 $80,763 $61,994 
v3.24.3
Earnings Per Share (Tables)
9 Months Ended
Sep. 28, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders (in thousands, except share and per share data):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Net income attributable to common stockholders$16,501 $11,788 $63,922 $49,651 
Weighted average number of common shares outstanding, basic215,231,886 213,416,502 214,836,643 212,933,763 
Effect of dilutive securities(a)
6,204,320 7,446,726 6,414,712 7,700,469 
Weighted average number of common shares outstanding, diluted221,436,206 220,863,228 221,251,355 220,634,232 
Earnings per share attributable to common stockholders, basic$0.08 $0.06 $0.30 $0.23 
Earnings per share attributable to common stockholders, diluted$0.07 $0.05 $0.29 $0.23 
(a) For the three months ended September 28, 2024 and September 30, 2023 there were potential common shares totaling approximately 2.5 million and 2.9 million, respectively, and for the nine months ended September 28, 2024 and September 30, 2023, there were potential common shares totaling approximately 2.5 million and 2.8 million, respectively, that were excluded from the computation of diluted EPS as the effect of inclusion of such shares would have been anti-dilutive.
v3.24.3
Leases (Tables)
9 Months Ended
Sep. 28, 2024
Leases [Abstract]  
Schedule of Lease, Cost
Supplemental cash flow information related to leases was as follows (in thousands):
Nine Months Ended
September 28, 2024September 30, 2023
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$5,507 $885 
Finance leases843 — 
Schedule of Assets and Liabilities, Lessee
Supplemental balance sheet information related to leases was as follows (in thousands):
September 28, 2024December 31, 2023
Operating leases
Other non-current assets$57,876 $58,638 
Accrued expenses and other liabilities9,062 7,828 
Other non-current liabilities56,504 58,642 
Total operating lease liabilities65,566 66,470 
Finance leases
Property, plant and equipment9,712 10,858 
Accumulated depreciation(2,891)(2,415)
Property, plant and equipment, net6,821 8,443 
Current maturities of long-term debt1,878 2,121 
Long-term debt922 2,608 
Total finance lease liabilities$2,800 $4,729 
v3.24.3
Acquisitions and Restructuring (Tables)
9 Months Ended
Sep. 28, 2024
Acquisition, Restructuring and Related Activities [Abstract]  
Schedule of Acquisition and Restructuring Related Expense
Acquisition and restructuring related expense, net consists of the following (in thousands):
Three Months Ended Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Business restructuring costs$444 $3,348 $1,232 $5,426 
Acquisition transaction and integration costs701 — 1,256 794 
Total $1,145 $3,348 $2,488 $6,220 
Schedule of Charges for Facility Closure and Other One Time Termination Benefits
The following tables summarize the status of the Company’s restructuring related expense and related liability balances (in thousands):
2024 Activity
Liability as of December 31, 2023
Costs RecognizedCash PaymentsNon-cash charges
Liability as of September 28, 2024
One-time termination benefits$2,353 $488 $(2,101)$— $740 
Facility-related— 182 (182)— — 
Other562 (456)67 179 
Total$2,359 $1,232 $(2,739)$67 $919 
2023 Activity
Liability as of December 31, 2022
Costs RecognizedCash Payments
Liability as of September 30, 2023
One-time termination benefits$2,422 $4,894 $(3,731)$3,585 
Other— 532 (470)62 
Total$2,422 $5,426 $(4,201)$3,647 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed, including measurement period adjustments recorded through September 28, 2024 (in thousands):
Preliminary AllocationMeasurement
Period
Adjustments
Preliminary Allocation
As of June 26, 2024As of September 28, 2024
Cash and cash equivalents$3,898 $134 $4,032 
Receivables3,701 (730)2,971 
Inventory8,978 582 9,560 
Prepaid expenses and other current assets269 830 1,099 
Property, plant and equipment37 — 37 
Other assets2,565 — 2,565 
Net Investment in Lease1,867 5,449 7,316 
Intangible assets31,550 (3,075)28,475 
Accounts payable and accrued liabilities(4,302)(3,046)(7,348)
Deferred tax liabilities
— (1,810)(1,810)
Total identifiable net assets acquired48,563 (1,666)46,897 
Goodwill17,835 936 18,771 
Preliminary purchase price$66,398 $(730)$65,668 
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination
The estimated preliminary fair value and useful lives of the identifiable intangible assets are as follows:
Estimated Useful LivesEstimated Amounts
(in years)(in thousands)
Finite lived intangible assets
Tradename15$2,600 
Customer relationships1521,200 
Developed technology104,600 
Noncompete agreements575 
Total$28,475 
v3.24.3
Nature of Operations and Organization (Details)
Sep. 28, 2024
manufacturing_facility
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of manufacturing facilities 7
v3.24.3
Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Revenue from External Customer [Line Items]        
Net sales $ 227,569 $ 220,304 $ 724,531 $ 713,983
United States        
Revenue from External Customer [Line Items]        
Net sales 182,435 174,317 562,510 543,471
Total International        
Revenue from External Customer [Line Items]        
Net sales 45,134 45,987 162,021 170,512
Canada        
Revenue from External Customer [Line Items]        
Net sales 12,533 10,754 47,000 41,655
Europe        
Revenue from External Customer [Line Items]        
Net sales 16,807 17,495 71,290 72,705
Rest of World        
Revenue from External Customer [Line Items]        
Net sales 15,794 17,738 43,731 56,152
Residential pool        
Revenue from External Customer [Line Items]        
Net sales 200,794 198,073 652,697 646,608
Commercial pool        
Revenue from External Customer [Line Items]        
Net sales 14,172 9,518 34,259 30,595
Flow control        
Revenue from External Customer [Line Items]        
Net sales $ 12,603 $ 12,713 $ 37,575 $ 36,780
v3.24.3
Inventories (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Raw materials $ 87,359 $ 103,559
Work in progress 21,378 15,374
Finished goods 120,626 96,247
Total $ 229,363 $ 215,180
v3.24.3
Accrued Expenses and Other Liabilities - Accrued Expenses and Other Liabilities (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Jun. 29, 2024
Mar. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Jul. 01, 2023
Apr. 01, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]                
Selling, promotional and advertising $ 47,467     $ 48,440        
Employee compensation and benefits 20,569     16,923        
Warranty reserve 20,052 $ 24,870 $ 23,357 22,154 $ 17,036 $ 16,826 $ 18,000 $ 19,652
Inventory purchases 18,097     20,790        
Insurance reserve 10,837     9,450        
Operating lease liability - short term 9,062     7,828        
Payroll taxes 4,155     1,700        
Freight 4,019     6,034        
Short-term notes payable 3,956     2,292        
Deferred income 2,197     4,021        
Professional fees 2,140     1,449        
Taxes - non income 1,582     679        
Business restructuring costs 659     1,690        
Other accrued liabilities 14,917     12,093        
Total $ 159,709     $ 155,543        
v3.24.3
Accrued Expenses and Other Liabilities - Warranty Reserve (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 28, 2024
Jun. 29, 2024
Mar. 30, 2024
Sep. 30, 2023
Jul. 01, 2023
Apr. 01, 2023
Movement in Standard Product Warranty Accrual [Roll Forward]            
Beginning balance $ 24,870 $ 23,357 $ 22,154 $ 16,826 $ 18,000 $ 19,652
Acquisitions 1,105          
Accrual for warranties issued during the period 9,167 11,637 8,202 16,382 10,135 5,424
Payments (15,090) (10,124) (6,999) (16,172) (11,309) (7,076)
Ending balance $ 20,052 $ 24,870 $ 23,357 $ 17,036 $ 16,826 $ 18,000
v3.24.3
Accrued Expenses and Other Liabilities - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Payables and Accruals [Abstract]        
Warranty expense $ 9.2 $ 16.4 $ 29.0 $ 31.9
v3.24.3
Income Taxes (Details)
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Income Tax Disclosure [Abstract]        
Effective tax rate 21.10% (23.70%) 20.90% 19.90%
v3.24.3
Long-Term Debt - Long-Term Debt (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Dec. 31, 2023
Line of Credit Facility [Line Items]    
Other bank debt $ 11,267 $ 8,775
Finance lease obligations 2,800 4,729
Subtotal 984,067 1,111,942
Less: Current portion of the long-term debt (14,079) (15,088)
Less: Unamortized debt issuance costs (10,082) (17,574)
Total 959,906 1,079,280
Term Loan | First Lien Term Facility, due May 28, 2028    
Line of Credit Facility [Line Items]    
Long-term debt, gross 970,000 975,000
Term Loan | Incremental B First Lien Term Facility, due May 28, 2028    
Line of Credit Facility [Line Items]    
Long-term debt, gross 0 123,438
Revolving Credit Facility | ABL Revolving Credit Facility    
Line of Credit Facility [Line Items]    
Long-term debt, gross $ 0 $ 0
v3.24.3
Long-Term Debt - Additional Information (Details)
$ in Thousands
1 Months Ended 9 Months Ended
May 22, 2023
Apr. 30, 2024
USD ($)
Apr. 30, 2023
Sep. 28, 2024
USD ($)
Sep. 30, 2023
USD ($)
Line of Credit Facility [Line Items]          
Payments of long-term debt       $ 129,971 $ 9,325
Incremental Term Loan B | First Lien Term Facility          
Line of Credit Facility [Line Items]          
Payments of long-term debt   $ 123,100      
Long-term debt   $ 0      
Term Loan | First Lien Term Facility, Due May 28, 2028          
Line of Credit Facility [Line Items]          
Leverage ratio threshold for mandatory prepayment of zero 2.5        
Leverage ratio threshold for mandatory prepayment of fifty percent 3.0        
Term Loan | First Lien Term Facility, Due May 28, 2028 | Minimum          
Line of Credit Facility [Line Items]          
Mandatory annual prepayment, percentage of excess cash     0.00%    
Term Loan | First Lien Term Facility, Due May 28, 2028 | Maximum          
Line of Credit Facility [Line Items]          
Mandatory annual prepayment, percentage of excess cash     50.00%    
v3.24.3
Derivatives and Hedging Transactions - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Dec. 31, 2023
Derivative [Line Items]          
Other (expense) income $ 705 $ (1,932) $ 1,989 $ (1,798)  
Interest rate swaps          
Derivative [Line Items]          
Derivative, notional amount 250,000   250,000    
Interest rate swaps | Cash Flow Hedging          
Derivative [Line Items]          
Derivative, notional amount 600,000   600,000   $ 600,000
Existing Swap Agreements          
Derivative [Line Items]          
Derivative, notional amount 250,000   250,000    
Foreign exchange contracts          
Derivative [Line Items]          
Other (expense) income $ (600) $ 1,200 $ 300 $ (300)  
v3.24.3
Derivatives and Hedging Transactions - Gross Fair Values and Location of Derivative Instruments (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Dec. 31, 2023
Other Current Assets    
Derivatives, Fair Value [Line Items]    
Other Assets $ 2,084 $ 227
Other Current Assets | Interest rate swaps    
Derivatives, Fair Value [Line Items]    
Other Assets 2,084 0
Other Current Assets | Foreign exchange contracts    
Derivatives, Fair Value [Line Items]    
Other Assets 0 227
Other Non-Current Assets    
Derivatives, Fair Value [Line Items]    
Other Assets 9,435 21,398
Other Non-Current Assets | Interest rate swaps    
Derivatives, Fair Value [Line Items]    
Other Assets 9,435 21,398
Other Non-Current Assets | Foreign exchange contracts    
Derivatives, Fair Value [Line Items]    
Other Assets 0 0
Accrued Expenses and Other Liabilities    
Derivatives, Fair Value [Line Items]    
Other Liabilities 394 872
Accrued Expenses and Other Liabilities | Interest rate swaps    
Derivatives, Fair Value [Line Items]    
Other Liabilities 0 0
Accrued Expenses and Other Liabilities | Foreign exchange contracts    
Derivatives, Fair Value [Line Items]    
Other Liabilities 394 872
Other Non-Current Liabilities    
Derivatives, Fair Value [Line Items]    
Other Liabilities 2,976 445
Other Non-Current Liabilities | Interest rate swaps    
Derivatives, Fair Value [Line Items]    
Other Liabilities 2,976 445
Other Non-Current Liabilities | Foreign exchange contracts    
Derivatives, Fair Value [Line Items]    
Other Liabilities $ 0 $ 0
v3.24.3
Derivatives and Hedging Transactions - Effects of Derivative Instruments by Contract Type in AOCI (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Tax expense on the gain reclassified from AOCI to earnings $ 1,100 $ 1,100    
Interest Expense        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Tax (benefit) expense on the gain (loss) recognized in AOCI (2,400) 200 $ 200 $ 400
Tax expense on the gain reclassified from AOCI to earnings     3,300 (2,800)
Cash flow hedge gain to be reclassified within 12 months 6,600 6,600    
Interest Expense | Interest rate swaps        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Gain (Loss) Recognized in AOCI, Interest rate swaps (9,542) 5,244 716 12,753
Gain (Loss) Reclassified From AOCI to Earnings, Interest rate swaps $ 4,372 $ 4,284 $ 13,127 $ 11,191
v3.24.3
Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring - USD ($)
$ in Thousands
Sep. 28, 2024
Dec. 31, 2023
Interest rate swaps    
Debt Instrument [Line Items]    
Assets: $ 11,519 $ 21,398
Liabilities: 2,976 445
Interest rate swaps | Level 1    
Debt Instrument [Line Items]    
Assets: 0 0
Liabilities: 0 0
Interest rate swaps | Level 2    
Debt Instrument [Line Items]    
Assets: 11,519 21,398
Liabilities: 2,976 445
Interest rate swaps | Level 3    
Debt Instrument [Line Items]    
Assets: 0 0
Liabilities: 0 0
Foreign exchange contracts    
Debt Instrument [Line Items]    
Assets: 0 227
Liabilities: 394 872
Foreign exchange contracts | Level 1    
Debt Instrument [Line Items]    
Assets: 0 0
Liabilities: 0 0
Foreign exchange contracts | Level 2    
Debt Instrument [Line Items]    
Assets: 0 227
Liabilities: 394 872
Foreign exchange contracts | Level 3    
Debt Instrument [Line Items]    
Assets: 0 0
Liabilities: 0 0
Supplemental Retirement Plan assets    
Debt Instrument [Line Items]    
Assets: 7,551 5,910
Liabilities: 7,551 5,910
Supplemental Retirement Plan assets | Level 1    
Debt Instrument [Line Items]    
Assets: 7,551 5,910
Liabilities: 7,551 5,910
Supplemental Retirement Plan assets | Level 2    
Debt Instrument [Line Items]    
Assets: 0 0
Liabilities: 0 0
Supplemental Retirement Plan assets | Level 3    
Debt Instrument [Line Items]    
Assets: 0 0
Liabilities: $ 0 $ 0
v3.24.3
Fair Value Measurements - Financial Assets and Liabilities Not Carried at Fair Value (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Short-term investments $ 0 $ 25,000
Carrying Value | Level 2    
Debt Instrument [Line Items]    
Short-term investments 0 25,000
Long-term debt and related current maturities 970,000 1,098,438
Fair Value | Level 2    
Debt Instrument [Line Items]    
Short-term investments 0 25,000
Long-term debt and related current maturities $ 973,036 $ 1,098,422
v3.24.3
Segments and Related Information - Additional Information (Details)
9 Months Ended
Sep. 28, 2024
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
v3.24.3
Segments and Related Information - Financial Information by Reportable Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Revenue, Major Customer [Line Items]        
External net sales $ 227,569 $ 220,304 $ 724,531 $ 713,983
Segment income 33,416 28,909 132,300 119,731
Operating Segments        
Revenue, Major Customer [Line Items]        
External net sales 227,569 220,304 724,531 713,983
Segment income 54,044 46,521 183,446 169,993
Capital expenditures 6,819 6,644 17,507 22,192
Depreciation and amortization 6,352 6,011 18,284 17,672
Intersegment sales        
Revenue, Major Customer [Line Items]        
External net sales 4,159 1,813 17,234 9,640
North America | Operating Segments        
Revenue, Major Customer [Line Items]        
External net sales 194,968 185,070 609,510 585,126
Segment income 51,569 40,108 166,646 144,346
Capital expenditures 6,240 6,524 15,701 21,110
Depreciation and amortization 6,081 5,765 17,493 16,978
North America | Intersegment sales        
Revenue, Major Customer [Line Items]        
External net sales 4,093 1,734 17,108 9,453
Europe & Rest of World | Operating Segments        
Revenue, Major Customer [Line Items]        
External net sales 32,601 35,234 115,021 128,857
Segment income 2,475 6,413 16,800 25,647
Capital expenditures 579 120 1,806 1,082
Depreciation and amortization 271 246 791 694
Europe & Rest of World | Intersegment sales        
Revenue, Major Customer [Line Items]        
External net sales $ 66 $ 79 $ 126 $ 187
v3.24.3
Segments and Related Information - Reconciliation of Segment Income to Income from Operations Before Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Revenue, Major Customer [Line Items]        
Operating income $ 33,416 $ 28,909 $ 132,300 $ 119,731
Acquisition and restructuring related expense 1,145 3,348 2,488 6,220
Amortization of intangible assets 7,576 7,523 21,425 22,777
Interest expense, net 13,209 17,448 48,600 55,939
Loss on debt extinguishment 0 0 4,926 0
Other (income) expense, net (705) 1,932 (1,989) 1,798
Total other expense 12,504 19,380 51,537 57,737
Income from operations before income taxes 20,912 9,529 80,763 61,994
Total segment income        
Revenue, Major Customer [Line Items]        
Operating income 54,044 46,521 183,446 169,993
Corporate expense, net        
Revenue, Major Customer [Line Items]        
Operating income $ 11,907 $ 6,741 $ 27,233 $ 21,265
v3.24.3
Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Jun. 29, 2024
Mar. 30, 2024
Sep. 30, 2023
Jul. 01, 2023
Apr. 01, 2023
Sep. 28, 2024
Sep. 30, 2023
Earnings Per Share [Abstract]                
Net income attributable to common stockholders $ 16,501 $ 37,581 $ 9,840 $ 11,788 $ 29,453 $ 8,410 $ 63,922 $ 49,651
Weighted Average Number of Shares Outstanding, Basic                
Weighted average number of common shares outstanding, basic (in shares) 215,231,886     213,416,502     214,836,643 212,933,763
Effect of dilutive securities (in shares) 6,204,320     7,446,726     6,414,712 7,700,469
Weighted average number of common shares outstanding, diluted (in shares) 221,436,206     220,863,228     221,251,355 220,634,232
Earnings Per Share, Basic and Diluted                
Earnings per share attributable to common stockholders, basic (in usd per share) $ 0.08     $ 0.06     $ 0.30 $ 0.23
Earnings per share attributable to common stockholders, diluted (in usd per share) $ 0.07     $ 0.05     $ 0.29 $ 0.23
Excluded from the weighted average number of common shares outstanding, dilutive due to being anti-dilutive (in shares) 2,500,000     2,900,000     2,500,000 2,800,000
v3.24.3
Commitments and Contingencies (Details) - classAction
Oct. 02, 2024
Dec. 19, 2023
Subsequent Event    
Loss Contingencies [Line Items]    
Number of period to file an amended complaint 30 days  
Southfield and Erie    
Loss Contingencies [Line Items]    
Number of security class actions   2
v3.24.3
Leases - Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Right-of-use assets obtained in exchange for lease obligations:    
Operating leases $ 5,507 $ 885
Finance leases $ 843 $ 0
v3.24.3
Leases - Supplemental Balance Sheet Information (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Dec. 31, 2023
Operating leases    
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other non-current assets Other non-current assets
Other non-current assets $ 57,876 $ 58,638
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Accrued expenses and other liabilities Accrued expenses and other liabilities
Accrued expenses and other liabilities $ 9,062 $ 7,828
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other non-current liabilities Other non-current liabilities
Other non-current liabilities $ 56,504 $ 58,642
Total operating lease liabilities 65,566 66,470
Finance leases    
Property, plant and equipment 9,712 10,858
Accumulated depreciation $ (2,891) $ (2,415)
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Property, plant, and equipment, net of accumulated depreciation of $108,726 and $95,917, respectively Property, plant, and equipment, net of accumulated depreciation of $108,726 and $95,917, respectively
Property, plant and equipment, net $ 6,821 $ 8,443
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Current portion of long-term debt Current portion of long-term debt
Current maturities of long-term debt $ 1,878 $ 2,121
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Long-term debt, net Long-term debt, net
Long-term debt $ 922 $ 2,608
Total finance lease liabilities $ 2,800 $ 4,729
v3.24.3
Stockholders’ Equity (Details)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 28, 2024
USD ($)
vote
$ / shares
shares
Sep. 30, 2023
$ / shares
Sep. 28, 2024
USD ($)
vote
$ / shares
shares
Sep. 30, 2023
$ / shares
Dec. 31, 2023
$ / shares
shares
Equity [Abstract]          
Preferred stock authorized (in shares) | shares 100,000,000   100,000,000   100,000,000
Preferred shares par value (in usd per share) $ 0.001   $ 0.001   $ 0.001
Common stock, authorized (in shares) | shares 750,000,000   750,000,000   750,000,000
Common stock, par value (in usd per share) $ 0.001   $ 0.001   $ 0.001
Number of votes | vote 1   1    
Common stock dividends declared (in usd per share) $ 0 $ 0 $ 0 $ 0  
Common stock dividends cash paid (in usd per share) $ 0 $ 0 $ 0 $ 0  
Share repurchase program amount | $ $ 450.0   $ 450.0    
Number of shares repurchased (in shares) | shares 0        
Remaining amount authorized for repurchase | $ $ 400.0   $ 400.0    
v3.24.3
Stock-based Compensation (Details)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 28, 2024
USD ($)
incentivePlan
Sep. 30, 2023
USD ($)
Sep. 28, 2024
USD ($)
incentivePlan
$ / shares
shares
Sep. 30, 2023
USD ($)
Mar. 31, 2021
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense | $ $ 2.7 $ 2.6 $ 7.3 $ 6.7  
Number of equity incentive plans | incentivePlan 2   2    
2021 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Common shares authorized for future issuance (in shares)         13,737,500
2021 Plan | Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock options, expiration term     10 years    
2021 Plan | Time Based Restricted Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     3 years    
Granted (in shares)     781,719    
Granted (in usd per share) | $ / shares     $ 14.01    
2021 Plan | Performance Based Restricted Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     3 years    
Granted (in shares)     304,518    
Granted (in usd per share) | $ / shares     $ 14.17    
v3.24.3
Acquisitions and Restructuring - Acquisition and Restructuring Related Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Acquisition, Restructuring and Related Activities [Abstract]        
Business restructuring costs $ 444 $ 3,348 $ 1,232 $ 5,426
Acquisition transaction and integration costs 701 0 1,256 794
Total $ 1,145 $ 3,348 $ 2,488 $ 6,220
v3.24.3
Acquisitions and Restructuring - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 26, 2024
Sep. 28, 2024
Sep. 28, 2024
Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]        
Restructuring costs     $ 1,232 $ 5,426
ChlorKing        
Restructuring Cost and Reserve [Line Items]        
Consideration transferred $ 61,600      
Transaction costs   $ 700 1,300  
Employee Severance        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges   0 $ 700  
Restructuring costs   $ 400    
v3.24.3
Acquisitions and Restructuring - Facility Closure and Other One-Time Termination Benefits (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Restructuring Reserve [Roll Forward]    
Beginning balance $ 2,359 $ 2,422
Costs Recognized 1,232 5,426
Cash Payments (2,739) (4,201)
Non-cash charges 67  
Ending balance 919 3,647
One-time termination benefits    
Restructuring Reserve [Roll Forward]    
Beginning balance 2,353 2,422
Costs Recognized 488 4,894
Cash Payments (2,101) (3,731)
Non-cash charges 0  
Ending balance 740 3,585
Facility-related    
Restructuring Reserve [Roll Forward]    
Beginning balance 0  
Costs Recognized 182  
Cash Payments (182)  
Non-cash charges 0  
Ending balance 0  
Other    
Restructuring Reserve [Roll Forward]    
Beginning balance 6 0
Costs Recognized 562 532
Cash Payments (456) (470)
Non-cash charges 67  
Ending balance $ 179 $ 62
v3.24.3
Acquisitions and Restructuring - Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 28, 2024
Jun. 26, 2024
Dec. 31, 2023
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]      
Goodwill $ 953,175   $ 935,013
ChlorKing      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]      
Cash and cash equivalents 4,032 $ 3,898  
Measurement Period Adjustments, Cash and cash equivalents 134    
Receivables 2,971 3,701  
Measurement Period Adjustments, Receivables (730)    
Inventory 9,560 8,978  
Measurement Period Adjustments, Inventory 582    
Prepaid expenses and other current assets 1,099 269  
Measurement Period Adjustments, Prepaid expenses and other current assets 830    
Property, plant and equipment 37 37  
Measurement Period Adjustments, Property, plant and equipment 0    
Other assets 2,565 2,565  
Measurement Period Adjustments, Other assets 0    
Net Investment in Lease 7,316 1,867  
Measurement Period Adjustments, Net Investment in Lease 5,449    
Intangible assets 28,475 31,550  
Measurement Period Adjustments, Intangible assets (3,075)    
Accounts payable and accrued liabilities (7,348) (4,302)  
Measurement Period Adjustments, Accounts payable and accrued liabilities (3,046)    
Deferred tax liabilities (1,810) 0  
Measurement Period Adjustments, Deferred tax liabilities (1,810)    
Total identifiable net assets acquired 46,897 48,563  
Measurement Period Adjustments, Total identifiable net assets acquired (1,666)    
Goodwill 18,771 17,835  
Measurement Period Adjustments, Goodwill 936    
Preliminary purchase price 65,668 $ 66,398  
Measurement Period Adjustments, Preliminary purchase price $ (730)    
v3.24.3
Acquisitions and Restructuring - Acquired Intangible Assets (Details) - ChlorKing
$ in Thousands
Jun. 26, 2024
USD ($)
Business Acquisition [Line Items]  
Estimated Amounts $ 28,475
Tradename  
Business Acquisition [Line Items]  
Estimated Useful Lives 15 years
Estimated Amounts $ 2,600
Customer relationships  
Business Acquisition [Line Items]  
Estimated Useful Lives 15 years
Estimated Amounts $ 21,200
Developed technology  
Business Acquisition [Line Items]  
Estimated Useful Lives 10 years
Estimated Amounts $ 4,600
Noncompete agreements  
Business Acquisition [Line Items]  
Estimated Useful Lives 5 years
Estimated Amounts $ 75

Hayward (NYSE:HAYW)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Hayward.
Hayward (NYSE:HAYW)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Hayward.